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A survey of the virulence characters of Enterobacteriaceae
isolated from the urine of patients with urinary tract infections
showed that the most common character possessed by these strains was
the ability to cause haemagglutination of erythrocytes. Of 237
lower urinary tract infection isolates 99 produced mannose-resistant
haemagglutination (MRHA) of human group A erythrocytes.
These 99 strains were examined for transferable plasmids which
carried the gene for mannose-resistant haemagglutinating ability,
using drug resistance determinants as markers. Twelve of these
strains were able to co-transfer the MRHA gene with a resistance
plasmid (R-plasmid). None of the transconjugants of these strains
possessed a common plasmid and it was observed that loss of the MRHA
gene during transfer did not correspond to loss of an R-plasmid.
The MRHA gene was mobilised from an isolate, which did not
possess R-plasmids, on to an R-plasmid vector which had been
introduced into the strain. The genes responsible for MRHA
transposed freely between plasmids and insertion into a small
plasmid vector allowed an estimation of its size as 8.7 kilobases.
Further examination of the strains which possessed auto-
transferable MRHA genes revealed that these genes were also
transposable in some cases. In these strains the size of the
transposon varied between 7 and 8.4 kilobases.
Further evidence for the presence of MRHA transposons came from
the transconjugants of strains isolated from a single patient with a
(i)
series of recurrent urinary tract infections. These strains also
carried the MRHA gene on an R-plasmid which was able to persist in
the strains in the absence of selection for any of the resistance
determinants. Not all the transconjugants were MRHA-positive, but
the efficiency of transfer of the gene appeared to increase with
time. Transposons carrying the MRHA gene were extracted from these
plasmids and were estimated to have a size of 9.2kb when inserted
into a small plasmid vector.
A range of common antimicrobial drugs were tested for their
effect on the haemagglutination of a Proteus vulgaris and an
Escherichia coli strain, when present at sub-inhibitory concen¬
trations. Haemagglutination could only be completely inhibited by
the protein synthesis inhibitors. The presence of an R-plasmid in
the E. coli strain prevented this inhibition, unless the minimum
inhibitory concentrations were redetermined, in which case similar
inhibition of haemagglutination was still observed.
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Over the last twenty years a great deal of time and effort has
been devoted to elucidating the requirements and mechanisms of
bacterial pathogenicity. Many factors have been considered as
virulence determinants such as toxins, colicins, serum resistance
and adhesive fimbriae. The absolute requirements that a
bacterium needs to become virulent are still not clear, as not all
bacteria which are classified as pathogenic, i.e. able to cause
disease, possess all or one of the above mentioned factors. The
toxins produce the symptoms associated with clinical disease in
gastroenteritis, but fimbriae are needed to attach the bacteria to
the intestinal mucosa without which diarrhoea, caused by the
elaboration of the toxins, does not develop. In this case, the
fimbriae could, therefore, be classed as essential virulence
factors. In the urinary tract the picture is less clear, although
fimbriae are thought to be responsible for the ascension of the
bacteria to the kidneys for the manifestation of the more serious
forms of urinary tract infection (UTI), the presence of fimbriae on
the bacteria is more common in pyelonephritis than it is in lower
urinary tract infections.
This thesis is concerned with the fimbriae of uropathogenic
bacteria, using knowledge and techniques gained from the work on
fimbriae involved in other types of infection. The introduction
covers the discovery of fimbriae, their classification and genetics
and possible methods for combatting this type of pathogenicity.
2
I IDENTIFICATION OF FIMBRIAE
Discovery of bacterial haemagglutination and fimbriae
The phenomenon of haemagglutination by Escherichia coli was
first described by Guyot in 1908. He found that 12 out of 18 of his
strains were capable of agglutinating the red blood cells from one
or more of the 13 species of animal that he tested. Each strain
produced the same degree of haemagglutination with the erythrocytes
from different individuals of the same species. Guyot also observed
that the factor responsible for the haemagglutination reaction was
not a bacterial secretory product.
The first extensive experimental work on the biological
properties of the agglutination by E. coli was performed by
Rosenthal (1943). In addition to erythrocytes, he also determined
the effect that E. coli produced with leucocytes, thrombocytes,
spermatozoa, yeast cells, mould spores and pollen. The
agglutination test was performed by mixing a drop of the test cell
suspension with a loop of bacteria on a slide and mixing thoroughly.
The formation of clumps immediately, or within five minutes, was
classified as a positive reaction. Of the 70 faecal E. coli tested,
24 gave a positive agglutination reaction to at least one of the
cell types. Twelve of these isolates agglutinated human
erythrocytes. The agglutination factor was thermo-1abi1e,
unaffected by absolute alcohol, the pH of the media and formalin
treatment of the cells, but was not present in the filtrates of
broth cultures. Rosenthal (1943) expressed the idea that if this
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agglutination of cells also occurred in vivo it could have some
bearing on pathogenicity and virulence.
Electron microscopy revealed the existence of filamentous
appendages on the bacterial surface that were present in addition to
flagella (Houwink and van Iterson, 1950). These were
morphologically distinct from flagella, appearing as shorter, thin,
fragile structures with a smaller diameter than the flagella. They
were formed on bacteria which were in contact with a solid surface,
but not on free-swimming organisms, unless they were at the surface
of a liquid medium (Houwink and van Iterson, 1950). E. coli
possessing these filaments, designated fimbriae, could be
distinguished from non-fimbriated organisms by their ability to
agglutinate erythrocytes (Duguid et al., 1955), which supported the
theory that they were involved in attachement (Houwink and van
Iterson, 1950), and revealed the mechanism by which
haemagglutination occurred. The agglutination reaction, caused by
direct union of the bacteria with the erythrocytes, was not enzymic
as it occurred at pH 3 to 12, and after treatment of the bacteria
with formaldehyde, ethanol and phenol (Duguid et al., 1955).
Separation of the filaments from the flagella could be achieved
by grinding, differential centrifugation and low pH - at which the
filaments, unlike flagella, did not disintegrate (Weibull and
Hedvall, 1953). In addition, the fimbriae were not destroyed by
pepsin, trypsin, ribonuclease or deoxyribonuclease.
Electrophoretic mobility measurements on fimbriated and non-
fimbriated variants of an E. coli B (Brinton et al., 1954) gave a
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bimodal distribution, the fimbriated variants had a greater
viscosity, with the fimbriae bearing a weaker negative charge than
the normal bacterial surface, therefore assisting the approach to
negatively charged substrates.
Early work on the prevalence and classification of fimbriae among
bacterial species
The first work on haemagglutination was performed with E. coli.
Many, but not all, of the strains tested possessed this ability
(Duguid et al., 1955). These workers snowed by electron microscopy
that 31 of 47 E. coli isolated from various sites of the body
possessed fimbriae. The ability of the strains to cause haemag¬
glutination was tested with erythrocytes from 18 species of animal
including guinea pigs and man. The test was performed with a 24h
peptone water culture of the test organism and a saline washed
suspension of erythrocytes. The reaction was allowed to occur in
the depression of a white tile which had been chilled to between 3
and 5°C on ice. On the basis of the results obtained, the strains
were divided into four groups (Duguid et al., 1955). Group I
contained 26 strains which had a similar pattern of activity as they
strongly agglutinated most of the erythrocyte types, however, human,
goat and sheep erythrocytes were only agglutinated weakly and no
agglutination was found with ox cells. Group II showed a peculiar
agglutination spectrum as the five haemolytic strains in this group
agglutinated ox erythrocytes and gave strong reactions with sheep,
goat and human cells. Group III contained three strains which
expressed weak haemagglutination of unusual kinds, which was not
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compatible with the other groups. Thirteen strains were classified
as Group IV and these showed no activity for erythrocytes under any
conditions. Possession of fimbriae correlated with the common
patterns of haemagglutination. The 31 strains belonging to Groups I
and II were all shown to possess fimbriae under the electron
microscope. No fimbriae were seen on the strains in Group III,
although they possessed haemagglutination activity, or on the non-
haemagglutinating bacteria of Group IV (Duguid et al., 1955).
It seemed improbable that E. coli would be the only species in
the Enterobacteriaceae to possess fimbriae, so over the next few
years, there were investigations of other genera. Ten Enterobacter
cloacae strains, out of 13 tested, were found to produce some degree
of haemagglutination (Constable, 1956), and fimbriae were observed
by electron microscopy, on all of these 10 strains. Fimbriae were
absent from the three strains which were haemagglutination negative.
Guinea pig and fowl erythrocytes were agglutinated by most of the
strains, whereas only three showed haemagglutination of human, ox or
sheep erythrocytes (Constable, 1956).
Constable (1956) observed that not all the bacteria in a single
culture possessed fimbriae, possibly this was due to loss during
centrifugation and washing, but the bacteria that were fimbriated
always appeared to have a uniform number of filaments per cell.
This correlates with the observation of Duguid et al. (1955) that
some of his strains readily underwent genetic variation between
haemagglutinating and non-haemagglutinating forms. Constable (1956)
also observed that there was a quantitative relationship between the
degree of agglutination and the percentage of fimbriate organisms in
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that culture, except for one strain which produced strong
agglutination but fimbriae were only present on 1% of individual
bacteria in the culture.
In a survey of 247 Shigella strains (Duguid and Gillies, 1957)
fimbriae and haemagglutinating activity was observed in 103 of a
total of 180 Shigella flexneri of various serotypes. This
occurrence of fimbriae and haemagglutination varied depending on the
culture conditions but these two properties were always present or
absent together. Neither property was found in Sh. sonnei,
Sh. dysenteriae or Sh. boydii. All the fimbriae of Sh. flexneri
strains appeared to be alike in their pattern of haemagglutination,
and closely resembled the fimbriae of Group I E. coli (Duguid
et al., 1955). The fimbriated Sh. flexneri also showed a readily
reversible mutation between the fimbriated and non-fimbriated form,
depending on the culture conditions (Duguid and Gillies, 1957).
It had been reported that mannose could strongly inhibit the
agglutination of fowl cells produced by a diffusible E. coli
haemagglutinin (Collier and de Miranda, 1955). Similarly, mannose
was found to inhibit the haemagglutination of all the Sh. flexneri
strains if added to the reaction mixture. The same effect was also
produced by °l-methyl-mannoside and yeast mannan (Duguid and Gillies,
1957), but no inhibition was seen with other sugars. It appeared,
therefore, that mannose was present in the receptors on the
erythrocytes, however, mannose had no inhibitory effect on the
haemagglutination of non-fimbriated strains.
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Strains possessing fimbriae and haemagglutination ability were
demonstrated in Salmonella, Proteus, Klebsiella and Chromobacterium
species (Duguid and Gillies, 1958). Most of the fimbriate organisms
were also capable of haemagglutination and underwent the reversible
variation of fimbriate to non-fimbriate. Further work on Klebsiel la
spp. (Duguid, 1959) showed that the fimbriae could be clearly
distinguished from the capsule and occurred in acapsular mutants.
Two types of haemagglutination were also distinguished, mannose-
sensitive (MSHA), as previously described, and mannose-resistant
(MRHA). The two types of reaction were caused by morphologically
distinct fimbriae and further characterised by different haemag¬
glutination patterns (Duguid, 1959).
A large number of Salmone11ae were also examined (Duguid
et al., 1966) of which 1184 were found to be fimbriate and 269
permanently non-fimbriate. Again, reversible variation of the
fimbriated organisms was observed. Most of the fimbriated organisms
expressed mannose-sensitive haemagglutination which were designated
as Type 1 fimbriae (Duguid et al., 1966). The remaining fimbriated
organisms which showed no haemagglutination were designated as
possessing Type 2 fimbriae. Non-fimbriated S. sendai strains
possessed mannose-resistant haemagglutinating activity, the bacteria
were eluted from the erythrocytes when the reaction was warmed to
50°C (Duguid et al., 1966), in a similar manner to the reversible
elution observed with Type 1 fimbriae (Duguid et al., 1955).
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By this time it was possible for the different patterns of
haemagglutination reaction to be classified as being caused by six
types of adhesive fimbriae (Duguid et al., 1966).
Type 1 Relatively thick fimbriae. MSHA. Comprised of protein
subunits. Present on most fimbriated E. co1i, Ent.
cloacae, Sh. f1exneri, K. aerogenes and Serratia
marcescens.
Type 2 Non-haemagglutinating. Present on Salmonella gallinarum,
S. pullorum, S. paratyphi and S. dublin. Same dimensions
as Type 1.
Type 3 Thin type. MR adhesin. Almost all strains of
K. aerogenes and S. marcescens. Most also possess Type 1.
Only agglutinate erythrocytes if they have been pretreated
with tannic acid.
Type 4 Fimbriae of Proteus. Very thin. MRHA. Active on fresh
untanned cells. They have a different spectrum of
activity - strongly agglutinate sheep and fowl
erythrocytes and moderate agglutination with most other
types.
Type 5 Monopolar fimbriae of Pseudomonas echinoides (Heumann and
Marx, 1964). MS. Bind to sheep erythrocytes, but no
agglutination due to monopolar nature.
Type 6 Very long, thick and very few per cell. Either non-
haemagglutinating or very weak MS. Present on Klebsiella
ozanae.
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Possible role of fimbriae in pathogenicity
In the late 1950s, it was not known what the exact role of the
fimbriae was. It was possible that the increased surface area the
fimbriae provided could function in the acquisition of nutrients
(Hinterberger, 1901). However, the occurrence of haemagglutination
ability in many pathogenic bacteria of different species suggested
that they may function in vivo as a means of attaching bacteria to
the host cells to allow action of toxins (Duguid and Gillies, 1957).
Apart from the production of exotoxins, little was known of the
mechanism by which pathogenic bacteria initiated their attack on the
respiratory and alimentary mucosa.
The lack of fimbriae on the surface of Sh. sonnei, Sh.
dysenteriae and Sh. boydii, however, indicated that this property
was not an essential pre-requisite in the pathogenesis of dysentery
(Duguid and Gillies, 1957). In addition, 269 of the 1453
Salmonel la strains tested by Duguid et al. (1966) were non-
fimbriated, inferring that fimbriae were also non-essential to the
pathogenicity of Salmonella spp. Against this conclusion is the
fact that a large proportion of the strains tested did produce
fimbriae, so they must confer some advantage on the host bacteria to
weigh against the extra burden on the cell of producing the
fimbriae.
The exact nature of the role and importance of the fimbriae
still remained to be elucidated, particularly in those infections
caused by E. coli.
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II PLASMID-ENCODED FIMBRIAE OF ENTERIC E. COLI
Isolation and analysis of the K88 antigen from diseased pigs
The discovery in 1961 of a new antigen (^Irskov et al., 1961)
possessed by E. coli strains isolated from pigs with enteritis or
oedema, heralded the beginning of a greater knowledge of the
association between fimbriae and pathogenicity. The strains G7 and
E68 were first described by Sojka et al. (1960). 0rskov et al.
(1961) found that these strains could possess both the B type and L
type of K antigen at the same time. The B type antigen was
designated K85 and the L type antigen K88. The K88 antigen was
common to strains G7 and E68, but was not demonstrable if the
cultures were grown at 18°C. Heating the strains at 100°C for one
hour also abolished agglutination (^)rskov et al., 1961).
Additional strains isolated from diseased piglets in different
countries were also shown to possess the K88 antigen (<j)rskov et al.,
1964) suggesting that it might have some bearing on pathogenicity.
An investigation of these strains by their sera absorption patterns
indicated that the antigen was composed of several antigenic factors
which could be present in different combinations, as all strains
possessed K88, but they were not identical (0rskov et al., 1964).
Strains G7 and E68 were given the designation K88a,b and three other
strains the designation K88a,c. No variation from K88a,b to K88a,c
was found during the examination of individual colonies of strain G7
(0rskov et al., 1964). G7 had been shown to act as a genetic donor
strain for the K88 antigen (0rskov et al., 1961), however, transfer
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of K88a,c from the other strains could not be demonstrated (ijjrskov
et al., 1964).
Further work on the transmission of the K88 antigenic
determinant showed that transconjugants of the parent G7 strain also
acquired the chromosomal met marker (0rskov and ^Irskov, 1966). In
some cases the ability to transfer chromosomal markers was retained
by the transconjugants when the K88 antigen had been lost. The K88
factor could not be transferred from culture filtrates and treatment
of a culture of strain G7 with acriflavine cured the bacteria of the
K88 antigen. It was therefore concluded that the antigenic
determinant was carried on an episome (0rskov and 0rskov, 1966).
Extraction of the K88 antigen from a transconjugant, strain
D520 was accomplished (Stirm et al., 1967b). The K88 antigen could
be released into the medium by the agar gel precipitation technique
and the amount of liberated material could be increased with gentle
heating to 60°C or blending. The antigen could be obtained in a
pure form due to its insolubility at pH 3.5 to 5.5. Chemical
analysis of the antigen extract showed it to be a pure protein
containing all the common amino acids except cysteine-cystine. The
purified antigen was capable of precipitating K88 antibodies from
D520 antiserum and was immunogenic in rabbits (Stirm et al., 1967b).
Purification and biochemical analysis of the K88 variants
K88ab,ac and ad, subsequently discovered by Guinee and Jansen
(1979), showed small differences in molecular weight from 23,500 to
26,000 which could be caused by amino acid substitutions (Mooi and
de Graaf, 1979). These small differences in amino acids would also
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explain the antigenic heterogeneity. All the variants possessed the
a determinant. Therefore, it is probably this factor which is
essential to the fimbriae and could be involved in receptor
recognition.
Examination of K88-positive strains and purified K88 antigen
under the electron microscope showed the antigen as fine filaments,
more flexible than fimbriae (Stirm et al., 1967a). Both K88
positive strains and the purified antigen expressed MRHA of guinea
pig erythrocytes if grown at 37oc, no HA was observed with K88-
negative strains (Jones and Rutter, 1974). Elution occurred when
the temperature was increased. These results again illustrated the
correlation between the presence of fimbriae and haemagglutination
ability, although K88 had a different structure from all the E. coli
fimbriae previously described (Stirm et al., 1967a).
Involvement of K88-positive strains in neonatal diarrhoea in piglets
Infections caused by E. coli in piglets and weaned pigs are
characterised by the proliferation of strains of certain serotypes
in the small intestine, but not in the stomach (Smith and Jones,
1963). This colonisation of the small intestine by large numbers of
bacteria and production of enterotoxins gives rise to the clinical
disease (Smith and Halls, 1967). Work by Smith and Halls (1968) on
the enumeration of a porcine enteropathogenic E. coli strain in wall
scrapings and contents of the small intestine of pigs revealed
larger numbers of the organism in the wall scrapings, probably due
to adherence of organisms to the epithelial cells. Fluorescent
staining techniques of three K88-positive enteropathogenic strains
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showed them attached to the villi of the small intestine with very
few adhering to the colonic mucosa (Arbuckle, 1970). Non-
enteropathogenic strains were found attached to the villi only in
small numbers. The ability to attach to the epithelium could
possibly allow enteropathogenic strains to overcome gut motility and
assist their survival.
Enteropathogenic E. coli (EPEC) strains isolated from diseased
piglets frequently possess the K88 antigen (Gossling and Rhoades,
1967). The role of K88 was studied by comparing a K88-positive
strain with three K88-negative derivatives of this strain obtained
by ethidium bromide treatment, UV irradiation and a spontaneous
mutant (Jones and Rutter, 1972). The presence of K88 antigen on the
surface enabled the K88-positive strain to adhere to the intestinal
mucosa whereas the K88-negative strains remained distributed through
the lumen. The K88-positive strain was able to kill 50% of the
conventionally reared piglets challenged, compared to the 3% killed
by a K88-negative strain. But there is the possibility that the
induced mutagenesis might have caused further damage to the strains.
The K88 antigen therefore appeared to be essential for virulence of
the bacteria in these piglets (Jones and Rutter, 1972). The ability
to synthesise enterotoxin also contributes to entero-pathogenicity;
a large porportion of EPEC strains produce enterotoxin and ot-
haemolysin, properties which are carried by transmissible plasmids
(Smith and Linggood, 1971). Experiments showed that the K88 antigen
was needed for adhesion of the bacteria to the intestinal mucosa and




Adhesion of K88-negative E. coli of porcine origin
A survey of haemolytic E. coli isolates from faecal swabs of
piglets with post-weaning diarrhoea showed that only one strain
possessed the K88 antigen (Riising et al., 1975). Strains belonging
to serogroup 0149:K91 were the most frequently isolated. These
results suggested a minor role for the K88 antigen in this
particular infection.
Other K88-negative porcine EPEC which were able to colonise the
small intestine were shown by bacterial counts, fluorescence and
electron microscopy to adhere to the villous epithelium (Nagy
et al., 1976). AS K88-negative strains and acapsular mutants are
able to adhere and colonise the small intestine, other surface
factors must be present in addition to the polysaccharide K
antigens. Hohmann and Wilson (1975) noted the presence of an
unusual surface structure on a K88-negative strain which adhered to
the epithelial surface of the small intestine. This structure under
the electron microscope was seen as long strands which were wide at
the base and narrowed at the tip, and the strands were usually
branched.
Adhesion is important in pathogenicity even if it is not
mediated by fimbriae, as in a minority of infections. As indicated
above, surface appendages are still involved even if they do not
have a regular fimbrial appearance.
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Discovery of an adhesive K antigen oil strains infecting calves and
lambs
It was observed by Smith and Halls (1967) that EPEC of porcine
origin, as well as dilating ligated segments of pig intestine (a
test for enterotoxin production), also dilated segments of intestine
from calves and lambs. However, enteropathogenic strains isolated
from calves and lambs, though able to dilate calf and lamb
intestine, had no effect on pig intestine. Furthermore, human
enteropathogenic strains failed to dilate intestine from all three
species.
Three other EPEC which were able to dilate ligated segments of
intestine from piglets less than a week old, but not those of older
piglets, were classified as atypical strains (Moon and Whipp, 1970).
Tests performed with ligated intestinal segments from pigs, piglets,
calves and lambs indicated that the enterotoxin produced by the
atypical E. coli was probably identical with that produced by the
calf and lamb strains, and the two groups of strains also resembled
one another (Smith and Linggood, 1972). This enterotoxin resembled
the heat-stable toxin (ST) rather than the heat-labile form (LT),
whch are both produced by typical EPEC of porcine origin (Smith and
Gyles, 1970). The enterotoxin was plasmid-controlled as was a K
antigen possessed by the calf and lamb strains (Smith and Linggood,
1972).
The ability to produce this calf and lamb common K antigen
(Kco) was transferred from one calf and two lamb enteropathogenic
strains to E. coli K12 with the concomittant transfer of enterotoxin
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production (Smith and Linggood, 1972). An examination of 74
enterotoxigenic strains isolated from cases of calf diarrhoea,
demonstrated that 70 also possessed Kco and none of the enterotoxin-
negative strains possessed the K antigen (Guinee et al., 1976).
Infection experiments performed with Kco-positive and Kco-
negative strains, derived by acridine orange treatment of Kco-
positive transconjugants, indicated that the Kco antigen was
important in pathogenicity. Lambs infected with the Kco-positive
strains developed diarrhoea, whereas lambs challenged with Kco-
negative strains remained healthy. This was despite the fact that
the cured strains still produced enterotoxin (Smith and Linggood,
1972); it would therefore appear that these two determinants are
carried on different plasmids. Lambs challenged with atypical pig
strains also remained healthy. This indicated that Kco functioned
in the same way as K88 by facilitating adhesion to the intestinal
epithelium, and adhesion of the antigens was species specific (Smith
and Linggood, 1972).
In a separate study, when eleven calf and lamb enteropathogenic
strains were examined, the Kco antigen was demonstrated on nine of
them by slide agglutination (0rskov et al., 1975). The antigen
could only be demonstrated if cultures were grown at 37°C. Heating
the culture at 100°C for one hour, or growth at 18°C, gave a
negative result. The Kco antigen was given the designation K99
(<|)rskov et al, 1975).
Suspensions of K99-positive strains caused MRHA of sheep
erythrocytes, but on warming to 37°C the bacteria did not elute
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completely(Burrows et al., 1976). These strains also adhered to
brush border cells from calves, the adhesion being inhibited by 85%
in the presence of purified K99 antigen. Electron microscopy showed
the antigen as fine, branched, filamentous projections covering the
surface of the bacteria (Burrows et al., 1976).
Strains of enterotoxigenic E. coli (ETEC) isolated from pigs
were also found to express K99 (Moon et al., 1977). One of these
strains and other K99-positive ETEC, isolated from calves, produced
the K99 antigen in the pig ileum in vivo. The ability to adhere to
the villous epithelium led to colonisation and the production of
diarrhoea in newborn piglets. ETEC isolated from the faeces of
piglets with neonatal diarrhoea presented four different phenotypes:
1) K99 and ST-positive, 2) ST-positive, 3) K88 and LT-positive, 4)
K88 and ST-positive. Phenotypes 1 and 2 also showed multiple drug
resistance and belonged mostly to serogroup 0101 (Shimizu et al,
1984).
Extraction and purification of the K99 antigen was achieved by
salt extraction, ammonium sulphate precipitation and diethylamino-
ethyl sephadex column chromatography (Isaacson, 1977). The antigen
was composed of two subunits, a major component of 22,500 daltons
and a minor component of 29,500d. A later report by de Graaf et al.
(1980b) gave the apparent molecular weight of the K99 subunit as
18,500, but further purification procedures had been applied.
However, the difference in molecular weight was unexplained, apart
from the fact that the minor component could be another K99 antigen
which co-purified with the major component. Isaacson et al. (1981)
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showed that heat denaturation of the antigen in the presence of
mercaptoethanol gave two components, whereas denaturation inthe
absence of ^-mercaptoethanol gave only the smaller component.
The presence of two surface antigens on the K99 reference
strain E. coli B41 was confirmed when different purification
procedures gave antigens with differing chemical properties. The
K99 antigen purified by column chromatography was composed primarily
of protein with an isoelectric point (pi) of greater than 10. This
purified antigen agglutinated horse but not guinea pig erythrocytes
(Isaacson, 1977). If the antigenic component of E. coli B41 was
prepared by acid precipitation, instead of chromatography, it
retained its capacity to agglutinate guinea pig erythrocytes. This
antigen preparation contained a second antigen which was not present
in the purified extract from the column. This second antigen had a
pi value of 4.2 (Isaacson, 1978), the value that Morris et al.
(1978) had reported as the pi value of the K99 antigen.
Immunoelectrophoresis and haemagglutination studies with the
antigen extract from E. coli B41 demonstrated the presence of a
cationic and an anionic haemagglutinin (Morris et al., 1980).
Antibodies to the cationic haemagglutinin were demonstrated in all
antisera raised against K99-positive E. coli, whereas antibodies
against the anionic haemagglutinin could only be demonstrated in
antisera raised against K99-positive E. coli of serogroup 09 and
0101 (Morris et al, 1980). This second anionic haemagglutinin was
designated F41 (de Graaf and Roorda, 1982).
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Factors affecting expression of K99
The presence of various compounds in the growth media represses
the expression of K99. Glucose and other carbon sources, such as
pyruvate, arabinose and lactose, were shown to inhibit expression at
relatively low concentrations (Isaacson, 1980a). The repression
produced by glucose could be overcome by the addition of cAMP to the
media. The presence of L-alanine in the media was also capable of
/
repressing the production of K99 antigen (de Graaf et al, 1980), but
this effect could be reversed if L-threonine or L-isoleucine were
added (Isaacson, 1983). The presence of sodium acetate also
suppressed the production of K99 (Francis et al., 1983).
Work performed by Ferreiros and Criado (1983) showed that
although these compounds affect the production of K99 antigen, the
adhesive ability of the strains was not likewise affected. Glucose
decreased the production of antigen with increasing concentrations,
completely inhibiting at 1-1.5% (w/v), whereas haemagglutination
ability was only slightly lowered by 2% (w/v) glucose. An
increasing concentration of L-alanine in the media "reduced both the
expression of the K99 antigen and haemagglutination. However, this
was not seen with the reference strain E. coli B41 as antigen
expression was unaffected and the haemagglutination titre actually
increased. Antigen production was also inhibited by increasing
concentrations of tetracycline, chloramphenicol, streptomycin and
gentamicin. This inhibition was not observed with haemagglutination
ability (Ferreiros and Criado, 1983).
20
These anomalies suggested that different structures were
responsible for the two properties and that they were expressed in
different ways, with the genes controlled by different mechanisms
(Ferreiros and Criado, 1983).
Isolation of strains possessing antigens other than K88 and K99
K88-negative porcine ETEC strains which did not adhere to
isolated intestinal cells in vitro were shown to adhere to the
intestinal epithelium in vivo (Nagy et al., 1977). Growth of one of
these, strain 987, in the pig small intestine, yielded a higher
percentage of fimbriated cells than were produced in vitro.
However, if the bacteria were very highly fimbriated, adhesion
in vitro could be observed. The adhesion was a saturable process
and inhibition of adhesion could be achieved in the presence of
purified fimbriae (Isaacson et al., 1978). Other E, coli strains of
porcine origin were tested for agglutination with 987 fimbriae
antiserum, and several K88-negative ETEC gave a positive result
(Nagy et al., 1977). These results were consistent with the theory
that fimbriae still facilitate adhesion and colonisation by K88-
negative ETEC strains. This type of fimbriae was designated as 987P
(Nagy et al., 1977).
Normally ETEC strains which produce adhesive fimbriae express
only one of the several antigenic types known. However, two ETEC of
porcine and human origin were isolated which produced K88 and 987P.
Both strains also produced ST and LT (Schneider and To, 1982).
These strains varied reversibly between K88-positive, 987P-negative
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to K88-positive, 987P-positive, similar to other 987P possessing
strains which vary from 987P-negative in vitro to 987P-positive
in vivo, except that the two strains mentioned above also express
the K88 antigen (Schneider and To, 1982).
It had also been shown that the K99 reference strain, E. coli
B41, possessed two distinct surface antigens (Isaacson, 1978;
Morris et a 1., 1980). Both antigens caused MRHA of sheep
erythrocytes, but only the F41 antigen agglutinated guinea pig
erythrocytes.
The F41 antigen was present on E. coli strains belonging to
serogroup 09 and 0101 (Morris et al., 1980), but not on E. coli of
serogroups 08, 020 and 064 (Morris et al., 1982). This antigen was
isolated and purified by mechanical detachment from the cells,
ammonium sulphate precipitation and sepharose gel filtration. The
purified antigen was composed of protein subunits with a molecular
weight of 29,500 and was filamentous in structure. The purified
antigen produced stronger haemagglutination with human and guinea
pig erythrocytes than with horse or sheep erythrocytes (de Graaf and
Roorda, 1982).
A K99-negative mutant of E. coli B41, possessing only F41
fimbriae was able to attach to calf enterocytes in vitro, and this
adhesion was competitively inhibited by the presence of purified
haemagglutinin(Morris et al., 1982). Piglets infected with this
mutant developed diarrhoea within 16 hours.
Further work on E. coli B41 by Chanter (1983) led to the
extraction of two mannose-resistant eluting (MRE) haemagglutinins
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from the K99-negative mutant of strain B41. One of these adhered to
calf brush-borders and was composed of subunits with a molecular
weight of 34,000 as determined by SDS-PAGE. This haemagglutinin did
not have a regular fimbrial appearance, but consisted of fine
fibrillar structures. The second haemagglutinin had a definite
fimbrial structure and was composed of two subunits of molecular
weights 49,500 and 48,000. This antigen did not adhere to calf
brush-borders (Chanter, 1983). From these results it would appear
that the F41 antigen had two components, a fimbrial component and an
adhesin component. Allowing for a slight discrepancy in subunit
molecular weight, the 34,000 component probably corresponds to the
antigen isolated by de Graaf and Roorda (1982).
F41 fimbriae were also found on porcine ETEC which did not
produce K88, K99 or 987P (3P~ strains) (To, 1984; Moon et al.,
1980; Awad-Masalmeh et al., 1982). Electron microscopy of these
strains also showed an irregular, poorly defined, filamentous
material surrounding the bacteria (Morris et al., 1983). These
strains were virulent in neonatal piglets and calves (Morris et al.,
1983).
Adhesive antigens of human enteric E. coli
In 1970 Drucker et al. observed that EPEC adhered to the small
intestine of infants who had died of gastroenteritis. These strains
did not possess the K88 antigen, but it seemed probable that the
adhesion was due to a surface antigen which had not yet been
identified. The adhesion was not caused by Type 1 fimbriae, as it
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was not inhibited by mannose (McNeish e t a 1., 1 975). A
characteristic of these strains was their ability to proliferate in
the small intestine and then produce enterotoxin.
The ETEC strain HI0407, which was isolated from a case of human
diarrhoea, possessed a plasmid-associated, heat-labile, surface
antigen which was similar to K88 (Evans et al., 1975). This antigen
appeared to function in virulence by facilitating colonisation. A
laboratory passed derivative of this strain, H10407P, was unable to
proliferate in the small intestine and produce diarrhoea. Electron
microscopy of strains H10407 and H10407P showed that H10407
possessed fimbriae-like structures on its surface, whereas H10407P
did not (Evans et al., 1975). Strain H10407 was only able to adhere
when it expressed the antigen (Cheney and Boedeker, 1983). Rabbits
could be protected from challenge with strain H10407 with antiserum
raised against the colonisation factor antigen (CFA) (Evans et al.,
1975).
Strain H10407 possessed three plasmids of molecular sizes 87,
61 and 5.4 kilobases (kb), whereas strain H10407P had lost the 87kb
plasmid (Evans et al., 1975). Therefore, it appeared that this
plasmid coded for the colonisation factor antigen, designated CFA/I
(Evans and Evans, 1978), in contrast to the observations of Gyles
et al. (1974) who had assigned a role in enterotoxin production to
this plasmid. Evans et al. (1975) concluded that it must therefore
be the 61kb plasmid that was responsible for enterotoxin production.
However, loss of CFA/I from EPEC strains was later found to
correlate with the loss of ST and the 87kb plasmid (Murray et al.,
1983). The 61kb plasmid was found to specify production of both ST
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and LT (Yamamoto and Yokoto, 1983). The confusion over the exact
location of the genes was explained by Moseley et al. (1983), who
showed that the 87kb plasmid contained sequences homologous to the
gene for STIb and the 61kb plasmid sequences homologous for STIa.
With the use of a conjugal transfer system, the CFA/I:ST plasmid
could be transferred to many other bacterial species (Yamamoto
et al., 1984).
The anti-CFA antiserum prepared against strain H10407 was used
to examine other ETEC for the presence of CFA/I (Evans et al.,
1978). Of the 29 strains from various serogroups tested, 25
possessed CFA/I. The agglutination could be prevented by heating
the culture at 65°C for one hour or growing it at 18°C; similar
inhibitory conditions to those associated with the other antigens
previously described. The CFA-positive E. coli were also able to
adhere to rabbit intestinal villi, and the production of CFA/I
correlated to the presence of fimbriae (Evans et al., 1978).
The CFA/I-positive organisms also caused MRHA of human group A
erythrocytes, whereas only MSHA was observed with CFA-negative
isolates (Evans et al., 1977). The MRHA could be prevented if the
culture was grown at 18°C, a condition which also inhibited CFA
antisera agglutination, proving the association between the MRHA of
erythrocytes and CFA/I (Evans et al., 1977).
Extraction and purification of CFA/I from the bacterial cells
was performed by homogenisation, membrane filtration, ammonium
sulphate precipitation and diethylaminoethyl sephadex column
chromatography (Evans et al., 1979a). The purified CFA/I was
composed of a polymer of identical subnits with a molecular weight
of 23,800 and was capable of producing MRHA of human group A
erythrocytes.
The ETEC belonging to serogroups 06 and 08 did not possess
CFA/I, but a second heat-labile surface antigen designated CFA/II
(Evans and Evans, 1978). Unlike CFA/l, which causes MRHA of human,
bovine and chicken erythrocytes, CFA/II only produced MRHA with
bovine and chicken erythrocytes (Evans et al., 1979b). CFA/II also
mediated adherence of the bacteria to the mucosal surface of the
small intestine. Each CFA was possessed by distinct serogroups of
E. coli, but 98% of all human ETEC possessed one or other of these
two antigens (Evans and Evans, 1978).
CFA/II, like CFA/l, was piasmid-mediated. However, unlike
CFA/I, it appeared that the genes for both ST and LT production were
carried on the same plasmid as the colonisation antigen (Penaranda
et al., 1980). Loss of CFA/lI correlated with loss of all or part
of a 87kb plasmid. Loss of the whole plasmid always resulted in
loss of enterotoxin production (Penaranda et al., 1983). This
plasmid was found in E. coli belonging to serogroups 06, 08, 080,
085 and 0139, but was not auto-transferable.
The CFA/II antigen is composed of coli surface antigens (CS)
(Smyth, 1982). There are three of these, CS1, 2 and 3, which are
present in different combinations in E. coli of different serotypes
and biotypes (Mullany et al., 1983). ETEC of serogroup 06:H16
biotype A, produced CS1 and 3, whereas strains of the same
serogroup, but of biotype B or C, produced CS2 and 3, and strains of
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serogroup 08:H9 only produced CS3 (Levine et al., 1984b). Transfer
of the plasmids from these strains, by mobil isation, into E. coli
K12 resulted in a marked decrease in the amount of HA in the
transconjugant as CS3 was the only antigen expressed (Smith et al.,
1983; Mullany et al., 1983). However, HA was restored when the
plasmids were transferred back to an 06:H16 strain. Electron
microscopy showed that CS1 and 2 were fimbrial, and morphologically
indistinguishable from Type 1 (Smyth, 1984), whereas CS3 consisted
of thin, flexible, wiry, fibrillar fimbriae (Levine et al., 1984b).
A third colonisation factor antigen was isolated from EPEC
responsible for an outbreak of diarrhoea in Senegal (Darfeuille
et al., 1983). None of the strains possessed either CFA/I or
CFA/II, however, their HA pattern was similar to that of CFA/I,
although the strains were not agglutinated by anti-CFA/I antiserum.
A further distinguishing factor was that the HA was not inhibited by
N-acetylneuraminic acid which inhibits CFA/I and II. This antigen,
designated CFA/III (Darfeuille et al., 1983) was a protein composed
of subunits with a molecular weight of approximately 16,000.
Another fimbrial antigen was isolated from a bacterium
responsible for diarrhoea in a patient in Bangladesh (Thomas et al.,
1982). The strain, E. coli E8775 belonged to serogroup 025:H42 and
caused MRHA of human and bovine erythrocytes, but did not
agglutinate CFA/I or II antisera. The biological properties of this
fimbrial antigen corresponded to others previously described.
Forty-eight strains, belonging to serogroups 025, 0115, 0167, of 472
ETEC tested, possessed this antigen, but its role in colonisation
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has not been confirmed (Thomas et al., 1982). There are other
distinct ETEC fimbriae which have been described by Deneke et al.
(1979, 1981) and Wevers et al. (1980), isolated from single
outbreaks of infection, so their relevance in overall E. coli
pathogenicity is not established.
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Ill FIMBRIAE OF UROPATHOGENIC E. COLI
Role of E. coli fimbriae in human urinary tract infections
E. coli is the most common cause of urinary tract infections
(UTI) and as the importance of adherence to epithelial cells has
been shown in the pathogenesis of diarrhoea, it would seem probable
that these urinary E. coli would also possess adhesive fimbriae to
attach to uroepithelial cells to resist expulsion by the flow of
urine.
There are three different types of UTI, pyelonephritis which is
the most severe and defined as the patient with a fever of at least
38.5°C, transiently decreased renal concentrating capacity and/or a
capillary sedimentation rate of 25mm/h or more, indicating renal
parenchymal involvement; cystitis or symptomatic bacteriuria, which
presents acute micturition symptoms, an absence of loin pain,
temperature not exceeding 38°C and >10^ bacterial/ml of urine; and
asymptomatic bacteriuria (ABU) which is diagnosed when there are
>105 bacteria/ml of urine in two consecutive samples (Svanborg-Eden
et al., 1976). If the same organism is capable of causing all three
types of infection then an added characteristic of the bacteria or a
deficiency in the host defence mechanism must be responsible for
this difference.
Attachment to human uroepithe 1ia1 cells from healthy
individuals by E. coli, isolated from patients with significant
bacteriuria (>10^ bacterial/ml of urine), was examined (Svanborg-
Eden et_al., 1976, 1977). After the ba/teria and epithelial cells
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had been incubated together for an hour, the number of adherent
bacteria was counted after washing and centrifugation. The E. coli
isolated from patients with pyelonephritis adhered in significantly
higher numbers to the epithelial cells than the strains responsible
for ABU. Adhesion of the cystitic strains was variable. A further
study demonstrated that the greatest adhesive ability was found with
strains isolated from pyelonephritis cases, adhesion of cystitic
strains was intermediate and very little adhesive ability was
observed with strains isolated from patients with ABU or from the
faeces of healthy children (Svanborg-Eden et al., 1978). An
exception to this was strains from serogroup 04:K12 which adhered
well to epithelial cells irrespective of the origin of the bacteria.
E. coli isolated from patients with asymptomatic reinfections
adhered better than the strains which were isolated from the
patients at the original screening (Svanborg-Eden et al., 1979),
perhaps indicating a role for fimbriae in recurrent UTI. When a
single pyelonephritis strain of E. coli was examined, it adhered to
epithelial cells from girls prone to UTIs in greater numbers than to
the epithelial cells from healthy controls (Kallenius and Winberg,
1978), so host factors may also be involved.
The adhesion described above appeared to be mediated by Type 1
fimbriae as the presence of fimbriae on the surface correlated with
the epithelial cell attachment and MSHA of guinea pig erythrocytes.
However, although D-mannose inhibited the HA, it did not affect the
epithelial cell adherence (Svanborg-Eden and Hansson, 1978). It
seemed that these two events were separate, with no correlation
between the two. This discrepancy was explained when Kallenius and
Mollby (1979) found another specific adhesin on the surface of
uropathogenic E. coli. The adhesion of this factor to uroepithelial
cells was not inhibited by D-mannose and the strain caused MRHA of
human erythrocytes. This strain, Tl, was not agglutinated by CFA/I
antiserum, indicating that the adhesin was distinct from those of
enteropathogenic E, coli. Electron microscopy showed that the
strain was heavily fimbriated (Kallenius and Mollby, 1979).
The same trend of an increase in the percentage of bacteria
causing MRHA of human erythrocytes with increasing severity of
infection was also observed (Hagberg et al., 1981), and these
authors also demonstrated the presence of Type 1 and MR fimbriae on
the same cell.
Extraction and purification of fimbriae from uropathogenic
E. coli (Korhonen et al., 1980b) and labelling them with 125i showed
specific binding to human uroepithelial cells (Korhonen et al.,
1980a). Binding was shown to be specific as it was inhibited in the
presence of excess unlabelled fimbriae, but not by an excess of an
unrelated protein. These purified fimbriae were free from other
cell wall and membrane contaminants and they retained MS and MRHA
activity (Korhonen et al., 1980a).
Characterisation of different types of fimbriae from UTI E. coli
Two upper UTI E. coli strains, C1212 and C1214, both belonging
to serogroup 06:K2:H1 were compared as they expressed different HA
activities (0rskov et al., 1980). Strain C1212 showed MRHA of human
erythrocytes and mannose-resistant attachment to uroepithelial
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cells, but it did not attach to the urinary mucus. Strain C1214
expressed MSHA of guinea pig erythrocytes and mannose-sensitive
attachment to buccal epithelial cells and urinary mucus, this showed
very little attachement to uroepithelial cells. Strain C1214
possessed Type 1 fimbriae. Strain C1212 also possessed fimbriae and
these were designated as F7 (0rskov et al., 1980). This F7 antigen
showed no antigenic relationship with other classified MR adhesins.
This antigen was subsequently found in 7 other 06:K2:H1 strains
(0rskov et al., 1982b). The subunits of the F7 antigen had a
molecular weight of 22,000 (Klemm et al., 1982). This antigen was
formed by two or three different structures, the first two of which
were designated F7^ ancj 2* A third structure was designated
pseudotype 1 as its amino acid sequence was closely related to the
N-terminal amino acid sequence of the Type 1 fimbrial subnit ((j)rskov
et al., 1982b).
The E. coli F8 antigen was first found in serotype 075:K-:H5,
but then to more commonly occur in 018:K5:H- strains (0rskov et al.,
1982b). During a survey of 267 E. coli strains from patients with
acute cystitis or pyelonephritis, three new antigens designated F10,
Fll and F12 were demonstrated by crossed immunoelectrophoresis.
These antigens were shown to be fimbrial in nature by immune
electron microscopy, and caused MRHA of human erythrocytes and
epithelial cell adherence. The F10 antigen was only found on
strains from serogroup 07:K1:H1, and antigens Fll and F12 were found
on some 04:K12:H5 strains (0rskov et al., 1982a). Most of these
strains also produced Type 1 fimbriae. The F12 antigen was later
shown to be most frequently present on 016:K1:H6 strains. The
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antigen was purified from one of these latter strains by ammonium
sulphate precipitation and gel chromatography (Klemm et al., 1983).
The molecular weight of the subunits was 18,200.
Uropathogenic E. coli fimbriae are also classified by the type
of receptors they have on human erythrocytes. The P-fimbriae
associated with pyelonephritogenic E. coli recognise the structure
o(.-D-galactopyranosyl-(1^4)->B-D-galactopyranoside which is part of
the pK and P antigenic determinants of the P blood group system
(Kallenius et al., 1980a and b). Binding of pyelonephritogenic
E. coli to cells of the p phenotype is much less. This erythrocyte
receptor is also present on uroepithelial cells (Kallenius et al.,
1981a). both the globoside (pK) and trihexosyl ceramide (P) are
recognised by the same strains and the attachment can be inhibited
by the disaccharide oL-D-Galp-(l-*4))l-D-Galp (Vaisanen et al., 1981).
This recognition occurs with 91% of pyelonephritis strains, the
other 9% recognising a different receptor structure and being
classed as X-fimbriae, although they still cause MRHA of human
erythrocytes (Kallenius et al., 1981b). Strains can possess both
types of fimbriae. A much lower percentage of P-fimbriae are found
on isolates from cystitis and ABU (19% and 14% respectively)
(Kallenius et al., 1981b).
Purified P-fimbriae are morphologically similar to Type 1 but
there is no antigenic cross-reactivity between the two. The
purified P-fimbriae give multiple bands in SDS-PAGE with molecular
weights ranging from 17,000 to 22,000 (Korhonen et al., 1982).
These multiple peptides were not antigenically identical and
33
originated from different filaments, but could be separated by-
immune precipitation (Rhen et al., 1983c). One of these strains
E. coli KS71 which possessed four different fimbrial antigens, A, B,
C and D, showed rapid phase variation between the alternate
antigenic types (Rhen et al., 1983b). The question arises as to
whether the different antigenic types could all be classed as P-
fimbriae or if only one component or peptide is responsible for the
haemagglutination.
Some pyelonephritic E. coli can agglutinate human erythrocytes
which lack the P blood group antigens, and these strains show blood
group-M-specific haemagglutination activity (Vaisanen et al.,
1982a). Three phenotypes MM, MN and NN exist in this system, the M
and N antigens being sia 1 og 1 ycoprotein glycophorin A. The
difference in specificity between M and N arises from different N-
terminal sequences. The fimbriae of the above strains caused strong
MR agglutination of the MM and MN phenotype and a very weak reaction
with the NN phenotype. The agglutination of the 'M' fimbriae was
not inhibited by neuraminidase.treatment of the erythrocytes and the
receptor was probably part of the N-terminal sequence. Some, but
not all, M-fimbriae recognise terminal N-acety1-D-glucosamine
(Vaisanen-Rhen et al., 1983).
Other strains, which express MRHA independent of the P-blood
group system, have this type of HA inhibited by pretreatment of the
erythrocytes with neuraminidase (Parkkinen et al., 1983). These 'S'
fimbriae show a strong affinity for (°C2-3 ) -1 inked sialyl
galactosides. The fimbriae could be purified from the bacteria and
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were still capable of HA, and gave a single band in SDS-PAGE with an
apparent molecular weight of 17,000 (Korhonen et_al., 1984).
Purification of an X-specific fimbria from E. coli of serogroup
075 showed it to be a protein with 35-39% hydrophobic amino acids
and a subunit molecular weight of 16,000, properties similar to
other E. coli fimbriae. There was also antigenic cross-reactivity
between different strains possessing these X-fimbriae. Electron
microscopically the fimbriae appeared as coil-like structures on the
bacterial surface, which bound to erythrocytes, and were therefore
morphologically distinct from other E. coli fimbriae (Vaisanen-Rhen,
1984).
Properties of an afimbrial adhesin from a urinary E. coli isolate
A non-fimbrial adhesin was recently extracted from a uropatho-
genic E. coli isolate (Goldhar et al., 1984). Extraction was
achieved by heating a broth culture of the organism at 65°C f°r an
hour. The isolated adhesin was capable of producing MRHA of human
erythrocytes and inhibiting the adherence of these afimbriate
bacteria to tissue culture cells. The adhesin was sensitive to
pronase but not to trypsin or periodate, and was destroyed by
heating at 100°C (Goldhar et al., 1984).
Other factors associated with urinary tract virulence
There is some controversy over the importance of the K antigens
of E. coli in urinary tract infections. Using the mouse model
Nicholson and Glynn (1975) showed that UTI could be produced in mice
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if the E. coli were inoculated into the bladder after sutures had
been inserted in the bladder wall to act as foreign bodies.
Infection of the kidneys occurred less frequently than that of the
bladder, but the kidney infection was directly proportional to the
amount and activity of the E. coli K antigen. In contrast, Verweij-
van Vught et al. (1983) compared strains of E. coli isolated from
UTIs and mutant strains without K antigen and concluded that the K
antigens were of minor importance for mouse nephropathogenicity.
How revelvant is the mouse model to human infections? Evans et al.
(1981) demonstrated K1 antigen in 29% of their urinary tract
isolates, most of the Kl-positive organisms being capable of
producing MRHA of human and monkey erythrocytes. These two factors
also correlated closely with the productionof ^-haemolysin.
The production of a haemolysin has also been connected with
virulence of E. coli in pyelonephritis (Fried and Wong, 1970).
Intravenous injection of haemolytic E. coli produced severe pyelo¬
nephritis in 37% of mice challenged, compared to lack of infection
produced by non-haemolytic E. coli (Fried et al., 1971). The
occurrence of haemolytic E. coli is much more common in UTI isolates
than in organisms isolated from the faeces and is associated with
other factors implicated in urinary tract virulence (Hacker et al.,
1983; Hughes et al., 1982, 1983). Cloning of a DNA sequence
encoding the haemolysin gene into a non-haemolytic faecal isolate of
E. coli gave the strain a slightly enhanced virulence in rat
peritonitis (Welch et al., 1981).
Certain 0 serogroups become more common among isolates with the
increasing severity of infection (Lindberg et al., 1975). Colicin V
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synthesis is also more common among UTI isolates (Minshew et al.,
1978a), but its necessity for virulence could not be shown when the
Col V plasmid was transferred to E. coli K12 (Minshew et al.,
1978b), unlike its importance in calf enteritis (Smith, 1974).
It seems likely that no one factor on its own can be classed as
determining the virulence of a bacterium, but rather that a
combination of two or more characters each contribute to virulence
(Minshew et al., 1978a; Hughes et al., 1983).
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IV GENETIC STUDIES ON E. COLI FIMBRIAE
Methods for studying the fine structure of genes
For complete elucidation of the regulation and expression of
genes, it is desirable to remove them from the original host cell,
which may possess contaminating factors, into the defined genetic
environment of a laboratory strain. If the factor of interest is
plasmid-mediated then transfer to an E. coli K12 offers some
resolution of the problem, except for control by promoters present
in the other genes of an unclassified plasmid.
The ideal solution is the cloning of the gene of interest,
either from the host chromosome or indigenous plasmid into a vector
of which all the properties are known. Positions of any promoters
will have already been defined and a detailed restriction enzyme
digest map will have been prepared. With cloning it is inevitable
that pieces of non-essential DNA will also have been inserted into
the vector, but the use of tranposon insertional mutagenesis allows
the determination of the size and position of structural and
regulatory genes within the cloned DNA.
Using the above mentioned techniques, work on the genetics of
most of the major fimbrial types has been carried out.
A brief section on plasmids, transposons and restriction
enzymes precede the sections on fimbriae, to aid understanding and
clarify some of the terms and techniques which follow.
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Plasmlds and transposons
Plasmids are extrachromosomal genetic elements that can
replicate independently of the bacterial chromosome. Plasmid
molecules are composed of covalently closed circular DNA and can
range in size from 1 to 300kb. The F factor was the first
discovered, then R-factors when it was noted that antimicrobial drug
resistance could be transferred between bacteria (Watanabe, 1963).
Plasmids have since been detected in most of the bacterial species
examined and can encode for a wide variety of functions. Some
plasmids, though, have no known function.
Larger plasmids can usually promote their own transfer between
strains, whereas smaller plasmids, with less coding capacity in
their genome are either incapable of transfer or can be mobilised by
a larger plasmid in the same cell. Plasmids can be present in
different copy numbers with respect to the host chromosome. Large
plasmids of greater than 35kb tend to have a low copy number with
only 1 to 4 copies per chromosome. Smaller plasmids usually have
much higher copy numbers, and there can be as many as 40 copies per
chromosome. These small plasmids are usually almost totally
dependent on gene products encoded by the host chromosome, because
of their own limited coding capacity. For independent replication
of a plasmid it must contain at least one origin of replication
(Saunders, 1984).
Transposons are DNA sequences that are capable of transferring
themselves from one DNA molecule to another; this transfer is termed
transposition. Transposons, unlike plasmids cannot replicate
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independently and have to be present in a functional replicon such
as a plasmid, bacteriophage or chromosome. Transposable elements
can be divided into three classes: Class I - IS like elements.
These are short and encode only determinants for their own
transposition. Some IS elements exist in composite transposons,
e.g. Tn5 possesses copies of IS50; Class II - Transposons with a
similar structure and function to Tn3. Most of these encode
functions in addition to those required for transposition; Class
III - Transposing bacteriophages. Phage Mu uses replicative
transposition as the normal mechanism for vegetative replication and
prophage insertion (Kleckner, 1981).
The transposition event is recA independent as it can occur
without the normal host recombination mechanisms. Transposition is
also a replicative process and results in a copy of the transposon
in the donor and one in the recipient molecule.
One of the best characterised transposons is Tn3. This has
homologous inverted repeat DNA sequences flanking the functional
genes, which probably act as recognition sequences for the
transposase enzyme. This enzyme is the product of the tnpA gene of
the transposon. The enzyme cuts the donor and target DNA molecules
in preparation for transposition and subsequently joins the two
molecules to form a cointegrate. In some cases a transposon also
encodes a resolvase enzyme, the product of the tnpR gene of the
transposon. This enzyme resolves the cointegrate at a specific res
site on the transposon. The resolvase enzyme can also regulate its
own synthesis as well as that of the transposase enzyme.
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Transposons that do not encode a resolvase rely on the host cell for
resolution (Saunders, 1984).
Most transposons exert strong polar effects on expression of
genes in an operon which lies distal to the site of the inserted
element. The polarity of these elements is thought to involve
transcription termination mechanisms.
Restriction enzymes and gene cloning
It was found that when bacteriophage X was grown upon cells of
E. coli strain C, and then used to infect E. coli K12 cells, its DNA
was degraded by enzymes present in the cell that recognised it as
foreign. The DNA of the recipient was not degraded as it had been
chemically modified by methylation of certain adenine and cytosine
bases. The restriction enzymes responsible for the degradation are
endonucleases which recognise specific sequences in the foreign DNA.
Restriction enzymes have been isolated from many bacterial species
and there are two classes (Type I and II). Type II are the most
important in genetic manipulations.
The target sequences of Type II restriction enzymes have a two¬
fold axis of symmetry in the nucleotide bases. Enzymic cleavage can
result in a clean (blunt) or staggered ('sticky') break. The
staggered cleavage gives fragments with single stranded ends,
usually of 2 or 4 bases, depending on the size of the recognition
sequence, which have a free 5' or 3' end. These single-stranded
ends will be complementary to each other, and to those of other
fragments cleaved by the same enzyme, and they can be joined by
hydrogen bonds. These hydrogen bonds can be converted to covalent
links by the action of ligases produced by E. coli or 'phage T4.
Hybrid molecules can be formed by mixing digested plasmid DNA and
similarly digested DNA from another source and allowing ligation in
vitro. These hybrids can then be transformed into bacterial cells
(Broda, 1979).
DNA fragments generated by cleavage with the enzyme can be
resolved by agarose gel electrophoresis to allow determination of
their size. Every plasmid has a unique combination of restriction
endonuclease target sites and, therefore, different enzymes give
different size fragments when cutting the same plasmid. By
analysing the resultant patterns it is possible to map the position
on a plasmid of the isolated fragments. These physical maps of
plasmids can be converted to genetic maps by a comparison of
plasmids produced by deletion mutations, or plasmids where insertion
of a transposon has inactivated the function of a gene (Broda,
1979).
The enzyme generated DNA fragments can be transferred in a
single-stranded form from an agarose gel to a nitrocellulose filter.
The filters are then soaked in a solution containing radio-actively
labelled single-stranded probe DNA and hybridisation allowed to
occur. DNA homologous to the probe DNA will form duplexes and the
position of the radiolabelled DNA can be determined and related to
the position of DNA fragments on the original gel.
The DNA fragments produced by restriction endonuclease
digestion can be cloned into a vector to form a hybrid molecule,
which after transformation into a bacterial host will also allow the
matching of a genetic function to a region of the original plasmid.
An ideal plasmid vector for cloning should have a low molecular
weight for more efficient transformation and a higher copy number,
single sites for a large number of restriction enzymes so that only
one fragment will be produced when the vector is digested, and a
readily selectable phenotype for the easy isolation of recombinant
clones. The most widely used artificial plasmid vector is pBR322
which contains ampicillin and tetracycline resistance determinants
and replication genes (Old and Primrose, 1980).
Hybrid DNA molecules can be introduced into bacterial
recipients by transformation or the in vitro packaging of the DNA
into 'phage followed by transduction. The double-stranded linear
DNA of 'phage X has short single-stranded 5' projections of 12
nucleotides whose sequences are complementary. These are used when
the DNA circularises when it is injected into the bacterial host,
the cohesive termini associating to form the cos site. DNA can be
efficiently packaged into 'phage particles if the cohesive ends are
33 to 46kb apart (the maximum size for the >s genome). Only a small
region surrounding the cos site is required for recognition by the
packaging system, so it was possible to construct plasmids which
contained the X cos site and normal plasmid functions (Collins and
Bruning, 1978; Collins and Hohn, 1978). These plasmids were called
cosmids and can be used as cloning vectors with the in vitro
packaging system, if the ligated recombinant DNA molecule is
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supplied with high concentrations of 'phage head precursor, 'phage
tails and packaging proteins (Old and Primrose, 1980).
Packaging the recombinant cosmids into the 'phage heads limits
the size of inserted DNA fragment, suitable sizes of which can be
produced by partial digestion, with a restriction enzyme, of the DNA
from which the insert will be derived. Following packaging in vitro
the recombinant cosmid DNA is injected into the host cell where it
circularises due to the 'phage cos site, but then replicates as a
normal plasmid.
Cloning and organisation of the Type 1 fimbrial genes
The genes encoding production of E. coli Type 1 fimbriae are
chromosomally determined, therefore to clone the gene the whole
bacterial chromosome has to be digested by restriction enzymes.
Hull et al (1981) were able to isolate suitable length chromosomal
fragments of E. coli strain J96 by partial digestion with the
restriction endonuclease Sau3A and ligate these fragments to the
ampicillin resistant vector, pHC79. The in vitro packaging of these
cosmids by 'phage X allowed transduction of the recombinant
molecules into a non-fimbriated laboratory strain. Of the
ampicillin resistant transductants obtained about 1% were shown to
be fimbriated by a positive haemagglutination test and electron
microscopy. Comparison of the restriction map of the cosmid with a
plasmid present in the original strain showed no similarities,
confirming that this gene was chromosomal ly determined (Hull et al.,
1981).
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Plasmid pSH2 was obtained by further restriction of the 40kb
DNA insert in pHC79, and the cloning of a 11.2kb fragment containing
the gene for Type 1 fimbriae into the vector pACYC184 (Orndorff and
Falkow, 1984a). Insertion and deletion mutagenesis of plasmid pSH2
with transposon Tn5 and the subcloning of parts of the pSH2 fimbrial
gene allowed the localisation of five genes within the 11.2kb
fragment responsible for construction and expression of the Type 1
fimbriae. Each gene encoded a polypeptide, and three of these,
17,000, 86,000 and 30,000d in size, were involved in assembly of the
fimbriae. Assembly of the 17,000d fimbrial subunits into fimbriae
was not seen in mutants which lacked either the 86,000 or 30,000d
polypeptides, but the subunit synthesis and processing was
unaffected. Another polypeptide of 23,000d was involved in
regulation of expression of the fimbriae, as mutants in this region
lead to a 40-fold increase in the amount of fimbrial antigen per
cell. The fifth, 14,000d polypeptide did not appear to be
genetically associated with fimbriation, but it did immuno-
precipitate with the fimbriae, suggesting some involvement. The
organisation of the five genes within the 11.2kb fragment was
determined and it appeared that a promoter for transcription of the
genes was present within the operon, as Tn5 mutagenesis at either
end of this region had no effect on synthesis of the fimbriae
(Orndorff and Falkow, 1984a).
Further work on the hyperpiliated (Hyp) mutants showed that the
increase in the amount of fimbrial antigen was manifested as an
increase in number and length of the fimbriae on the cell (Orndorff
and Falkow, 1984b). None of these mutants produced the 23,000d
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polypeptide described above, but the introduction of this gene, on a
plasmid, into the cells reduced the amount of fimbriation to almost
normal. It therefore appeared that the 23,000d polypeptide is an
inhibitor which acts in trans to regulate the level of expression of
the gene cluster (Orndorff and Falkow, 1984b).
Type 1 fimbriae are produced by many strains of enterobacteria,
and the genes endcoding the production of Klebsiella pneumoniae Type
1 fimbriae have been cloned (Purcell and Clegg, 1983). Chromosomal
DNA fragments were again prepared by restriction enzyme digest,
cloned into vector pMF7 and packaged by X . About 1% of the
transductants possessed the fimbrial gene. The fimbrial genes were
subcloned into pBR322 and pACYC184. The smallest insertion capable
of producing MSHA of guinea pig erythrocytes was ll.lkb. Tn5
insertions into this fragment showed a region of 5.5kb necessary for
the production of fimbriae.
There is a similarity in chemical composition between purified
Type 1 fimbriae of E. coli and K. pneumoniae, despite a lack of
antigenic cross reactivity (Fader et al., 1982). Possibly,
therefore, distinct DNA sequences have evolved which encode related
adhesins. The E. coli transconjugants which possessed the
recombinant plasmid did not exhibit Type 1 fimbrial phase variation.
Purcell and Clegg (1983) hypothesised that this might be due either
to an excess of fimbriae because of the high copy number of
recombinant plasmid, or because the regulatory gene which controls
phase variation had not been cloned.
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Cloning of the K88 antigen variants
The K88ab antigen was cloned with the associated raffinose
utilisation determinant (Raf) into pBR322 (Mooi et al., 1979). The
two determinants were located on a 72.5kb plasmid, pRI8801, which
was digested with restriction enzymes Hind III and Sal I and the
fragments ligated to pBR322. Six K88-positive clones out of 257
tested were obtained, each clone expressing the K88 antigen at a
different level. The smallest insert in the recombinant plasmids
was 11.2kb, but all the cloned fragments expressing the K88-positive
phenotype at a high level were in the same orientation. In the
reverse orientation, barely detectable levels of K88 antigen were
produced. None of these clones expressed the Raf phenotype. One
clone containing a 5.8kb insert in pBR322 was Raf-positive, K88-
negative. The generation of deletions within the cloned K88 DNA
fragment demonstrated that a 6.2kb region was essential for K88
expression. This region was ligated into pBR322 to give pFM205. No
difference in structure of K88 between the recombinant and parent
strains could be detected. However, an enzyme-linked immuno-
absorbent assay (ELISA) demonstrated that the recombinant strain
produced four times as much antigen as the parent. The K88 and Raf
genes were not closely linked, but separated by about 29kb (Mooi
et al„ 1979).
The presence of pFM205 in minicells was used to study the
expression of the genes of the cloned K88ab DNA fragment (Mooi
et al., 1981). The presence of seven polypeptides with apparent
sizes of 81,000, 30,000, 29,000, 27,500, 26,000 and 17,000d were
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detected. The 26,000d polypeptide reacted with specific anti-K88ab
antiserum indicating that it was the fimbrial suhunit, which was
translated as a precursor molecule.
Deletion mutants of pFM205 were generated, each containing a
deletion in one of the five K88 genes (Mooi et al., 1982) and the
gene products analysed in minicells. In strains containing a
deletion in the gene for the 17,000 or 81,000d polypeptides the
K88ab subunit was synthesised and transported to the cell surface in
reduced amounts, but no adhesion or HA was observed, suggesting
possible incomplete assembly into the mature fimbriae. Strains with
a deletion in the 27,500 polypeptide gene expressed the adhesive
phenotype, although very little K88ab antigen could be detected.
Those strains possessing a plasmid with a deletion in the gene for
the 27,000d polypeptide synthesised the K88ab subunit, but it
appeared to be rapidly degraded (Mooi et al., 1982).
The 26,000d fimbrial subunit transiently accumulated in the
periplasmic space before translocation across the outer membrane,
probably by the 81,000d polypeptide (Mooi et al., 1983). Deletions
in this gene resulted in the subunits remaining in the periplasmic
space where they were associated with the 17,000 and 27,000d poly¬
peptides. The 27,000d polypeptide might be involved in stabilising
the conformation of the subunits required for translocation. In
mutants lacking the 17,000d polypeptide most of the subunits were
present in the periplasmic space, associated with the 27,000d
polypeptide, with small amounts translocated across the outer
membrane, but these subunits were incapable of adhesion suggesting
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the 17,000d polypeptide has a role in modification before assembly
(Mooi et al., 1983).
Proximal to the gene for the 81,000 polypeptide is a region of
approximately l,000bp which codes for the additional structural
gene, gene A, which is involved in the biosynthesis of the K88ab
adhesin and produces a polypeptide (Mooi et al., 1984). A deletion
in this gene resulted in the accumulation of fimbrial subunits
inside the cell, it therefore appeared that the gene product was
required for export of the subunits. The polypeptide was not
detectable, but determination of the nucleotide sequence of gene A
allowed an estimation of the primary structure and approximate
molecular weight of 17,600 for this polypeptide (pA). pA has many
characteristics in common with fimbrial subunits, raising the
possibility that there might be two interdependent surface
structures, the K88ab adhesin, and the fimbrial subunit (Mooi
et al., 1984) as with the Pap fimbriae (Normark et al., 1983).
The determinant for the K88ac antigen was cloned into the
vector pBR313 from a K88/Raf plasmid (Shipley et al., 1981). The
size of the inserted fragment in the K88-positive phenotype was
11.9kb. This fragment was then cloned into pBR322 to give pPS002.
pPS002 was transformed into a minicell producing strain and at least
six polypeptides were detected. One of these polypeptides with a
molecular weight of 23,500 precipitated with K88ac antiserum, it was
therefore assumed that this was the fimbrial subunit, and was
present in very large amounts. The other polypeptides ranged in
size from 18,000 to 70,000d (Shipley et al., 1981).
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Deletion and Tn5 insertion mutants of pPS022 were generated.
The deletion of 5kb from the cloned fragment still resulted in a
functional K88-positive phenotype. The vector containing the 6.5kb
insert was designated pMK005 (Kehoe et al., 1981). Tn5 insertion
mutants of pMK005 were isolated and mapped. From the position of
the mutations and the resulting phenotypes, it appeared that there
were two regions of the K88 operon. One mutant was adhesive and
K88+, but MRHA-, indicating that the two properties were not
identical. In minicells, PMK005 expressed at least four
polypeptides with molecular weights 70,000, 29,000, 23,500 and
17.,000d. Four cistrons adh A, B, C and D were demonstrated. adhA,
B and C formed one operon and adh D the second operon. adh D
encodes the 23,500d fimbrial subunit, adh C the 17,000d polypeptide,
adh B the 29,000d polypeptide and adh A the 70,000d polypeptide. It
seemed possible that the gene products of adh C acted as a positive
regulator for expression of the adh D cistron, and in the absence of
the adh A product the K88 antigen was shed into the supernatant
instead of being assembled into fimbriae. It is therefore possible
that the 70,000d polypeptide forms part of the structure attaching
the fimbriae to the cells (Kehoe et al., 1981).
The presence of the recombinant plasmids in minicells also
allowed the localisation of the polypeptides within the cell (Dougan
et al., 1983). The 70,000d polypeptide was located mainly in the
outer membrane. The 26,000 and 17,000d polypeptides were located in
the periplasmic space - the 29,000d polypeptide being processed to
give the 26,000d polypeptide, and the fimbrial subunit could be
detected in the inner and outer membranes.
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Expression of the K88ac genes of pMK005 was dependent on the PI
promoter of pBR322. If this promoter was replaced by that of the
Trp operon, high levels of K88ac antigen were expressed when the
promoter was repressed and growth of the cells was inhibited when
the promoter was derepressed (Kehoe et al., 1983). It appeared that
a single transcription unit initiating at the PI promoter was
involved in expression of the genes as the polar effect produced by
the various Tn5 insertions all reduced the levels of K88ac antigen.
Mutations in the proximal end of the cloned sequence resulted in a
lack of the antigen on the surface although low levels of the
fimbrial subunit could be detected in the cells. Mutations in this
proximal region could be complemented in trans and the region was
designated adh E. Because of the trans complementation adh E must
have its own promoter, but could not stimulate K88 biosynthesis in
mutants lacking the PI promoter (Kehoe et al., 1983).
The genes encoding the K88ad variant were cloned by J.H.
Meijerink (unpublished results) and from the DNA sequence of the
cloned gene the amino acid sequence of the K88ad subunit was deduced
(Gaastra et al., 1983).
Similarities exist between the organisation of the K88 and
Type 1 operons. Both have a similar number of genes which are
required for synthesis of the fimbriae, and the genes involved in
assembly of the fimbriae are all clustered together. No equivalent
to the 23,000d regulatory polypeptide was found in the K88 operon
however (Orndorff and Falkow, 1984a).
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Cloning and organisation of the K99 antigen genes
The determinant for the production of the K99 antigen was
cloned from plasmid pRI9901 into E. coli K12. This plasmid
originated from the K99 reference strain, E. coli B41, and also
codes for streptomycin resistance, but ST and LT are not produced
(van Embden et al», 1980). Hindlll digestion of the plasmid was
used to insert fragments into pBR322 with a loss of the tetracycline
resistance determinant. Recombinant plasmids were used to transform
E. coli K12 strain C600 with selection being made for ampicillin
resistance and transformants were screened for tetracycline
sensitivity. One out of 45 transformants tested was K99-positive,
and the recombinant plasmid in this strain was designated pRI9902.
Mapping of the plasmid revealed a 16.1kb insertion into pBR322. The
K99 determinant of pRI9902 was subcloned into pBR325 and a 6.5kb
fragment of the original K99 insertion was capable of expressing K99
antigen. Expression was still obtained if this fragment was in the
reverse orientation indicating that it was independent of vector
transcription and organised in one operon (van Embden et al., 1980).
The level of K99 production in the C600 transformants was
higher than that of the K12 strains possessing pRI9901 due to
plasmid copy number, but still lower than in the original wild type
strain. This must be due to host factors, as there was no
difference in the serology, adhesion or morphology between the
strains possessing the recombinant plasmid and the original isolate,
B41 (van Embden et al., 1980).
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The 6.5kb K99 DNA fragment was cloned back into pBR322 to give
plasmid pFK99, to give clearer expression of the polypeptides
encoded by the fragment in minicells (de Graaf et al., 1984).
Eleven polypeptides were expressed by the cloned K99 DNA, but the
total molecular weight of these exceeded the coding capacity of the
DNA fragment. Therefore, some of these polypeptides must be the
precursor forms of others. By inhibiting protein processing with
ethanol the polypeptides representing the mature structures could be
determined. It appeared that the cloned K99 DNA contained at least
seven structural genes encoding polypeptides of 19,000, 21,000,
21,500, 26,500, 33,500, 76,000 and 18,200d - the fimbrial subunit
(de Graaf et al., 1984).
In order to analyse the organisation of these structural genes
deletion mutants of pFK99 were constructed by restriction-ligation,
the position of the deletions and loss of production of certain of
the polypeptides determing the arrangement. The subunit gene was at
the proximal end of the operon, similar to the pap gene, but in
contrast to the position of the K88 subunit gene. It is probable
that the 19,000 and 26,500d polypeptides have a function in K99
biosynthesis similar to the 17,000 and 27,000d polypeptides involved
in K88 production. A deletion in the 19,000d polypeptide gene
reduced the amount of antigen produced, whereas a deletion in the
26,500d polypeptide gene completely prevented the production. No
indications were obtained for the functions of the 21,00 21,500 and
33,500d polypeptides (de Graaf et al., 1984). Both the K88 and K99
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operons encode high molecular weight polypeptides which are probably
involved in anchoring or assembly of the fimbriae.
The nucleotide sequence of the gene encoding the K99 subunit
has been determined (Roosendaal et al., 1984). The gene was 181
codons long including a signal peptide of 22 codons, which is very
similar to the structure of the Pap fimbrial subunit.
Construction of vectors coding for Pap fimbriae formation
The genes for production of MR fimbriae from uropathogenic
E. co1i were first cloned by Hull et a1. (1981) from the
pyelonephritic E. coli isolate J96 (04:K6). This was the same
organism from which the Type 1 fimbriae were cloned and the same
methods were employed as described previously (Hull et al., 1981).
The MR fimbriae of this strain were antigenical 1 y cross-reactive
with those isolated from another pyelonephritic E. coli by Korhonen
et al. (1980b), those fimbriae having a subunit molecular weight of
17,000.
The recombinant strain obtained expressed MRHA of human
erythrocytes alone and was heavily fimbriated when examined
electron-microscopical ly. Restriction enzyme analysis of the
recombinant plasmid again showed that the gene had been derived from
the chromosome. These fimbriae, designated Pap or P, had the same
subunit molecular weight, functional properties and antigenicity as
those on the wild type strain (Hull et al., 1981).
Restriction enzyme Eco RI fragments from the recombinant clone
were subcloned into the vector pACYC184. A resultant hybrid plasmid
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containing a 20kb insert still expressed the MRHA phenotype (Noxrmark
et al., 1983). Further deletion and ligation of this hybrid plasmid
reduced the size of fragment required for expression of MRHA to
11.8kb. The fimbriae expressed by this fragment still possessed the
same subunit molecular weight as the parent strain fimbriae.
Further transposon insertion/deletion mutagenesis suggested that an
8.5kb region of the fragment was the minimum amount of DNA required
to produce functional fimbriae. Mutations at the proximal end of
the 8.5kb fragment gave rise to a reduced titre of HA activity
(Normark et_al., 1983).
Analysis of the polypeptides produced by the cloned fragment in
minicells showed the expression of 12 polypeptides with molecular
weights ranging from 81,000 to 12,000 with six other minor poly¬
peptides, molecular weight range 82,000 to 17,500. The Pap fimbriae
subunit was identified as the 19,500 polypeptide by immunopre-
cipitation with fimbriae antiserum. Five of the minor polypeptides
were shown to be precursor forms of the major polypeptides by
inhibition of protein processing (Normark et al., 1983).
Subcloning from the fragment suggested that the gene encoding
the Pap fimbrial subunit (papA) was at the proximal end to the right
of the region where mutations gave rise to reduced HA activity.
Mutations in the papA gene resulted in an absence of Pap antigen on
the cell surface, though one mutant did express weak MRHA, therefore
the possibility arose that the fimbrial subunit and adhesin are
separate molecules (Normark et al., 1983).
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The organisation of the genes within the Pap DNA fragment was
determined by Norgren et al. (1984) employing subcloning, Tn5
insertional mutagenesis and cut back derivatives and examining the
protein products by SDS-PAGE. Five genes designated papA to papG
were identified as being important in Pap fimbriae formation. The
region proximal to the structural genes contains promoters for
transcription and translation. Tn5 insertions in papB markedly
decreased the amount of antigen expressed, suggesting a possible
role in regulation. Insertions in papA abolished expression and
formation of fimbriae. No detectable surface antigen was found on
strains with mutations in papC and papD, but a small amount of
antigen was detected in cell extracts, these genes may therefore
have a role in localisation of the fimbriae on the surface.
Mutations in papA, B, C and D also repressed MRHA activity.
Mutations in papE, F and G repressed MRHA activity, but the amount
of Pap antigen was unaffected, and fimbriae could be observed on the
cells. This region is obviously not required for fimbriae
formation, but for the production of MRHA (Norgren et al., 1984;
Lindberg et al., 1984).
Construction of a frameshift mutation in papA inhibited
agglutination of antiserum and no papA gene product was produced
(Lindberg et al., 1984). This frameshift mutation had little
polarity effects on the distal pap genes, and the mutant was still
capable of agglutinating Pi erythrocytes. Tn5 insertions in the
distal region of the Pap fragment inhibited HA, but had no effect on
fimbriae formation. The region encoding papE, F and G was subcloned
into pBR322 and, if it was provided with a promoter, could
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complement mutations with Tn5 insertions in this region. Polarity
effects of the Tn5 insertions in papE, F and G showed that
transcription of all three genes was from left to right. Both the
papF and papG genes are essential for HA activity, however,
mutations in papE did not affect the HA titre. A strain with
mutations in papA and papE failed to agglutinate PI erythrocytes.
Fimbriae prepared from strains with mutations in papE, F or G had
the same apparent molecular weight, as determined by SDS-PAGE, as
pili from the wild type strain (Lindberg et al., 1984).
Determination of the nucleotide sequence of the papA gene gave
a sequence of 701 base pairs (B3ga et al., 1984). Translation of
this sequence gave a 185 amino acid containing protein, the
predicted sequence giving a mature protein with a molecular weight
of 16,500 daltons.
Hybridisation using pap operon DNA as a probe, revealed that
homologous DNA sequences were present in a large number of
uropathogenic E. coli, whereas homology was not normally found with
the DNA of faecal E. coli (BSga et al., 1984). Further work
indicated though that the papA gene could have evolved within the
species as most E. coli express Type 1 fimbriae which have an N-
terminal amino acid sequence very similar to the Pap fimbriae.
Examination of other E, coli UTI isolates showed that gene sequences
homologous to the entire pap operon existed at multiple sites in the
chromosome, but the DNA sequences adjacent to the operon were
variable (Hull et al., 1985).
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Hybridisation of the pap operon with DNA from eight genera of
extraintestinal enterobacterial isolates including E. coli showed
that homologous sequences were present among E. coli from all the
sites of infection tested (Hull et al., 1984). All the isolates
were tested for MRHA of human erythrocytes, but only the E. coli and
two Morganella species gave positive results. However, the DNA from
both the Morganel la showed no homology with the probe DNA. Not all
MRHA-positive E. coli were also hybridisation-positive and vice
versa, this might be due to the existence of an incomplete operon.
From these results it was concluded that Pap fimbriae were
restricted to E. coli (Hull et al., 1984).
The A, B and C components of the P-fimbriae of E. coli KS71
(04:K12) have also been cloned (Rhen et al., 1983a). The cloning
was performed using restriction enzyme Sau3A and the pHC79 cosmid
vector, as described previously (Hull et al., 1981). Recombinant
strains were tested for the presence of fimbriae with anti-KS71ABC
antiserum. Purification of the fimbriae from positive strains and
visualisation by SDS-PAGE analysis showed that each recombinant
strain produced only one of the KS71 fimbrial antigens (Rhen et al.,
1983a). The purified fimbriae from these three different classes of
recombinants were morphologically identical when observed by
electron microscopy. Agglutination of PI erythrocytes only occurred
when recombinants expressed A or B fimbriae, no agglutination of PI
or p erythrocytes was observed with C fimbriae. A and B fimbriae
were also antigenically cross-reactive. It seems likely that the
genes for the production of the three types of fimbriae are located
on different parts of the chromosome (Rhen et al., 1983a). It is
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possible that the fimbrial components of E. coli KS71 might be
analogous to the F7 antigenic components of E. coli, because of
similarities in their molecular weight and N-terminal amino acid
sequence (Rhen et al., 1983a).
Molecular studies on the F7 fimbrial antigen
The F7 fimbrial antigen gene from E. coli AD110 or C1212
(06:K2) (^rskov et al., 1980) , an isolate from a patient with upper
UT1 was cloned into the vector pJB8 and transduced by 'phage X into
the E. coli K12 strain JA221 (van Die et_al., 1983). Of the
recombinant strains obtained, two out of 800 examined expressed MRHA
of human erythrocytes. Homology between the recombinant plasmids
present in these two strains was shown by DNA-DNA hybridisation.
The plasmids had a common 16kb insert, which was subcloned into
pACYC184 to give plasmid pPIL110-35. The resultant recombinant
strain was capable of producing stronger MRHA than the wild type
parent, and the strains were heavily fimbriated when examined with
the electron microscope (van Die et al., 1983).
The purified fimbriae of AD110 consist of three subunits of
different molecular weights. Analysis of the fimbriae of the
recombinant strain by SDS-PAGE revealed that only the 17,000d
subunit was present, later shown to be F72* Preliminary evidence
showed that at least five genes within a 9kb region of the cloned
fragment were involved in assembly of the fimbriae (van Die et al.,
1983).
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Transposon Tn5 and (a Tn3-like element originating from the
E. coli F factor) insertion mutants of pPIL110-35 produced either
MRHA-positive or negative phenotypes. The site of the insertions
was mapped and it was shown that all MRHA-negative strains possessed
insertions within an 11.5kb restriction fragment (van Die et_al.,
1984) and the mutations were located in four domains. Due to the
polar effects of Tn5, it appeared that four transcriptional units
were involved in the expression of the MRHA phenotype. The 11.5kb
fragment was subcloned into pBR322 and the resultant recombinant
plasmid was capable of expressing surface fimbriae. Complementation
studies between subclones of the pBR322 recombinant and insertion
mutants distinguished five complementation groups, implying that
five genes, A to E, are involved in the formation and expression of
fimbriae. A mutation in any of these genes lead to loss of fimbriae
on the surface (van Die et al., 1984).
The products of the genes were analysed in minicells, revealing
four proteins of molecular weights 75,000, 36,000, 23,000 and
17,000. Gene B synthesised the 75,000, gene C the 23,000, and gene
E the 36,000 polypeptides. No product of gene D was found, which
could be due either to low level of production or that the gene has
a regulatory function. The 17,000 protein is probably the product
of gene A, but this could not be confirmed because of the presence
of another 17,000d polypeptide. Immunoprecipitation revealed that
the 17,000d protein is the fimbrial subunit with an 18,000d
precursor. Mutations in the region encoding the second 17,000d
polypeptide had no effect on MRHA ability (van Die et al., 1984).
60
Genetic analysis of the fimbrial genes of other E. coli 06 isolates
Clegg (1982) also cloned the chromosomal determinant for MR
fimbriae from an E. coli 06, H~ isolate (strain IA2), from an acute
urinary tract infection. The bacterial chromosome was partially
digested with EcoRI restriction endonuclease and the fragments
cloned into the ampicillin resistant cosmid vector pMF7. One out of
148 ampicillin resistant transductants tested expressed MRHA
ability. The large, inserted fragment of the recombinant plasmid
was again subcloned into pACYC184. Additional subcloning of a 6.9kb
fragment into pBR322 to give plasmid pDC5 resulted in a MRHA-
positive phenotype, which was expressed at 37°C but not 18°C.
Recombinant plasmids possessing smaller fragments were MRHA-
negative. Despite the presence of the gene on a high copy number
vector there was no appreciable increase in the HA titre between the
recombinant strain and the wild type parent (Clegg, 1982). This
implies that the fragment encoding the fimbrial genes must also code
for a regulatory gene which controls the amount of fimbriae
produced.
Tn5 insertion mutations in the cloned fragment of pDC5 resulted
in the identification of a 4.5kb region essential for HA ability
(Clegg and Pierce, 1983). Different HA-negative mutants could
complement one another to restore the HA activity, and four
complementation groups were distinguished. Insertions of the
transposable element, mini mu, which carried a promoterless 1acZ
gene indicated that transcription of the genes was left to right,
and more than one operon was present (Clegg and Pierce, 1983). The
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presence of at least four polypeptides was detected in minicells
possessing pDC5, the molecular weights of the polypeptides were
71,000, 45,000, 27,000 and 17,000. The 17,000d polypeptide was
identified as the fimbrial subunit by immune precipitation. Mutants
possessing deletions in the genes for the three other polypeptides
still synthesised the fimbrial subunit, indicating that
transcription and translation of this gene did not require the
products of the other genes. There was also a possible fifth,
regulatory, polypeptide as deletions in the region outside the four
genes resulted in no production of the 71,000 and 45,000d
polypeptides (Clegg and Pierce, 1983).
A large degree of restriction map homology between this operon
and the one described by Normark et al. (1983) existed, but
significant differences, such as the position of the gene for the
fimbrial subunit and a lack of cross-reactivity between the fimbriae
were obvious (Clegg, 1982).
Partial digestion by enzyme Sau3A of the chromosome from an
E. coli 06 UTI isolate, strain 536, and an E. coli 018 faecal
isolate followed by cloning of the DNA fragments into vector pJC74,
gave rise to one MRHA-positive recombinant out of 600 tested from
the faecal isolate and one MRHA-positive clone out of 200 tested for
the uropathogenic E. coli isolate (Berger et a 1., 1982).
Restriction enzyme analysis of the cloned fragments showed different
patterns for the two types. The clones were unstable, exhibiting a
high segregation rate unless cultured in the presence of ampicillin
to select for the vector.
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The cloned fimbrial genes from E. co1i 536 were later
classified as X-fimbriae, because neuraminidase treatment of the
erythrocytes prevented MRHA (Hacker et al., 1985). Two different
fimbrial subunits of 16,500 and 22,000d were synthesised by strain
536. The MRHA-positive cosmid clones derived from this strain
produced the 16,500 but not the 22,000d protein and all were
fimbriated. Subcloning of the X-fimbria determinant gave rise to
two recombinant phenotypes, haemagglutination and fimbria-positive
and haemagglutination-positive but lacking fimbriae. These
subclones were stable, unlike the original recombinant plasmid. Tn5
mutagenesis demonstrated that a DNA fragment of 6.5kb was required
for HA and fimbriae production, a 1.5 to 2kb region adjacent to the
MRHA gene encoded the fimbrial structural protein. These results
again indicated that haemagglutination and fimbriae, although
closely related, are two separate entities (Hacker et al., 1985).
Cloning of an afrimbrial adhesin, AFA-1
About 10% of E. coli which express MRHA do not produce any
visible fimbriae (Duguid et al., 1979). Labigne-Roussel et al.
(1984) cloned the chromosomal gene for an afimbrial, P blood group
independent adhesin from E. coli KS52 (02), isolated from a case of
pyelonephritis. The DNA fragments from the partially digested
chromosome were cloned into the cosmid vector pHC79. Three of 400
transductants screened expressed MRHA. Analysis of the inserted
fragments in the three recombinant plasmids revealed a common
sequence of approximately 25kb. All or part of this common region
was subcloned into pBR322 followed by further subcloning of the
fragment into pBR322. A recombinant plasmid designated pIL14
contained a 6.7kb insert which conferred all the properties
associated with the MRHA-positive phenotype on the recipient cell.
Inserted fragments which were slightly smaller than this (6.1kb)
gave a negative MRHA reaction when broth supernatant fluids were
tested, although whole cell suspensions were positive. The
expression of the former property also appeared to be orientation
dependent (Labigne-Roussel et al., 1984).
The protein adhesin was purified from the supernatant fluid by
ammonium sulphate precipitation and dialysis. SDS-PAGE analysis
showed a major protein band of 16,000d, which was present in K12 and
minicell clones. This protein was designated AFA-1. The presence
of pIL14 in K12 also conferred the ability to adhere to
uroepithelial cells. No homology was found between the cloned 6.7kb
insert and the regions of the E. coli J96 chromosome which code for
Type 1 and P fimbriae (Labigne-Roussel et al., 1984).
Linkage between the genes for F7 and Pap fimbriae and haemolysin
production
Cloning of large chromosomal fragments into vector pHC79 from
E. coli strains J96 (Minshew et al., 1978a) and C1212 ($rskov
et al., 1980) which both expressed haemolysin (Hly) and MRHA gave
rise to some clones which expressed both phenotypes (Low et al.,
1984). These results indicated that the two genes were closely
linked. Hybridisation between the cloned DNA fragments from two
strains with phenotypes Hly-positive, MRHA-positive and Hly-
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negative, MRHA-positive, and probes for the MRHA gene (mrh)
constructed from genes of the pap operon, suggested that there were
two distinct gene clusters encoding MRHA ability. One cluster was
linked to the haemolysin gene (hi y) and was present on two
restriction fragments of 5.8 and 7.2kb, the other cluster was not
linked to hly and was present on two fragments of 3.8 and 3.9kb.
The mrh and hly genes of strain C1212 were separated by 4 to 5kb on
the recombinant plasmid, whereas the two genes on the recombinant
plasmid derived from strain J96 were separated by 14 to 15kb.
Therefore, although the two genes are closely linked the intervening
distance can vary (Low et al., 1984). Further hybridisation
experiments with other E. coli 06 isolates also showed linkage
between the two gene clusters, although again the distance between
them was variable.
Analysis of the regions flanking hly showed homologous regions
about lkb in length. Additional homologous sequences were also
present in other strains. Hybridisation showed that the DNA between
the gene clusters was shared by most non—pathogenic faecal E coli,
even though they lacked homology with hly and mrh (Low et al.,
1984).
The variable distance between the two gene clusters suggested
that linkage had occurred through several independent events, or by
a single event followed by rearrangement. If the sequences flanking
the hly genes were similar to insertion sequences, transposition of
the gene to the region close to the mrh gene could have occurred,
explaining the homology between the DNA separating the gene clusters
and the chromosome of faecal E coli (Low et a1., 1984).
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Transposition of the hly gene has not been demonstrated (Hacker
et al., 1983), the ability to transpose may have been lost during
the course of evolution. Linkage of the two gene clusters could
have arisen from a selective advantage conferred by this association
(Low et al., 1984).
Hacker et al. (1983) observed that mutants of one UTI E. coli
isolate which spontaneously lost its ability to synthesise
haemolysin also lost MRHA ability, which supports the view that
these two genes are linked.
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V OVERCOMING BACTERIAL PATHOGENICITY
Resistance to adherence due to genetic factors
It was observed that K88-positive E. coli did not adhere to the
brush borders of all pigs. The difference between these pigs arose
due to simple Mendelian genetics. The pigs with brush borders that
did not allow adherence of K88-positive E. coli appeared to possess
a natural resistance to infections with these organisms (Sellwood
et al., 1975).
The adhesion-positive and -negative pigs arise from the
products of two alleles at a single locus, the positive phenotype
being dominant. The adhesion-negative piglets have a much greater
survival rate than the adhesion-positive piglets when challenged
with K88-positive E. coli (Rutter et al., 1975).
Further work on these pigs distinguished five different
phenotypes (A-E) which had differing susceptibilities to the K88
antigenic variants. Phenotype A was susceptible to adhesion by
K88ab, ac and ad, phenotypes B and C were susceptible to two of the
variants, phenotype D to only one and phenotype E was resistant to
adhesion of all three variants (Bij1sma et al., 1982). K88ad did
not inhibit adhesion of K88ab and ac, but K88ab and ac could
completely inhibit adhesion of the K88ad variant, and K88ab blocked
K88ac adehsion.
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• It would appear from these results that the adhesion-negative
piglets had lost the cell surface receptor for the fimbriae, thereby
preventing adhesion.
By expanding on this theory, attempts were made to prevent
*
bacterial adhesion and colonisation with receptor analogues. If
mice were challenged with E. co 1 i bearing Type 1 fimbriae,
approximately 70% of the animals showed bladder colonisation. The
administration of £<.-methylglucoside to the animals did not alter the
colonisation, but animals challenged with E. coli in -methy1-
mannoside only gave a colonisation rate of 20% (Aronson et al.,
1979).
Adherence of P-fimbriated E. coli can also be blocked by the
synthetic disaccharide receptor, but the adherence might also be
enhanced if this disaccharide then becomes incorporated into the
cell membranes (Kallenius et al., 1980b, 1981a; Leffler and
Svanborg-Eden, 1980, 1981). The elimination of the lipid portion
from the receptor analogue should prevent its incorporation into the
membrane. The form of receptor analogue used is important due to
heterogeneity of fimbrial types.
Effect of sub-inhibitory concentrations of antibiotics on adhesion
At drug concentrations below the minimum inhibitory
concentration (MIC) for the bacteria, antibiotics produce structural
and morphological changes in the bacterial cell. The best
documented is the action of penicillin G, which causes a loss of the
lipoteichoic acid adhesion from Streptococcus pyogenes with a
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concomittant loss of ability to adhere to human buccal cells (Alkan
and Beachey, 1978). Similar effects occur with E. coli when
inhibition of mannose-sensitive fimbriae is seen, resulting from
abnormalities in cell wall biosynthesis, causing the cells to become
filamentous. Loss of adhesion only occurred if the penicillin was
added while the cells were growing, no effect being seen if the
antibiotic was added once the fimbriae had been formed and assembled
on the cell surface (Beachey et al., 1981).
Inhibition of adhesion by Type 1 fimbriae could also be seen
with growth in sub-inhibitory concentrations of streptomycin, the
effect was dose-related and not apparent with cells already
possessing fimbriae (Eisenstein et al., 1979). Reductions in
adhesive ability were parallelled by reductions in the number of
fimbriae on the surface. The adhesion of isogenic strains
r
possessing a single step chromosomal mutation to high level
streptomycin resistance was unaffected by the presence of sub-MIC
levels of streptomycin (Ofek et al., 1979). One such mutant
described by Beachey et al. (1981), although resistant to high
levels of streptomycin, was unable to produce MSHA or adhere to
buccal cells if grown in less than 0.03 of the MIC of streptomycin.
The cells were still fimbriate, but the fimbriae were longer and
when purified were incapable of agglutination, possibly due to
misreading on the ribosomes. Again, streptomycin had no effect on
preformed fimbriae. Changes in antigenic structure were also
observed by agglutination tests (Eisenstein et al., 1979). Other
antibiotics such as gentamicin, neomycin, tetracycline,
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spectinomycin and chloramphenicol produced similar effects to
streptomycin (Eisenstein et al., 1980).
Reductions in adhesion can also be obtained for pyelonephritic
MR fimbriae. One quarter MICs of ampicillin reduce the amount of
attachment of the bacteria to uroepithelial cells, although this
effect was not seen with chloramphenicol and nitrofurantoin
(Sandberg et al., 1979). A greater reduction in adhesive ability
could be shown if the bacteria were pretreated with ampicillin and
$ globulin. Results contradictory in part to those described above
(Sandberg et al., 1979) were obtained by Vosbeck et al. (1979).
Sub-MICs of tetracycline, clindamycin and trimethoprim-sulfametrole
reduced the adhesion of a pyelonephritogenic E. coli to an
epithelial cell culture line. Penicillin G, ampicillin, mecillinam,
cephacetri1e, cephalexin, cefotaxime, chloramphenicol and
streptomycin had no effect on adhesive ability and nalidixic acid
increased the amount of adhesion. Reductions in adhesion of other
E. coli strains from UTIs and diarrhoea to the cell culture line
were produced by quarter MICs of streptomycin, tetracycline,
trimethoprim, chloramphenicol, clindamycin and sulfametrole (Vosbeck
et al., 1982).
Further work on the suppression of P-fimbriae formation by
sublethal concentrations of antibiotics showed that at 1/8 to 1/2
the MIC of trimethoprim, sulfadiazine, sulphamethoxazole and
sulfathiazole markedly reduced the agglutination of human
erythrocytes and the adhesion to buccal cells of three strains of
pyelonephritogenic E. coli (Vaisanen et al., 1982b). There was also
a corresponding decrease in the number of fimbriae per cell. In
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cells treated with sublethal concentrations of trimethoprim no major
changes were seen in the outer membrane protein patterns, but
freeze-fracture electron micrographs showed deorganisation of the
outer and cytoplasmic membranes.
Promethazine and imipramine can inhibit adhesion of a
nephropathogenic E. coli to cultured HEp-2 cells (Molnar et al.,
1983). Indomethacin has no effect on preventing renal infection in
rats as it has no antibacterial activity, but reduced incidence of
disease from 74 to 48% two days after were noted (Glauser et al.,
1983).
Reductions in the adhesion of Proteus sp. of uropathogenic
origin by sub-MICs of piperacillin and sagamicin have also been
observed (Savoia et al., 1983).
Sub-MICs of antibiotics can also affect the secreted enzymes
and toxins of bacteria. Lincomycin and clindamycin suppress the
production of the streptolysin S of Streptococcus pyogenes, whereas
chloramphenicol and erythromycin had no effect on the haemolysin
(Shibl and Al-Sowaygh, 1979). The o(. and _p-haemo 1 y s in s of
Staphylococcus aureus could be inhibited by streptomycin and
novobiocin which also induced production of protein A (Nordstrom and
Lindberg, 1978). Clindamycin prevents the formation of the
coagulase, <*.-haemolysin, DNAase and other toxins of S. aureus. The
E. coli haemolysin is inhibited by streptomycin and the proteases of
Pseudomonas aeruginosa by tetracycline. Sub-MICs can also stimulate
some toxins. Clindamycin stimulates the enterotoxin of E. coli and
Vibrio cholerae and the jl-haemolysin of S. aureus and pneumococci is
stimulated by penicillin (Gemmell, 1982). Growth of ETEC in the
presence of tetracycline and lincomycin stimulates the production of
an increased amount of extracellular and intracellular LT. Analysis
of this toxin revealed that the subunits were not nicked, unlike the
normal toxin. Lincomycin does not stimulate the production of ST
(Yoh et al., 1983), but the action of ST can be blocked by other
drugs (Greenberg and Dunn, 1984). These differential effects might
be explained by the peripheral or cytoplasmic position of the
ribosomes synthesising the proteins in question (Shibl, 1983).
Antibiotic concentrations below the MIC can also promote
phagocytosis. Sub-MICs of clindamycin reduce the adhesion of
E. coli to buccal cells and by promoting phagocytosis enhance
killing of the organism by polymorphonuclear leukocytes (Bassaris
et al., 1984). The filamentous cells produced by growth in sub¬
inhibitory concentrations of ampicllin or mecillinam showed no
increased susceptibility to the bactericidal effects of serum or
blood, and in fact showed a slightly increased resistance to these
effects compared to the control cells (Lorian and Atkinson, 1979).
Pre-treating Salmonella wien with sub-MICs of fosfomycin lead
to higher titres of antibody to S. wien in rabbits, than in rabbits
immunised with untreated S. wien (Viano et al., 1979). The titres
to the 0 and H antigens were also higher.
Development of vaccines
The pathogenic E, coli described so far are non-invasive in
that they do not penetrate the intestinal or urinary tract
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epithelial layer. It would therefore be logical to assume that
secretory IgA (SIgA) antibody would be involved and any vaccine
developed would have to be capable of stimulating mucosal immunity.
The use of purified fimbriae as vaccines for animals in
preventing neonatal deaths from diarrhoeal disease have been
encouraging. The parenteral vaccination of pregnant sows with K88
antigen gave a significantly greater resistance to disease among the
piglets suckled by these sows, than those suckled by unvaccinated
control sows, when the piglets were challenged with a large dose of
K88-positive ETEC (Rutter et al., 1976). Vaccination with the
antigen stimulated the production of anti-K88 antibodies, but no
neutralising activity against LT. No difference in the bactericidal
or bacteriostatic activities of the serum and mammary secretions was
observed between the vaccinated and control sows, indicating that
the K88 antibodies in the colostrum were affording protection by
neutralising the adhesive properties of the K88 fimbriae (Rutter
et al., 1976).
Similar results were obtained when pregnant sows were
vaccinated with purified K99 or 987P fimbriae and the suckling
piglets challenged with ETEC (Morgan et al., 1978). The incidence
and duration of diarrhoea and the degree of intestinal colonisation
was less if the piglets were challenged with ETEC bearing homologous
fimbriae to those with which the sow was vaccinated. These piglets
also had better weight gains than those piglets challenged with a
different fimbrial type (Morgan et al., 1978).
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The oral immunisation of rabbits with two doses of purified
CFA/I fimbriae gave a significant increase in the number of anti-
CFA/l-producing cells present in the rabbit intestinal mucosa.
These rabbits were significantly protected, compared to the
controls, when challenged with CFA/I-positive ETEC. This protection
was not seen if the rabbits were challenged with CFA/II-positive
ETEC, which revealed the specificity of the antibody response
(Cabada et al., 1981; Evans et al., 1982).
a
A significant and long-lasting increase in SIgA anti-CFA/II was
shown when eight, 2mg doses of purified CFA/II fimbriae were given
enterally. Three weekly l-2mg doses gave rise to prominent SIgA
anti-CFA/II, whereas three weekly O.lmg doses of CFA/II fimbriae did
not raise the SIgA anti-CFA/II (Boedeker et al., 1982). Fortunately
the repeated mucosal immunisation with CFA/II fimbriae did not
induce tolerance to the subsequent parenteral challenge with CFA/II-
positive E. coli (Levine et al., 1984a).
CFA/1 and II are the most common fimbrial antigens on ST/LT-
positive E. coli (Evans and Evans, 1978), but if a polyvalent,
broad-spectrum vaccine was to be produced to treat human diarrhoeal
disease other antigenic components would have to be present to
protect against CFA/I and II-negative fimbriated strains. Many
E. coli, pathogenic and non-pathogenic, possess Type 1 fimbriae
(Levine et al., 1980), therefore the immune system is probably
already primed to recognise them. Although Type 1 fimbrial vaccines
boosted the level of intestinal SIgA and serum IgG antibody,
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evidence of protection from challenge was not observed (Levine
et_al., 1984a).
Immunisation of monkeys with purified P-fimbriae gave high
titres of anti-fimbrial antibody which protected against acute and
chronic pyelonephritis caused by the renal inoculation of P-
fimbriated E. coli (Roberts et al., 1984).
As with the enteric E. coli, a wide variety of uropathogenic
fimbrial types exist, so any effective vaccine 'would have to be
broad-spectrum and consist of a combination of antigens. The
problem with giving a killed oral antigen vaccine, i.e. purified
fimbriae, is that multiple doses are required to prime the secretory
immune system and ensure a good local antibody response. However, a
live vaccine, consisting of an attenuated E. coli strain would be
able to colonise the intestine and stimulate the immune response to
the surface antigens without producing any clinical symptoms.
The ideal solution would be the successful cloning of all the
fimbrial antigen genes and the construction of a surface antigen
cocktail in a standard E. coli K12. The additional cloning of toxin





Bacterial Strains and Plasmids
The standard bacterial strains and plasmids used are listed in
Tables la and lb respectively. Clinical strains responsible for
urinary tract infections were isolated from patients in the Royal
Infirmary, Edinburgh; the City Hospital, Edinburgh and from
patients attending General Practitioners in the Edinburgh area.
Faecal E. coli strains were isolated from healthy members of the
Department of Bacteriology.
All bacterial strains were stored in brain heart infusion broth
containing 15% (w/v) sterile glycerol at -70°C.
Identification of Bacterial Strains
The API 20E microtube system (API system S.A., France) was
used, according to the manufacturer's instructions, for the
identification of urinary tract isolates.
Complex Media
The complex media used were Brain Heart Infusion (BHI) broth
(CM225), Nutrient Broth no. 2 (CM67), Diagnostic Sensitivity agar
(DSTA) (CM261), Columbia agar base (CM331) and MacConkey agar
(CM76), (Oxoid, Basingstoke, Hants.), and Mue 11 er-Hinton broth
(0757-01) (Difco, Detroit, Michigan). Each medium was made up
according to the manufacturer's instructions in distilled water.
77
Table la Standard Bacterial Strains
Strain and number Markers Reference
E. coli K12 J62 pro his trp lac Bachmann (1972)
E. coli K12 J62-2 pro his trp lac rifR Bachmann (1972)
E. coli K12 J53 pro met Bachmann (1972)
E. coli N99 galK2 proA strA Gottesman and
Yarmolinsky (1968)
Rosner (1972)
E. coli Tl MR Tcr Kallenius and Mollby
(1979)
E. coli NK1 MS MR Hly Kallenius et al. (1980c)
E. coli K12 Prototroph. Kindly given by
H.W. Smith
Table lb Standard Bacterial Plasmids
Plasmid
designation Markers Mr (kb) Reference
R483 Tp Sm Su Inc I 90 Hedges et al. (1972)
JR66a Km Sm Inc I o4 90 Hedges and Datta
(1973)
R1 Ap Cm Km Sm Su Inc FII 90 Meynell and Datta
(1966)
R15 Sm Su Inc N 58 Datta and Hedges (1971)
RP4 Ap Tc Km Inc P 52 Datta et al. (1971)
R6K Ap Sm Inc X 38 Kontamichalou et al.
(1970)
Sa Km Cm Sm Su Sp Inc W 33 Watanabe et al. (1968)
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Minimal Media
Minimal media as described by Davis and Mingioli (1950) was
used. Double strength media contained: 14.0g K2HPO4, 6.0g KH2P04>
0.9g tri-sodium citrate.2H2o, 0.2g MgS04.7H20, 2.0g (NH4)2S04, in
one litre of distilled water. Media was diluted to single strength
before use. This media was supplemented with 2.8mg/ml D-glucose
(BDH) (Smith, 1967) and combinations of L-proline, L-histidine, L-
trypotphan (BDH) and L-methionine (Sigma, Poole, Dorset) at 50pg/ml
each.
All media wtre sterilised by autoclaving at 121°C for 15
minutes. Supplements were aseptically added to minimal media after
sterilisation. The amino acid supplements were J •s'^ftcbad by
steaming for 25 minutes prior to addition.
Preparation of Plates
Agar plates were made by the addition of 15ml of sterile,
molten agar to plastic petri dishes (Sterilin, Middlesex). The
surfaces of all plates were flamed with a bunsen burner to remove
air bubbles. The agar was allowed to set, then the plates were
inverted and dried at 52°C for 10 to 15 minutes. In antimicrobial
drug sensitivity plates, the required drugs were added after the
molten DST agar had cooled to 50°C, and the plates were then poured
immediately, as before.
Minimal medium plates were prepared by mixing 50ml of sterile
double strength Davis-Mingioli media with the required amount of D-
glucose, amino acid supplements and antimicrobial drugs and making
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the volume up to 60ml with sterile distilled water. This was mixed
with 40ml of molten Bacteriological agar no. 1 (L11) (Oxoid) and
mixed gently before pouring.
Antimicrobial Drugs
The antimicrobial drugs and the concentrations used are listed
in Table 2. All antimicrobial drugs were dissolved in sterile
distilled water, except for chloramphenicol and rifampicin which
were dissolved in absolute ethanol and nalidixic acid and
sulphamethoxazole which were first dissolved in 0.1ml of IN NaOH and
then made up to the required concentration with sterile distilled
water.
Sensitivity Testing
Shaken overnight bacterial cultures in 4.5ml BHI broth were
diluted 10"^ in minimal media and 2pl spotted on to DST agar
containing antimicrobial drugs, with a multipoint inoculator (Mast
Labs., Liverpool). Plates were allowed to dry and incubated,
inverted, at 37°C overnight.
Determination of Sugar Utilisation, Haemolysin and Colicin
Production
This was performed in a similar manner to that described above
for the sensitivity testing, except that the bacterial cultures were
spotted on to minimal media supplemented with 1% (w/v) raffinose or
1 % (w/v) dulcitol as carbon source. Haemolysin production was
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Table 2 Antimicrobial Drugs
Antimicrobial Concentration3 Source
(jig/ml)
Ampicillin 10 Beecham Research Laboratories,
Middlesex
Chloramphenicol 10 Parke-Davis, Pontypool, Gwent
Kanamycin 10 Bristol Laboratories, Middlesex
Nalidixic Acid 10 Sterling Winthrop Laboratories,
Surrey
Rifampicin 25 Le Petite, Milan, Italy
Spectinomycin 100 Upjohn Ltd., Surrey
Streptomycin sulphate 10 Glaxo Laboratories Ltd.,
Greenford, Middlesex
Sulphamethoxazole 100 Wellcome Foundation Ltd.,
Beckenham, Kent
Tetracycline 10 Glaxo Laboratories Ltd.,
Greenford, Middlesex
Trimethoprim lactate 10 Wellcome Foundation Ltd.,
Beckenham, Kent
a unless otherwise stated
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tested by spotting cultures on to Columbia agar containing 5% (v/v)
defibrinated horse blood SR50 (Oxoid) and looking for a zone of
lysis around the colonies. Colicin production was determined by
spotting undiluted cultures on to nutrient agar flood seeded with
0.1ml of the sensitive E. coli K12 indicator strain. Lysis of the
indicator around the colonies indicated production of a colicin.
Determination of Broth MICs
Statically grown overnight Mueller-Hinton broth cultures were
subcultured into 4.5ml of fresh Mueller-Hinton broth containing
doubling dilutions of antimicrobial drugs. The broths were
incubated statically at 37°C overnight and the lowest concentration
of drug inhibiting visible bacterial growth determined.
Haemagglutination Assay
Haemagglutination ability was assayed by a modification of the
method of Svanborg-Eden and Hansson (1978). Bacterial cells
harvested by centrifugation at 4,000rpm for 15 minutes (Heraeus
Christ Bactifuge) from 4.5ml of a 48 hour static BHI broth culture
were resuspended in lOmM phosphate buffered saline (PBS) to a
concentration of 2 x 10^ bacteria/ml. The bacterial concentration
was determined by measuring the optical density of the cultures at
550nm in a Bausch and Lomb Spectronic 20 spectrophotometer and
referring this to a standard curve of optical density against
bacterial numbers, determined with a haemocytometer. A series of
50pl two-fold dilutions of the bacterial suspension, in either PBS
or 2.5% (w/v) D-mannose (Sigma) in PBS, were made in the V-bottomed
wells of a microtitre plate (Sterilin, Middlesex), and 50yil of a
citrated suspension of human group A or guinea pig erythrocytes (5 x
108 erythrocytes/ml) was added to each well. The plates were
incubated at 37°C for 30 minutes, after which time the results were
read. The plates were then maintained at 4°C overnight and the
results read again.
Plasmid Transfer
Genetic transfers were performed by inoculating donor cells
from a single colony on a MacConkey agar plate into 4.5ml BHI broth
and recipient cells from single colony growth into another 4.5ml BHI
broth. The cultures were incubated statically at 37°C. After
overnight growth, 0.1ml of the donor culture and 1ml of the
recipient culture were mixed in 4.5ml of fresh, prewarmed BHI broth,
and the mating mixture incubated statically at 37°C for the required
time, which varied from 1 to 18 hours (Smith, 1969) as specified.
At the end of this time the mixture was shaken vigorously to
separate donor and recipient cells which were then collected by
centrifugation at 4,000rpm for 15 minutes (Bactifuge). The pellet
was resuspended in 5.6ml of Davis-Mingioli (DM) medium without
supplements and further diluted in 10-fold steps in DM medium. A
0.1ml amount of each dilution was spread on the surface of selective
DM agar, allowing only growth of a plasmid-containing recipient
strain. Controls consisted of spreading donor and recipient cells
on separate selective plates of the same type. The plates were
allowed to dry and then incubated at 37°C for 48 hours. Resultant
single colonies were purified on selective plates.
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Plasmid Mobilisation
A 0.1ml amount of an overnight BHI broth culture of donor
cells, which contained a known R-plasmid, was added to 1ml of
recipient culture in 4.5ml of prewarmed BHI broth. The recipient
strain possessed plasmids which either carried a non-selectable
marker or were not able to promote their own transfer. The mixture
of donor and recipient was incubated statically at 37°C overnight.
The mixture was then spread on to minimal media plates selective for
R-plasmid containing recipients, as described for the plasmid
transfer. Plates were incubated at 37°C for 48 hours and the
resultant colonies purified on separate selective plates of the same
type.
R-plasmid transfer from one of these transconjugants to the
E. coli K12 recipient J62-2 was performed as described above. The
resulting transconjugants were tested for possession of the plasmid
from the original recipient culture by plasmid isolation and/or
testing for markers present in the original recipient.
Determination of Loss of a Selectable Marker
Single colony transconjugants, from a plasmid transfer, were
streaked on to DST agar plates containing one of each of the
original strain's antimicrobial drug resistance markers and a DST
agar plate lacking any antimicrobial drug as a positive control.
Plates were incubated at 37°C overnight." No growth along the streak
line on any of the selective plates indicated loss of that marker.
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Transduction by 'Phage PI
A modification of the thermal induction method (Goldberg
et al., 1974) was used. A 4.5ml nutrient broth culture of E. coli
N99 was incubated at 30°c overnight and then subcultured in fresh
nutrient broth for a further two hours. A two-fold dilution of this
culture was then incubated at 42°c for three hours until lysis was
seen. The PI lysate was filter-sterilised through a 0.2pm membrane
filter (Anderman and Co. Ltd., East Moseley, Surrey).
Overlays were prepared with 1.5ml of 0.8% (w/v) nutrient agar
(Oxoid), 0.5ml of appropriately diluted sterile PI lysate, 0.5ml of
an overnight nutrient broth culture of the indicator strain and 60pl
of 4% (w/v) calcium chloride. The overlay was poured on to nutrient
agar plates which were then incubated at 37°C overnight.
After incubation, overlays from plates showing semi-confluent
lysis were transferred to nutrient broth, vortexed and then
centrifuged at 4,000rpm for 30 minutes (Bactifuge). The supernatant
was filter-sterilised as above and a 0.5ml portion allowed to adsorb
to the E. coli J53 recipient for 30 minutes at 37°C. The
transducing 'phage preparation was plated on to minimal media
containing drugs selecting for the transduced gene and incubated at
37°C for 36 to 48 hours. Resulting transductants were purified on
the same type of selective media and their haemagglutination and
antimicrobial drug resistance properties determined.
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Large Scale Isolation of Plasmid DNA by Triton Lysis
The method of Meyers et al. (1976) was followed. One litre of
a shaken overnight nutrient broth culture of the organism was
centrifuged at 4,000g for 45 minutes. The cell pellet was
resuspended in 2ml of 25% (w/v) sucrose in 50mM Tris-HCl, pH 8.
After addition of 0.3ml of a 50mg/ml solution of lysozyme (Sigma)
in distilled water, the cells were shaken gently at 37°C for 5
minutes, then 2ml of 0.25M EDTA (Sigma) pH 8, was added and the
mixture shaken on ice for 5 minutes. The addition of 3ml of 2%
(w/v) Triton X-100 (BDH) in 50mM Tris-HCl, pH 8, 62.5mM EDTA
followed by gentle inversion at 0°C brought about lysis. The lysate
was cleared by centrifugation for 40 minutes at 40,000g. The
supernatant was removed with a wide-bore pipette and extracted twice
with equal volumes of TES (lOmM Tris, lOmM NaCl, 0.0316mM EDTA) pH
8, saturated phenol by centrifugation at 4,000rpm for 10 minutes
(Bactifuge). The upper aqueous layer was retained.
DNA was precipitated from the aqueous layer by the addition of
two volumes of cold 95% ethanol and holding at -70°C for 30 minutes.
The precipitated DNA was removed by centrifugation at 2,500rpm for 5
minutes (Bactifuge) and the pellet resuspended in 0.5ml TES, pH 8.
A 30pl sample was mixed with lOjil of bromophenol blue (0.05% (w/v)
in 50% (v/v) glycerol),loaded into the wells of a horizontal slab
gel (14 by 21.5cm) consisting of 0.5% agarose in Tris-Borate buffer
(89mM Tris, 2.5mM EDTA, 89mM Boric acid, pH 8.2). Samples were
electrophoresed through the agarose at 70 volts overnight. The gel
was then stained with a 0.75pg/ml solution of ethidium bromide in
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distilled water and visualised over a long-wave, ultra-violet light
source (Ultra-violet Products Inc., Cambridge).
Small Scale Isolation of Plasmid DNA by Triton Lysis
The procedure was carried out as above, except a 4.5ml
overnight broth culture was used and the volumes of the other
solutions reduced appropriately.
Small Scale Isolation of Plasmid DNA by Alkaline Lysis
The method of Birnboim and Doly (1979) was followed. A 1.5ml
volume of an aerated, overnight BHI broth culture of the organism
was harvested at ll,500g for 1 minute (MSE Micro centaur microfuge).
The pellet was resuspended in lOOjil of 2mg/ml lysozyme in 50mM
glucose, lOmM EDTA, 25mM Tris, pH 8. This was then maintained on
ice for 30 minutes and then 200pl of the lysing solution (0.1N
sodium hydroxide, 1% (w/v) sodium dodecyl sulphate) was added and
the mixture gently inverted. After maintenance at 0°C for 5
minutes, 150>il of 3M sodium acetate (Sigma), pH 4.8, was added and
mixed well, maintenance at 0°C for 60 minutes allowed precipitation
of the clot which formed. The clot was pelleted by centrifugation
at ll,500g for 10 minutes. DNA was precipitated by the addition of
lml of cold 95% ethanol and storage at -20°C for 30 minutes. The
precipitated DNA was pelleted by centrifugation at ll,500g for 5
minutes and then resuspended in lOOpl of 0.1M sodium acetate, 50mM
Tris, pH 8. The DNA was reprecipitated with two volumes of cold 95%
ethanol and kept at -20OC for 10 minutes. The pellet was recovered
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by centrifugation as above and dissolved in 3Ctyil TE (lOmM Tris, ImM
EDTA, pH 8).
The DNA samples were electrophoresed as before, but the agarose
was made up in Tris-Acetate buffer (40mM Tris, ImM EDTA, 5mM sodium
acetate, pH 8.2).
Preparation of Fimbriae
The method of Salit et al. (1983) was followed. Organisms were
grown statically in three litres of BHI broth for 48 hours at 37°C.
Cells were harvested at 10,000g for 10 minutes at 4oc. The
resulting pellet was washed in 50ml of 0.5% (w/v) sodium chloride,
recentrifuged and resuspended in 25ml of 50mM Tris-HCl buffer, pH
7.5. The suspension was then blended at high speed in four, 30
second bursts in a Waring blender. The debris was removed by
centrifugation at 20,000g for 30 minutes at 4°C and the supernatant
ultracentrifuged at 150,000g for 2.5 hours at 4°c.
The resultant pellet was resuspended in 1.2ml of 5M urea buffer
and mixed for several hours at 37°C in a Gallenkamp orbital
incubator. It was then diluted 1 in 5 with the Tris buffer. This
solution was layered over a 1M urea - 1M sucrose - 5mM Tris cushion
and ultracentrifuged at 150,000g for 16 hours. The pellet was
resuspended in 100pl of Tris buffer to give the sample for loading
on a polyacrylamide gel.
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Preparation of Polyacrylamide Gels
Polyacrylamide gels were prepared by a modification of the
method of Laemmli (1970). Slab gels measuring 17 by 14cm and
consisting of a 10% (w/v) acrylamide separating gel surmounted by a
lcm 4% (w/v) acrylamide stacking gel were used. The acrylamide
stock solution was prepared by the method of Weber and Osborn
(1969). A mixture of 22.2g of acrylamide (BDH) and 0.6g of methyl-
enebisacrylamide (BDH) were dissolved in 100ml of distilled water,
to give the acrylamide stock solution. The separating gel was
composed of 22.5ml of 0.7M Tris HC1 buffer, pH 8.8 containing 0.2%
(w/v) SDS, 20.25ml of acrylamide stock solution. This mixture was
degassed in a Buchner flask and 2.25ml of freshly prepared ammonium
persulphate (APS) solution (15mg/ml) and 0.065ml of NNN 'N' tetra-
methylethylene diamine (TEMED) (BDH) were then added. The gel was
then poured between two glass plates and covered with a layer of
water-saturated butan-2-ol during polymerisation. The stacking gel
was prepared with 5ml of 0.25M Tris HC1 buffer, pH 6.8, containing
0.2% (w/v) SDS, 2ml of acrylamide stock solution, 2.5ml of distilled
water, 0.5ml of APS solution and 0.02ml of TEMED. The water-
saturated butan-2-ol was removed from the surface of the polymerised
separating gel and the stacking gel was carefully poured on top, a
comb was inserted into the stacking gel which was then allowed to
polymerise. Fimbrial protein samples were solubilised in 0.0625M
Tris HC1 buffer, pH 6.8 containing 1% (w/v) SDS, 10% (v/v) glycerol,
1% (v/v) 2-mercaptoethanol and 0.001% (w/v) bromophenol blue, by
heating at 100°C for 3 minutes. The samples were then loaded into
the wells and electrophoresed at 60 volts through the stacking gel.
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The voltage was then Increased to 150 volts until the bromophenol
blue had run to the bottom of the separating gel.
The gels were stained for protein with Coomassie Brilliant Blue
overnight and destained by the method of Poxton and Sutherland
(1976). The staining solution contained 1.25g Coomassie Brilliant
Blue R, 1625ml distilled water, 625ml propan-2-ol, 250ml acetic
acid. The gels were destained for 30 minutes with gentle shaking
sequentially in each of solutions 2 to 5. The solutions contained:
2) 125mg Coomassie blue, 2000ml distilled water, 250ml propan-2-ol,
250ml acetic acid; 3) 63mg Coomassie blue, 2250ml distilled water,
250ml acetic acid; 4) 1000ml water, 800ml methanol, 200ml acetic
acid; 5) 10% (v/v) acetic acid in distilled water.
Electron Microscopy
Bacterial cultures were prepared as described by Ofek et al.
(1974). The organisms were cultured in 4.5ml of BHI broth,
statically, at 37°C for 48 hours, the cells were then washed twice
with 0.85% sodium chloride and diluted in .Hanks balanced salt
solution (pH 7.2) to a concentration of 2 x 10® bacterial/ml. A
drop of this suspension was loaded on to a formvar coated copper
grid and after 5 minutes excess fluid was removed with absorbent
paper. The dried grids were shadowed with platinum at an angle of




Photographic negatives of DNA agarose gels were prepared on
Kodak Plus-X pan film using a 5 x 4 inch plate camera fitted with a
Wrattan 22 orange filter. Polaroid photographs of polyacrylamide
gels were prepared utilising a Wrattan 58 green and a Wrattan 22





I SURVEY OF URINARY TRACT ISOLATES FOR VIRULENCE MARKERS
Clinical strains isolated from infections possess a variety of
characters that are classed as virulence factors. The importance of
each of these factors varies depending on the type of infection;
often it is not one character alone which determines the progress of
the disease, but a combination of two or more factors. Each one
plays a specific role, but contributes to the effect produced by the
others. For this reason a survey of the virulence characters of
strains isolated from a given infection often helps to put into
perspective the importance of a particular character of interest.
Distribution of specific characters among UTI isolates
All Enterobacteriaceae isolated from cases of significant
bacteriuria (>10^ organisms/ml of urine) were tested for the
possession of virulence characters and antimicrobial drug resistance
determinants as described in the Methods section of this work.
Resistance to an antimicrobial was defined as confluent growth on
DSTA plates, containing antimicrobial at the concentrations given in
Table 2, in the absence of growth of the control E. coli J62~2.
Similarly the ability to utilise 1% (w/v) raffinose or dulcitol
as sole carbon source in Davis-Mingioli (DM) medium, was determined
by confluent growth of the organisms in the absence of growth of
E. coli J62~2# Organisms which secreted a haemolysin were
identified as those which produced a zone of lysis of blood cells in
the blood agar plates. Colicin producers were distinguished by
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their ability to lyse the nutrient agar seeded sensitive indicator
strain.
Strains which possessed fimbriae and adhesive ability were
identified by their ability to agglutinate human and/or guinea pig
erythrocytes. The concentration of the suspension of bacteria for
use in the assay was originally determined by counting a diluted
culture of the organism using a haemocytometer. Latterly the number
of bacteria as determined with the haemocytometer was related to the
optical density (OD) reading at 550nm of the same culture, and the
standard curve produced could be used to convert OD readings of
subsequent cultures to the number of bacteria present. The
inhibition of the haemagglutinationof guinea pig cells by 2.5% (w/v)
mannose indicated the presence of Type 1 fimbriae. The inability of
the same concentration of mannose to inhibit the agglutination of
human group A erythrocytes indicated the presence of mannose-
resistant uropathogenic fimbriae. Figure 1 shows a
haemagglutination (HA) plate, with a negative and a positive
control, a mannose-sensitive organism and a mannose-resistant
organism, and illustrates the different patterns of HA obtained.
Source of strains used in the survey
One hundred strains isolated from the urine of patients with
significant bacteriuria in the Edinburgh Royal Infirmary and from
patients attending Edinburgh General Practitioners were collected
and classed as the lower UTI group. In addition, 100 urinary
isolates from patients with chronic UTIs in the City Hospital,
Edinburgh were surveyed. Fifty faecal E. coli strains were obtained
from members of the Department of Bacteriology. All members of this
Figure 1 HA assay plate showing the typical reactions obtained.
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latter group had no symptoms of clinical infection and therefore
provided a source of non-pathogenic bacteria which were used as a
control, to which the former two groups of strains could be
compared.
Pathogenic characters associated with the clinical strains
Each strain was tested for the possession of the characters
listed above. The results obtained are shown in Table 3. The
values given are the number of strains possessing that character
expressed as a percentage of the total number tested.
The percentage of both types of urinary isolates capable of
producing HA is greater than the percentage of faecal strains
which possess this character. These HA reactions were separated
into MSHA and MRHA, more faecal isolates (40%) produced MSHA
compared to only 26% of the lower UTI isolates. This indicates the
presence of Type 1 fimbriae which are common to both pathogenic and
non-pathogenic E. coli. In contrast, a larger proportion of the
lower UTI isolates (45%) was capable of MRHA compared to 30% of the
faecal isolates, and it is these MR fimbriae which are associated
with pathogenicity. Figure 1 shows a microtitre plate with typical
HA reactions. Production of haemolysin and utilisation of raffinose
and dulcitol are also higher among the lower UTI isolates than the
faecal isolates. However, three times as many (35%) of the faecal
isolates produce colicin V than the lower UTI isolates.
Comparison of isolates from acute and chronic UTIs
A comparison of the pathogenic characters of the lower UTI
isolates with those possessed by the isolates from the chronic UTIs
TABLE 3 Percentage of Gram-negative bacterial isolates expressing
virulence characters
Faecal Lower UTI Chronic UTI
Character Isolates Isolates (100) Isolates (100)
Haemagglutination (HA) 4« 66 62
MSHA 40 26 45
MRHA 30 45 33
Haemolysin production L 24 15
Colicin V production 34 12 18
Raffinose utilisation 16 24 16
Dulcitol utilisation 2 6 6
Significant difference between faecal isolates and the UTI isolates were
only found with HA (lower UTI's), Hly (lower UTI's) and ColV (lower and
chronic UTI's). Other values were not significant at the 5% level.
showed that the num ber of strains that produce HA is similar (Table
3). However, more chronic UTI isolates show the ability to produce
MSHA (45%) than MRHA (33%). This is in contrast to the lower UTI
isolates, more of which produce MRHA than MSHA.
The percentages of strains capable of haemolysin production and
utilisation of raffinose are also lower among the chronic UTI
isolates. Colicin V is produced by 18% of the isolates from the
chronic infections compared to its production by 12% of the lower
UTI isolates. The number of strains capable of utilising dulcitol
is the same in both groups.
Antimicrobial drug resistance in the clinical strains
Each strain was tested for its sensitivity to eight common
antimicrobial drugs, listed in Table 4. At the concentrations given
the percentage of lower UTI isolates possessing resistance
determinants to these drugs was greater than the percentage of
antimicrobial drug resistant faecal isolates, except for resistance
to sulphamethoxazole which was 5% higher among the faecal isolates.
It was found that antimicrobial drug resistance was higher
among the chronic UTI isolates than the lower UTI isolates, except
for resistance to tetracycline which was 2% lower among the chronic
UTI isolates.
Correlation between MRHA ability and other characters
The main character of interest was the ability of the strains
to produce MRHA. In order to determine if a correlation existed
between the MRHA ability of the strains and any of the other
TABLE 4 Percentage of Gram-negative bacterial isolates possessing
antimicrobial drug resistance determinants
Percentage Number
Antimicrobial Lower Chronic
Resistance Concentration Faecal UTI UTI
pg/ml Isolates Isolates Isolates
(50) (100) (100)
Ampicillin (Ap) 10 19 38 44
Chloramphenicol (Cm) 10 2 9 12
Kanamycin (Km) 10 2 9 12
Spectinomycin (Sp) 100 0 6 12
Streptomycin (Sm) 10 21 28 50
Sulphamethoxazole (Sx) 100 30 25 47
Tetracycline (Tc) 10 26 35 33
Trimethoprim (Tp) 10 7 12 23
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characters tested, the number of MRHA-positive isolates that
possessed each of the other characters was calculated and compared
to the total number of isolates which possessed that character
(Table 5). The evidence for correlation between any two characters
was produced by determination of the and probability (P) values
for each set of figures. A P value of 0.05 or less was designated
as being significant, i.e. that proportionately more MRHA-positive
isolates possessed that character than the total nu mber of
isolates, indicating a correlation or linking of the two characters.
On this criterion, only two P values were found to be significant,
MSHA ability among the lower UTI isolates which showed a
significant lack of association with MRHA ability, i.e. a smaller
proportion of the MRHA-positive isolates expressed MSHA than the
total population. Haemolysin production by the chronic UTI isolates
did show a significant association with MRHA ability (P « 0.01).
The most common virulence character among the UTI isolates
studied was the ability to cause HA, and MRHA ability was present in
a relatively high proportion (45%) of the lower UTI isolates.
Therefore this character must have an important role in
pathogenicity. Although a relatively low number of strains were
examined it was possible to perform statistical analysis. No
association between MRHA and any of the other characters was
observed, except for haemolysin production by the chronic UTI
isolates.
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TABLE 5 Correlation between MRHA and other characters
Lower UTI Isolates Chronic UTI Isolates
Total No Total No
Character No. MRHA+ P*value No. MRHA+ P value
MSHA 26 7 >0.02 45 17 >0.1
Haemolysin production 24 13 >0.1 15 9 <0.01
Colicin V " 12 4 >0.1 18 8 >0.1
Raffinose utilisation 18 8 >0.5 16 7 >0.1
Dulcitol " 6 2 >0.5 6 0 N/A
Ampicillin resistance 38 18 >0.5 44 14 >0.5
Chloramphenicol " 9 4 >0.5 12 2 >0.1
Kanamycin " 9 3 >0.1 12 3 >0.5
Spectinomycin " 6 1 >0.1 12 1 >0.05
Streptomycin " 25 9 >0.5 50 14 >0.1
Sulphamethoxazole " 25 8 >0.1 47 14 >0.5
Tetracycline " 35 19 >0.1 33 10 >0.5
Trimethoprim " 12 4 >0.1 23 5 >0.1
* Probability from test
N/A Not applicable
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II TRANSFER OF THE GENE RESPONSIBLE FOR MRHA FROM UTI ISOLATES
Examination of MRHA-positive strains for transferable plasmids
Previous reports had stated that the genes for the production
of MRHA fimbriae were chromosomal 1y located, but certain '
observations in this laboratory had lead to the assumption that a
plasmid location for these genes was possible. Therefore one aim
of this project was the identification of this putative plasmid.
The simplest method of detecting the presence of plasmids is to
allow the transfer of a selectable marker between the clinical
strain and a suitable recipient, and then select for the presence of
this marker in the recipient strain. The most convenient characters
to test for transfer are antimicrobial drug resistance determinants,
which are easy to select for by plating the mating mixture on to DM
agar plates containing the drug in question. As it is impossible to
select for transfer of MRHA ability directly, its transfer can only
be detected by screening the transconjugants obtained from, for
example, an R-plasmid transfer.
Transfer of R-plasmids from the clinical strains
Another 137 enterobacterial strains were isolated from the
urine of patients with lower UTIs in the Royal Infirmary, Edinburgh
and Edinburgh General Practice outpatients. These strains were also
screened for the characters outlined in section I and added to the
100 lower UTI strains used for the statistical survey. Ninety-nine
of these 237 strains were MRHA-positive for human group A
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erythrocytes and 62 of these were resistant to one or more of the
antimicrobial drugs tested.
Fifty-nine of the antimicrobial drug resistant strains were
tested for transfer of resistance plasmids. The remaining three
strains were resistant to Sx alone, and as this resistance
determinant is particularly difficult to use as a marker for R-
plasmid transfer these strains were not tested further.
Each clinical strain was mated with E. coli J62~2 f°r*18 hours
(Plasmid transfer, Methods) and the mixture was then plated on to DM
medium containing the supplements for strain J62~2 (proline,
histidine and tryptophan), rifampicin at 25jug/ml and an
antimicrobial drug, resistance to which was encoded by the clinical
strain. If no transfer of this latter marker was obtained the other
resistance markers of the clinical strain were individually tested
for transfer. Seventeen strains possessed transferable R-plasmids
and these are listed in Table 6 with their resistance pattern,
source, the selection agent and the resistance markers transferred.
Strain 815 transferred a Km R-plasmid and grew on the DM medium
containing this drug, but the resistance marker was subsequently
lost when the selective pressure was removed.
Haemagglutination of R-plasmid containing transconjugants
The transconjugants from the 17 strains listed in Table 6 were
assayed for their ability to produce MRHA of human group A
erythrocytes. Eight transconjugants from each strain were picked
off the mating plate and purified on the same type of selective
media. It was decided that for most purposes eight transconjugants
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Table 6 Clinical strains which possessed R-plasmids, their
resistance pattern, selection media and markers
transferred.





E. coli 116 H ApCmSmSpSxTp Sm Sm
E. coli 121 H ApCm Ap Ap
£. coli 738 H ApTc Ap Ap MRHA
E. coli 767 H SmSpSxTc Tc SxTc MRHA
E. coli 768 H ApCmSpSxTcTp Tp ApCmSxTcTp
E. coli 792 H
t
Ap Ap Ap MRHA
E. coli 810 H ApTc Ap ApTc MRHA
E. coli 815 H ApCmKmSmSpSxTc Km MRHA
E. coli 819 H ApTc Tc ApTc MRHA
P. mirabilis 828 H ApCmSmSxTc Tc ApTc MRHA
E. coli 838 H Ap Ap Ap MRHA
E. coli 1878 H ApKmSmSxTc Km ApKmSmSxTc MRH
E. coli 1995 GP KmSmSpSxTc Tc SmSpSxTc MRHA
E. coli 4730 GP ApCmSmSxTcTp Tp ApSmSxTp
E. coli 4757 GP SmTc Tc SmTc
E. coli 4811 GP ApTc Tc ApTc MRHA
E. coli 4950 GP ApKmSmSxTp Tp KmTp MRHA
H = Hospital
GP = General Practice
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from each mating would be purified and then tested further. Not all
the strains selected for purification were true transconjugants
and subsequently did not grow on the selective media. For this
reason, the number of transconjugants that were assayed varied.
These purified transconjugant strains were then inoculated into BHI
broth and assayed for HA ability. Transconjugants from 12 of the
original strains were shown to be MRHA-positive (Table 6). The
E. coli J62~2 recipient strain was used as a negative control for
these assays. The results obtained for strain 4950 are shown in
Figure 2.
The proportion of transconjugants from each strain that were
MRHA-positive varied. The numbers obtained are shown in the table
below.
Strain no. 738 767 792 810 815 819 828 838
No. MRHA+
No. tested
5/8 2/2 6/7 4/8 2/3 4/6 1/5 2/8
Strain no. 1878 1995 4811 4950
No. MRHA+
No. tested
2/6 2/6 '3/4 5/6
Each of the MRHA-positive transconjugants was tested on DM agar
containing the necessary J62~2 supplements (proline, histidine,
tryptophan) and DM agar containing proline and tryptophan, but
lacking histidine. If the strains are E, coli J62~2 they grow on
the fully supplemented plates but not the plates which lack
histidine. By this method it was confirmed that the MRHA gene had
been transferred to E. coli J62~2. Eleven of the clinical strains
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Figure 2 Microtitre plate showing some of the MRHA-positive and
MRHA-negative transconjugants obtained from strain 4950.
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which were able to transfer this gene were E. coli and the twelfth,
strain 828, was Proteus mirabilis, as determined with the Api
system. These J62-2 transconjugants will be referred to with the
suffix J6 after the strain number.
Molecular analysis of the MRHA-positive transconjugants
In order to determine the size and number of plasmid species
transferred, the DNA was prepared from the clinical strains and the
E. coli J62~2 transconjugants, by Triton X-100 lysis. The extracted
plasmid DNA was separated by agarose gel electrophoresis in parallel
with the DNA of at least three molecular size standards. After
completion of electrophoresis and ethidium bromide staining,
followed by destaining of the agarose gel in distilled water, the
distance moved by the standard plasmid bands was plotted against the
log^O of the standard plasmid molecular size. The standard curve
produced was used to determine the size of the test plasmids. The
plasmid data obtained are shown in Table 7, and Figures 3 to 6.
The sizes of the plasmids present in the clinical strains and
transconjugants varied between 53 and 73 kbases (kb), except for the
larger plasmids in strains 810, 4950 and 4950-J6. The variation in
molecular weight of the plasmids between 4950 and 4950-J6 probably
results from recombination or dimerisation between plasmids from
strain 4950 in 4950-J6. Smaller variations also exist between the
plasmids in the other E. coli clinical strains and their K12
transconjugants. In Figure strain 819 (lane 2) possessed a
105
Table 7 Plasmids present in the clinical strains and MRHA-positive
-~2 transconjugants
Clinical Plasmid sizes Transconjugant no. Plasmid sizes
Strain no. (kb) (kb)
738 73 738-J6 59
767 56 767-J6 -
792 - 792-J6 69
810 65 90 810-J6 58
815 - 815-J6 -
819 58 819-J6 53 71
828 - - 828-J6 53 71
838 - 838-J6 55
1878 - 1878-J6 68
1995 59 68 1995-J6 55 68
4811 68 4811-J6 68
4950 53 98 161 4950-J6 53 134
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Figure 3 Agarose gel of clinical strain 4950 and its MRHA-
positive J62~2 transconjugant 4950-J6. Plasmid







C = Chromosomal DNA
plasmid of 58kb which was visible on the original gel, but did not
reproduce on to the photograph.
No plasmid was common to most or all of the strains examined
which could be implicated as the carrier of the MRHA gene. There
was also a variation in the resistance pattern of the strains
examined, however the determinants for Ap and Tc resistance were
predominant (Table 6) on the plasmids in the MRHA-positive
transconjugants. The heterogeneity of the plasmid species indicates
that the presence of the MRHA gene in these 12 strains had not
arisen due to cross-infection of one plasmid species.
The transconjugants 738-J6, 792-J6, 810-J6, 838-J6, 1878-J6 and
4811-J6 contained a single plasmid, Figures 4 and 6 (strains 738-J6
and 810-J6 are not shown), therefore in these strains the MRHA gene
and the resistance determinants must be carried on the same plasmid.
Two sizes of plasmid were present in these strains, 68-69kb and 55-
59kb, but the resistance pattern of the similarly sized plasmids was
different.
In contrast, transconjugants 819-J6, 828-J6, 1995-J6 and 4950-
J6 all contained two plasmids (Figures 3, 4 and 5) which were of
similar molecular sizes in 819-J6, 828-J6 and 1995-J6. One of these
plasmids could be a virulence plasmid, i.e. carry the MRHA gene and
essential plasmid functions for replication and transfer, and the
$
second plasmid could possess the resistance determinants.
Alternatively both plasmids could be classed as R-plasmids, one of
which also possessed the MRHA gene. This can be determined in part
by measuring the transfer frequency of each gene between strains.
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Figure 5 Agarose gel of clinical strains 767,
their MRHA-positive transconjugants.
isolated by Triton-lysis.
819 and 828 and
Plasmids were
1 2 3 4 5 6 7
Lane 1 819-J6 Lane 5 R6K
2 819 6 RP4
3 828-J6 7 R15
4 828
C = Chromosomal DNA
Figure 6 Agarose gel of clinical strains 792, 767, 815 and 838,
and their MRHA-positive transconjugants. Plasmids were















No plasmids were observed in 767-J6, 815 or 815-J6 (Figure 6),
this could be due to the inability to detect a plasmid with the
technique used or that either the whole plasmid, in the case of 767-
J6, or the MRHA gene alone, in the case of 815-J6, had inserted into
the chromosome after transfer. The preparation of DNA from these
two strains and their transconjugants was repeated using alkaline
lysis, but still no plasmids could be detected (Figure 6).
Only one plasmid with a molecular size of 58kb was detected in
the clinical strain 819, whereas its transconjugant 819-J6,
possessed two plasmids of molecular sizes 53 and 71kb. Also no
plasmids could be detected in the clinical strains 792, 828, 838 or
1878 (Figures 4 and 6). This could possibly be explained by the
difficulties encountered in lysing clinical isolates with Triton X-
100, as it is only a gentle detergent and often a solution of SDS
had to be added to complete the lysis. Also several phenol/
chloroform steps often had to be performed before a suitable
solution from which to precipitate the DNA could be obtained. All
these points could contribute to a poor representation of the
plasmid content of some of the clinical strains.
As before, the DNA was prepared from those strains in which no
plasmid had been detected by alkaline lysis, but resolution of
plasmid bands was still not observed.
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Transfer frequencies of resistance determinants from E. coli J62-2
to E. coli J53
The MRHA gene had been transferred from clinical strains to
E. coli J62-2* However, in order to check that this was not just an
artefact and that the MRHA gene was readily transferable to other
strains, the MRHA-positive J62~2 transconjugants were mated with
E. coli J53 for one hour at 37°C. The J53 transconjugants were
selected on DM agar plates containing the J53 supplements, proline
and methionine, to select against J62—2, and the antimicrobial drug
used to select for the original transfer.
Strains which contained more than one plasmid, i.e. 819-J6,
828-J6, 1995-J6 and 4950-J6, were mated with E. coli J53 for one
hour as above, but plated on to the supplemented DM agar containing
Ap, Tc or Ap and Tc for strains 819-J6, 828-J6 and 1995-J6. The
mating mixture of strain 4950-J6 was plated on to Km, Tp, and Km and
Tp DM agar plates. This allows the frequency of transfer of the
resistance genes, both separately and together, to be calculated. A
suitable dilution of the donor culture was also plated on to
MacConkey agar to give the initial viable count of the organisms.
The transfer frequencies were determined using the equation:
No. of transconjugants /ml of culture
No. of donors/ml of culture
The transfer frequencies of the resistance determinants of
strains 810-J6 and 1878-J6 to E. coli J53 were also determined as
strain 810 originally possessed two plasmids and strain 1878-J6
possessed five resistance determinants. The calculated transfer
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frequencies are shown in Table 8. The Tc resistance determinant of
strain 767-J6 was also tested for transfer. This gene transferred
to E. coli J53 at a frequency of 3.09 x 10-^ even in the absence of
a detectable plasmid.
The similarity of the transfer frequencies of the resistance
determinants of strains 810-J6, 819-J6 and 828-J6 indicated that the
Ap and Tc resistance genes resided on the same plasmid, and in the
case of the transconjugants from strain 4950-J6 the Tp and Km
resistance determinants appeared to be carried on the same plasmid.
The Km and Tc resistance determinants of 1878-J6, and the Sm and Tc
resistance determinants of 1995-J6 also showed similar transfer
frequencies, implying the carriage of the genes on the same plasmid.
The presence of the resistance determinants on the same plasmid
was confirmed by randomly selecting 70 colonies from each of the
single antimicrobial drug plates for each of the six strains. These
colonies were tested for possession of the second resistance
determinant by spotting them on to DSTA plates containing the second
antimicrobial drug and DSTA plates without any antimicrobial, and
observing any growth on these plates after incubation for 18 hours
at 37°C. Strains 1878-J6 and 1995-J6 possessed more than two
resistance markers, therefore the selected J53 transconjugants from
these two strains were also tested for possession of Ap, Sm, Sx and
Sp,Sx resistance determinants respectively. It was found that of
each set of 70 transconjugants that was tested, all also possessed
the other resistance determinants of the J62~2 transconjugant.
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Table 8 Transfer frequencies for the resistance determinants from
E. coli J62~2 to E. coli J53.
Strain no. Transfer frequencies
810-J6 Ap 1.57 X 10-5 Tc 2.05 X 10~5 ApTc 1.48 X 10"5
819-J6 Ap 4.21 X 10~6 Tc 3.16 X 10-6 ApTc 2.11 X 10-6
828-J6 Ap 1.46 X 10"5 Tc 1.59 X 10-5 ApTc 3.29 X 10~5
1878-J6 Km 6.27 X 10-5 Tc 3.90 X 10~5 KmTc 4.58 X 10-5
1995-J6 Sm 1.13 X 10"4 Tc 9.65 X 10"5 SmTc 1.63 X 10"4
4950-J6 Km 2.02 X 10-5 Tp 1.99 X 10"5 KmTp 2.23 X 10-5
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Haemagglutination by the J53-transconjugants
Eight transcon j ugants, from the DM agar mating plates, from
each strain were purified on selective media of the same type, and
the purified strains used to assay HA ability. It was observed that
the transconjugants derived from a MRHA-positive parent could be
either MRHA-positive or MRHA-negative. The proportion of the J53
transconjugants that were MRHA-positive varied depending on the
strain. The number of MRHA-positive transconjugants are shown
in the table below.
Strain no. 738-J6 792-J6 810-J6 819-J6 828-J6 838-J6
No. MRHA+
No. tested
2/5 5/6 5/8 5/5 5/6 5/6
Strain no. 1878-J6 1995-J6 4811-J6 4950-J6
No. MRHA+ 4/6 5/6 5/8 5/8
No. tested
These results implied that the MRHA gene was not stably
inherited, however except for 738-J6 over half of the J53 trans¬
conjugants received the gene.
Plasmid-DNA content of MRHA-positive and MRHA-negative J53
transconjugants
In order to determine what differences existed between the
plasmid species in the MRHA-positive and MRHA-negative
transconjugants the plasmid DNA from both sets of strains was
extracted by Triton X-100 lysis and compared by agarose gel electro-
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phoresis (Table 9). The J53 transconjugants from strains 819-J6,
828-J6 and 1995-J6 (Figure 7) possessed only one plasmid compared to
the two observed in the J62~2 transconjugants. The 71kb plasmid
from 819-J6, the 68kb plasmid from 1995-J6 and the 53kb plasmid from
828-J6 were not present in the respective MRHA-positve or MRHA-
negative transconjugants, implying that these plasmids were either
cryptic or carried non-selectable markers.
The plasmid sizes in the corresponding MRHA-positive and MRHA-
negative J53 transconjugants were comparable, allowing for slight
differences of approximately two kbases in most cases. Therefore,
it appeared that loss of MRHA ability during or after transfer did
not correspond with loss of a plasmid. This suggested that
expression of the MRHA gene had been switched off in the MRHA-
negative transconjugants. It seemed less probable that the MRHA
gene had been lost from these strains as variations in the molecular
size of the plasmids gave larger sizes in the MRHA-negative
transconjugants of 738-J6, 838-J6 and 4811-J6, and plasmids of the
same size in the J53 transconjugants of 810-J6, 1878-J6 and 1995-J6.
Only MRHA-positive J53 transconjugants of 819-J6 were obtained so a
comparison was not possible.
The results presented in this section detail the first evidence
that the MRHA gene is plasmid encoded. The plasmids which possess
this gene form a heterogeneous population of R-plasmids, from which
the MRHA gene can be lost during conjugative transfer.
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Table 9 Plasmids present in the MRHA-positive and MRHA-negative
J53 transconjugants
Plasmid sizes (kb)
MRHA+ J53 MRHA- J53










4950-J6 53 134 134
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Figure 7 Agarose gel comparing tne plasmids present in the MRHA—
positive or -negative J53 transconjugants of strains
819-J6, 828-J6 and 1995-J6. Plasmids were isolated
using Triton lysis.









Ill MOBILISATION OF THE MRHA GENE BY AN R-P1ASMID
As stated at the beginning of section II, transfer of HA
ability cannot be selected for directly and another character of the
donor cell has to be used. Thirty-seven of the 99 MRHA-positive
clinical isolates possessed no resistance determinants which could
be used for selection after plasmid transfer. This problem can be
overcome by introducing an R-plasmid into the clinical isolate.
This provides a selectable marker and may also mobilise transfer
deficient plasmids.
Plasmid mobilisation by R483
The Tp R-plasmid, R483, was introduced from its E. coli J62~2
host into four of the antimicrobial drug sensitive clinical strains,
1864, 1871, 1872 and 1877, during an 18 hour mating.
Transconjugants expressing the Tp resistance determinant were
selected for on DM medium containing Tp at 100pg/ml but no amino
acid supplements, to allow only the auxotrophic clinical strains
which contained R483 to grow.
Two of the clinical strains, 1864 and 1871, stably inherited
R483. The transfer frequency for Tp into the clinical strains was
7.9 x 10~6 for strain 1864 and 1.1 x 10-^ for strain 1871. Strains
1864 (R483) and 1871 (R483) were then mated for 18 hours with
E. coli J62~2 and selection made on DM medium containing proline,
histidine, tryptophan, rifampicin at 25pg/ml and Tp at 100pg/ml.
1864 (R483) transferred the Tp resistance determinant to E. coli
J62~2 at a higher frequency (2.3 x 10"^) than 1871 (R483) which gave
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a transfer frequency of 4.4 x 10~5. Five transconjugants from 1864
(R483) and six from 1871 (R483) were purified on the same selective
media, and these purified strains were assayed for HA ability. One
of the transconjugants from 1871 (R483) was MRHA-positive for human
group A erythrocytes, but all the transconjugants from 1864 (R483)
that were tested were MRHA-negative. The MRHA-positive trans¬
con jugant, 1871-J6 (R483) was tested on DM agar containing all the
J62~2 supplements and DM agar with all the supplements except
histidine. Growth of 1871-J6 (R483) on the fully supplemented
plates, but not on the histidine-negative plates confirmed that the
transconjugant was a J62—2 strain. The HA titre (1/bacterial
dilution) was less for the transcon jugant than for the wild type
parent, as 1871-J6 gave a HA titre of 2 compared to the titre of 8
obtained for 1871 (Figure 8).
Plasmid determination of 1871 and 1871-J6
In order to determine the nature of the plasmid which had
transferred the MRHA gene from 1871 to 1871-J6, the plasmid DNA from
the two strains was prepared by alkaline lysis and characterised by
agarose gel electrophoresis (Figure 9). Strain 1871 possessed two
plasmids with molecular sizes of 26 and 52kb, whereas strain 1871-J6
contained only one plasmid with a molecular size of 98kb. DNA from
a J62~2 strain which contained the standard R483 plasmid had been
run in parallel with these two strains, and the molecular size of
R483 was calculated as 90kb. As the 98kb plasmid was the only one
detectable in 1871-J6, it suggested the possibility that R483 was
the only plasmid to transfer from the Tp-resistant strain 1871 and
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Figure 8 Microtitre plates showing the comparative HA titres of
strains 1871 and 1871-J6 and a MRHA-negative transconjugant.
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Figure 9 Agarose gel of strains 1871 and 1871-J6. DNA was
prepared by alkaline lysis.
Lane 1 R483 / Sa
2 1871-J6
3 1871
that the MRHA gene had been transferred on R483, rather than by the
transfer of one of the clinical plasmids. The presence of R483 in
1871-J6 was also inferred by the fact that when spotted on to DSTA
containing Sm or Sp growth of the transconjugants was observed,
implying that the Sm/Sp resistance determinant of this plasmid had
been co-transferred. Thus it appeared that molecular recombination
had occurred between R483 and either the chromosome or one of the
two plasmids of strain 1871.
Transfer of R483 and the MRHA gene to E. coli J53
In order to confirm that the MRHA character was readily
transferable, strain 1871-J6 was mated for 18 hours with E. coli
J53. Transconjugants were selected on DM medium supplemented with
proline and methionine and containing Tp at 100pg/ml. The Tp
resistance determinant transferred at a frequency of 1.75 x 10-5.
Eight transconjugants were purified on DM media containing Tp and
then spotted on to DSTA agar containing Sm or Sp to test for co-
transfer of these genes. All eight colonies possessed the Sm/Sp
resistant determinant. These transconjugants were then assayed for
their HA ability. One of these transconjugants, 1871-J5, was MRHA-
positive for human group A erythrocytes.
Bacteriophage PI transduction of the MRHA gene
To confirm that the MRHA gene was carried on R483 and not on
another plasmid that was not detectable in 1871-J6, PI transduction
was performed using the Tp resistance of R483 to select for
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transductants. The molecular size limit that PI can transduce is
approximately 102kb, close to the size of R483. Therefore, if
transduction of R483 is selected for and the MRHA gene is co-
transduced, it would indicate that the MRHA gene did reside in R483.
E. coli N99 contains a heat inducible PI lysogen. If this
strain is grown at 30°C growth proceeds normally, but growth of the
culture at 42°C induces the PI lysogen to enter the lytic cycle.
This heat induced lysate, when mixed with an indicator strain such
as 1871-J6, will infect the indicator and proceed through the lytic
cycle during growth at 37°C. The PI phage will pick up and package
DNA from the indicator strain as well as its own PI DNA. This
•phage preparation can, in turn, be used to transduce a suitable
recipient. Transductants were selected for on DM media containing
the E. coli J53 supplements (proline and methionine) and Tp at
100}ig/ml. Eight of the resultant transductants were purified and
spotted on to DSTA containing Sm or Sp. All the Tp-resistant
transconjugants were also Sm-resistant but not Sp-resistant, and
five out of eight of the transductants were MRHA-positive for human
group A erythrocytes (Figure 10). These transductants were tested
on DM agar containing the J53 amino acid supplements and DM agar
lacking methionine to check that the transductants were J53 strains.
As the MRHA gene had been co-transduced with the Tp and Sm
resistance determinants it seemed probable that all these genes were
carried on the same plasmid.
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Loss of R483 from 1871-J6 using an incompatible plasmid
As two plasmids of the same incompatibility group cannot stably
co-exist in the same cell, due to similarities in the replication
regions, the introduction of the inc I°C R-plasmid JR66a into a
strain containing R483 would, under suitable conditions, result in
the loss of R483. The concomittant loss of the MRHA gene with the
R483 resistance determinants would prove the physical association of
these markers.
Therefore, plasmid JR66a was introduced into 1871-J6 during a
one hour mating at 37°C. Strain 1871-J6 transconjugants containing
JR66a were selected on DM agar containing the J62~2 supplements, Km
at lOpg/ml and rifampicin at 25pg/ml. Eight of the resultant
transconjugants were purified on the same type of selective media,
and once purified were tested on DM agar containing the J62-2
supplements, Tp at lOOpg/ml and Km at lOpg/ml. If R483 had been
lost no growth of the organisms should occur on these latter plates.
All the strains tested were resistant to Tp, suggesting that R483
might still be present. In order to determine this, the 1871-J6
(JR66a) purified strains were mated for two and a half hours with
E. coli J53. Selection was made on DM agar containing the J53
supplements and either Tp at lOOjig/ml or Km at 10^ig/ml. Transfer of
the Km but not the Tp resistance determinant was observed. Ten of
the Km-resistant transconjugants were purified on the Km selective
media and then assayed for HA ability. All the transconjugants
tested were MRHA-negative for human group A erythrocytes. This
suggested that the MRHA gene had been lost concommitantly with R483,
but that the Tp-resistance determinant, Tn7, of R483, had transposed
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on to the bacterial chromosome first, conferring non-transferable
Tp-resistance on strain 1871-J6 (JR66a). As JR66a is also Sm-
resistant, loss of the Sm resistance determinant of R483 could not
be tested for.
Transposition of the MRHA gene to plasmid RP4
Previous results had shown that the MRHA gene had integrated
into R483. This could have occurred by either active transposition
of the MRHA gene into R483 or the gene could have been picked up by
R483. In order to demonstrate if the MRHA gene was capable of
transposition, another R-plasmid, RP4, was introduced into strain
1871-J6 during a five hour mating. Plasmid RP4 is only 52kb
compared to R483 which is 90kb, therefore, if transposition does
occur an increase in size of RP4 will be more readily identified and
measured. The procedure followed is outlined in Figure 11.
Transconjugants from the mating were selected on DM agar containing
the J62-2 supplements, Tp at 100}ig/ml and Km at lOjig/ml. Eight
transconjugants were purified on supplemented DM agar containing Tp
at lOOpg/ml and Km at lOpg/ml and also on supplemented DM agar
containing Tp at lOOpg/ml and Tc at lOpg/ml. Seven of the purified
transconjugants grew on the plates containing Tc, and five of these
also grew on the plates containing Km. One of the Tp, Km resistant
transconjugants was grown statically for 18 hours in BHI broth and
then successively subcultured three times in BHI broth in the
absence of antimicrobial drug selection. This will allow
transposition to occur between replicons.
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Figure 11 Series of mating experiments followed to allow
transposition of the MRHA gene into RP4.
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A suitable dilution of the third subculture was plated on to DM
agar containing the J62~2 supplements, Tp at lOOpg/ml and Km at
lOpg/ml. Organisms from this plate were purified on selective media
of the same type, then one of the purified strains was mated
with E. coli J53 for five hours. Transconjugants were selected on
DM containing the J53 supplements and Km at 20jig/ml. Nine hundred
and fifty seven transconjugants from this mating were spotted on to
DSTA and DSTA containing Tp at lOOjig/ml, to test for the Tp
sensitivity of the strains. Resistance to Tp indicates whether R483
or Tn7 is present. Of these 957 strains, 122 were Tp-resistant, 678
showed some mutation to Tp-resistance where only a few colonies grew
and 157 were Tp-sensitive.
Ten of the trimethoprim sensitive strains were purified on DM
agar containing the J53 supplements and Km at 20pg/ml. The 10
purified strains were assayed for their HA ability. Eight of these
strains were MRHA-positive for human group A erythrocytes, four gave
a HA titre of 2, and four a HA titre of 4, indicating that the MRHA
gene must have transposed on to RP4, and this plasmid had
transferred to E. coli J53 independently of R483.
Plasmid analysis of RP4 containing transconjugants
In order to determine the increase in size of RP4 due to the
insertion of the MRHA gene the plasmid DNA from one of the strains,
1871-J5 (RP4), with a higher HA titre was prepared and compared to
the native RP4 plasmid DNA (Figure 4b). An increase of only 1.3kb
was observed between the calculated molecular size of RP4 as 54.2kb
and the size of RP4 in 1871-J5 which was calculated as 55.5kb. This
121
size increase was too small to be the actual size of a functional
transposon. One reason for this could be the loss of non-essential
pieces of DNA from RP4, with the insertion of the transposon, to
retain the original size of the plasmid. Reported by Barth et al.
(1978) for Tn7 insertions in RP4. None of the resistance
determinants had been lost as all the transconjugants from the final
mating, above, were resistant to Ap, Km and Tc when spotted on to
DSTA containing these antimicrobials at lOpg/ml.
Transposition of the MRHA gene into plasmid Sa
In order to overcome the problem encountered with RP4 the inc W
R-plasmid Sa was introduced into 1871-J6 during a five hour mating.
This and the following procedure are outlined in Figure 12. Trans¬
conjugants containing Sa were selected on DM agar containing the
J62~2 supplements, Tp at 100)ig/ml and Cm at lOjig/ml. Eight trans-
conjugants were purified on selective media of the same type and
then one of these was successively subcultured three times in BHI
broth then plated on to DM agar containing the J62~2 supplements, Tp
at lOOpg/ml and Cm at lOpg/ml. Organisms growing on this plate were
purified on the same type of selective media and one of the purified
strains was mated for one hour with the JR66a-containing strain to
remove R483 and reduce the number of transconjugants which have to
be tested for Tp sensitivity. Transconjugants were selected on DM
agar containing the J62-2 supplements, Cm at 10pg/ml and neomycin
(Ne) at lOpg/ml. Plasmid JR66a will outgrow R483 and the resultant
transconjugants will contain plasmids Sa and JR66a.
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Figure 12 Outline of the procedure to allow transposition of the
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Figure 13 Agarose gel comparing the standard plasmid Sa to the Sa
plasmid species from the MRHA-positive 1871-J5.
Plasmids were isolated using alkaline lysis.
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Eight transconjugants were purified on the Cm, Ne containing
media, and one of these was mated with E. coli J53 for one hour. As
with the RP4 procedure, the J53 transconjugants were Tp-resistant,
but this determinant was non-transferable. Transconjugants were
selected for on DM media containing J53 supplements and Cm at
10}ig/ml. Six transcon jugants from this mating were purified and
assayed for HA ability. Four of these strains were MRHA-positive
for human group A erythrocytes, indicating that the MRHA gene had
transposed on to Sa.
Isolation of plasmids from 1871-J5 (Sa)
In order to demonstrate an increase in plasmid Sa due to the
insertion of the MRHA gene the plasmid DNA from 1871-J5 (Sa) and the
original Sa-containing J53 strain was prepared by alkaline lysis and
compared by agarose gel electrophoresis (Figure 13). The molecular
size of the standard Sa was calculated as 33.3kb and the Sa plasmid
species in 1871-J5 was calculated as 42kb. This gave the increase
in size of Sa due to the insertion of the MRHA gene as 8.7kb, very
similar to the original 7kb difference observed between R483 in
1871-J6 and the standard R483. This transposable element was given
the designation Tn4121.
Electron microscopy of strains 1871, 1871-J6 and J62-9
The ability of strain 1871-J6 to cause HA could have been due
to an artefact in the culture medium, as the transposition of the
MRHA gene had not previously been considered. For this reason
strains 1871, 1871-J6 and J62~2 were cultured for 48 hours in BHI
broth and then prepared for loading on to electron microscope (EM)
grids. Once dessicated, these prepared grids were shadowed with
platinum and observed under the EM. Using the EM it is possible to
see the exterior of the bacteria in greater detail and determine
whether they possess fimbriae.
It was shown that the surface of the clinical isolate, strain
1871, was covered with fimbriae (Figure 14a), the surface of E. coli
J62~2, the negative control, was devoid of fimbriae (Figure 14b),
but the MRHA-positive transconjugant, 1871-J6, also possessed
surface fimbriae (Figure 14c). This visually proved that the
ability of the transconjugants to cause HA could be related to the
production of fimbriae by these strains.
The identification of the MRHA on a transposon from a strain
which did not possess transferable R-plasmids provides a possible
explanation for the heterogeneous nature of the plasmid encoded MRHA
genes. Transposition could have originally occurred from the
bacterial chromosome to plasmids present in the same cell, allowing
its transfer and divergence through the bacterial population.
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IV FURTHER CHARACTERISATION OF THE PLASMID-ENCODED MRHA GENES
The existence and subsequent extraction of the transposable
MRHA gene from strain 1871 prompted the examination of the R-
plasmids which possessed this gene, and had transferred from the
clinical isolates to E. coli J62-2 (Section II), for similar
transposons.
Removal of transposons from plasmids possessing the MRHA gene
The extraction was performed byintroducing plasmid Sa into the
MRHA-positive transconjugants during a seven hour mating. The
subsequent procedure is outlined in Figure 15. Selection was made
on DM agar containing the J62~2 supplements, Cm at lOpg/ml and one
other antimicrobial drug, resistance to which was encoded by the
MRHA-positive J62~2 recipient strain (Table 10). This was Tc in the
case of 767-J6, 810-J6, 819-J6, 828-J6, 1878-J6, 1995-J6 and 4811-
J6, Ap for 738-J6, 792-J6, and 838-J6, and Tp for 4950-J6. Sa-
containing transconjugants of 815-J6 were selected on Cm alone due
to the loss of resistance markers from this strain (Section II).
Eight transconjugants from each mating were purified on the
same type of selective media, then one purified strain from each
mating was subcultured three times in BHI broth to allow
transposition of the MRHA gene to Sa. After subculture suitably
diluted cultures were plated on to DSTA containing Cm at lOpg/ml and
the antimicrobial which was used as the selection agent for the
mating. After growth four colonies from each plate were purified
and one of these from each strain was mated with E. coli J53 for one
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Figure 15 Mating series followed to obtain MRHA-positive, Sa-
containing transconjugants.
MRHA+ E. coli J62~2 (plasmid) E. coli J53 (Sa)
Selection
Cm and 2
E. coli J62-? (original plasmid ::Tn?)(Sa)
Subculture
x 3 BHI broth




E. coli J53 (Sa::Tn?)
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Table 10 MRHA-positive transconjugants and the selection procedure
for removing transposons.
Section Transconjugants Antimicrobial No.
Strain no. Media tested on Sensitivity MRHA+
738-J6 Cm Ap Cm Ap 16 ApS 6/8
767-J6 Cm Tc Cm Sx Tc 5 TcS 3/5
792-J6 Cm Ap Cm Ap All ApR -
810-J6 Cm Tc Cm Ap 8 ApS 4/7
815-J6 Cm Cm -
819-J6 Cm Tc Cm Ap Tc All Ap Tcr -
828-J6 Cm Tc Cm Ap Tc 27 Ap Tcs 3/8
838-J6 Cm Ap Cm Ap 15 ApS 5/7
1878-J6 Cm Tc Cm Km Tc All Tcr -
1995-J6 Cm Tc Cm Sm Tc 27 TcS 7/8
4811-J6 Oil Tc Cm Ap Tc 12 Ap Tcs 7/8
4950-J6 Cm TP Cm Km Tp All TpR -
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hour. Transconjugants were selected on DM agar containing J53
supplements and Cm at 10pg/ml. Seventy colonies from the mating
plate of each strain were spotted on to DSTA, DSTA containing Cm at
10pg/ml and DSTA containing each antimicrobial, resistance to which
was encoded by the original R-plasmid in the MRHA-positive
transconjugant.
It would be expected that all colonies would be Cm-resistant
due to the presence of Sa, but if no growth was observed on the DSTA
plates containing the other antimicrobials this would indicate that
the original plasmid had not been transferred during the short
mating time allowed.
The transconjugants from the seven strains which appeared to
contain Sa alone, from the sensitivity test results (Table 10,
columnm 4) were purified on the same type of selective media and
then tested on DM containing proline and methionine, and DM
containing only proline, to check that all the strains were J53.
HA ability of the Sa-containing transconjugants
Up to eight of these purified transconjugants from each of the
seven strains were assayed for their ability to agglutinate human
group A erythrocytes. The results obtained are shown in Table 10
(column 5).
In each case only the resistance markers for Sa were present in
the strains, indicating that the original clinical plasmid which
carried the MRHA gene was absent, and that the MRHA gene had
transposed on to Sa.
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Plasmid analysis of the MRHA-positive Sa-containing transconjugants
The DNA was extracted and purified from each of the E. coli
J53, Sa-containing strains by alkaline lysis. The plasmids from
738-J5, 767-J5, 810-J5, 828-J5, 838-J5, 1995-J5 and 4811-J5 were
compared to the standard Sa by agarose gel electrophoresis (Figure
16). Increases in the Sa plasmid species in all the MRHA-positive
transconjugants were observed, but there was a slight variation in
the size of this increase. Strains 738-J5, 1995-J5 and 4811-J5
possessed a 41.8kb plasmid and strains 767-J5, 810-J5, 828-J5 and
838-J5 possessed a 40.4kb plasmid. This was compared to a molecular
size of 33.4k"b obtained for plasmid Sa.
By deducting the size of Sa from the size obtained for the
plasmids in the transconjugants the size of the insertion due to the
presence of the MRHA gene was calculated as 8.4kb for strains 738-
J5, 1995-J5 and 4811-J5, and 7.0kb for strains 767-J5, 810-J5, 828-
J5 and 838-J5 (Table 11).
These values are very similar to the value obtained for Tn 4121
of strain 1871, therefore it is possible that the same gene and
transposon are present in all the strains, the 1.4kb difference in
the values obtained being accounted for by experimental variation,
and the ability of the gene to transpose has allowed its
diversification to a heterogeneous population of plasmids.
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Figure 16 Agarose gel comparing the standard plasmid Sa to the Sa
plasmids isolated from the MRHA-positive trans-
conjugants. Plasmid isolation was by alkaline lysis.
Lane 1 810-J5 Lane 6 1995-J5
2 738-J5 7 Sa
3 767-J5 8 R6K
4 4811-J5 9 RP4
5 828-J5
C = Chromosomal DNA
Table 11 Plasmid sizes in Sa-containing transconjugants.










Extraction of fimbrial proteins from the MRHA-positlve, Sa-
containing transconjugants
Preliminary work was carried out to examine the proteins
synthesised by the MRHA genes which had been inserted into plasmid
Sa. Fimbrial proteins were prepared from the MRHA-positive strains
728-J5, 767-J5, 810-J5, 828-J5, 1995-J5 and 4811-J5 which contained
Sa. The solubilised protein samples obtained were electrophoresed
through a polyacrylamide gel to separate the constituent proteins
contained in the samples.
Problems were encountered in obtaining a sufficiently high
protein concentration in the samples to visualise fimbrial protein
bands and in obtaining separation of these relatively small
molecular weight proteins. Fimbrial proteins from one strain, 4811-
J5 (Sa), were obtained in a sufficiently high concentration*,
however, success was not achieved with the other five strains.
Figure 17 shows the results obtained. Strain 4811-J5 (Sa) was
run in parallel with E. coli J53 as a negative control, E. coli T1
and NK1 as positive controls for uropathogenic fimbriae, and the
original clinical isolate, 4811. Complete purification of the
fimbrial proteins from other outer membrane proteins was not
obtained, but it could be seen that E. coli T1 contained a major
band of 18,000 and a minor band of 17,400d. E. coli NK1 also
possessed these bands, but the proteins were present in lower
amounts, and there was also a protein of 17,200d which was assumed
to be the Type 1 fimbriae. Strain 4811 possessed two major bands of
18,200 and 17,400d. Both these protein bands were present in strain
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Figure 17 Polyacrylamide gel showing the fimbrial proteins
extracted from strains 4811 and 4811-J5 (Sa).
Lane 1 Molecular size standards Lane 4 E. coli XI
2 4811 5 E. coli NK1
3 4811-J5 (Sa) 6 J53
4811-J5 (Sa) which also contained an additional band of 16,800d.
Very faint bands could be seen in the 17,500 to 16,500d region in
strain J53, but there were no major fimbrial proteins.
These values correspond to those found by other workers. Mett
et al. (1983) obtained a value of 18,000d for their uropathogenic MR
fimbriae, K1 emm et a 1. (1983) reported a value of 18,200d for the
F12 fimbriae and values obtained for the multiple P fimbriae bands
ranged from 17,000 to 22,000d (Korhonen et al., 1982).
Obviously further work needs to be done on the other five
strains for comparison.
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V EXAMINATION OF STRAINS FROM RECURRENT UTIs
A collection of strains had been built up over a period of two
years. All these strains were isolated from the urine of a single
patient who suffered from recurrent UTIs. It was observed that
resistance to Tp developed after treatment with this drug and that
the gene was carried on a transferable R-plasmid. However, when
treatment with Tp was discontinued the R-plasmid still persisted in
the strains isolated from the urine. The discovery of the carriage
of the MRHA gene on a plasmid lead to the re-examination of these
strains for the MRHA pathogenicity character. The presence of this
gene on the Tp R-plasmid could be a contributing factor to the long
term nature of the infection by improving the survival of both the
plasmid and the host bacterium.
Background to the work performed in this section
A study was carried out over a period of 25 months on an
elderly female patient who suffered from recurrent UTIs. Urine
specimens were collected twice weekly and the bacterial pathogen
causing the infection was isolated from the urine, identified and
sensitivity tested. The infection was initially treated with a
seven day course of co-trimoxazole (Tp and Sx) until the infecting
strain developed resistance to Tp. The Tp resistance determinant
was plasmid-encoded and readily transferred to E. coli J62~2 with
the co-transfer of resistance to Ap, Sm, Sp and Sx. Trimethoprim
therapy was stopped, but the R-plasmid persisted in the strains
isolated from the urine. Eleven months after the beginning of the
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study this R-plasmid was absent from the infecting strain but
subsequently reappeared three months later when the infection was
again treated with Tp. The R-plasmid again persisted in the strains
isolated from the urine for four and a half months until the patient
was treated with cephradine (Amyes et al., 1981). However, after a
further period of two and a half months a Tp-resistant E. coli was
again isolated from a further infection.
MRHA ability of the Tp-resistant transconjugants
Of the strains isolated, ninety-five transferred Tp-resistance
to E. coli J62~2 and it was these transcon jugants that were
examined further. The sensitivity of each transconjugant was tested
by spotting the culture on to DSTA containing the standard
antimicrobials used in Section I and listed in Table 4. All ninety-
five transconjugants were resistant to Tp, Ap and Sm at lOyg/ml and
Sp and Sx at lOOpg/ml. Each of these ninety-five strains were
cultured in BHI broth and assayed for their ability to agglutinate
human group A erythrocytes as before.
Twenty-four of the strains tested were MRHA-positive. These
MRHA-positive transconjugants were not spread evenly throughout the
25 month period. Of 65 transconjugants obtained over the first 19
months, only nine were MRHA-positive, whereas 15 out of 30
transconjugants obtained during the final six months of the study
were MRHA-positive (Figure 18). The presence of the MRHA gene in
the J62~2 transconjugants suggested that the gene was also plasmid
encoded in these strains, and that its efficiency of transfer with
the Tp R-plasmid increased with time and the number of re-
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infections, especially after cephradine treatment, but it is not
known if these two factors are related.
Plasmid analysis of the MRHA-positive transconjugants
In order to determine the size and number of plasmids that had
been transferred, the DNA was prepared from the 24 MRHA-positive
transconjugants by alkaline lysis and examined by agarose gel
electrophoresis (Figures 19 a and b). All the strains contained a
75kb plasmid, except for strains 110 and 112 where the calculated
molecular size of the plasmid was 83.8kb and 87.4kb respectively.
In addition, strains 91, 92, 94 and 102 contained a second plasmid
with a molecular size of lOOkb in the case of strains 91, 92 and 94,
and HOkb in strain 102. However, as the majority of strains
possessed only the smaller plasmid it could be assumed that it was
this plasmid that must carry the MRHA gene.
Plasmid analysis of the MRHA-negative transconjugants
The plasmid DNA from a selection of eight MRHA-negative
transconjugants spread over the 25 month isolation period was also
prepared and examined for comparison. These strains also contained
a single plasmid with a molecular weight of 70kb. The difference in
size of the plasmids in the two sets of transconjugants could be
seen when samples of both were run on the same gel. Figure 20 shows
strains 94, 92, 90 and 89 with MRHA-negative transconjugants
isolated in the same period.
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Figure 19a Agarose gel of plasmids isolated from strains 90 to 100.













C = Chromosomal DNA
Figure 19b Agarose gel of plasmids isolated from strains 101 to
112. Plasmid isolation was performed by alkaline lysis.
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Figure 20 Comparison of some MRHA- po s i t i v e and -negative
transconjugants. Plasmid isolation was by Triton lysis.
1 2 34 56789 10 11










Lane 1 MRHA strain Lane 7 MRHA-
2 94 8 89
3 92 9 R6K
4 MRHA- 10 RP4
5 MRHA- 11 R1
6 90
C = Chromosomal DNA
The absence of the MRHA gene from the transconjugants did not
correspond to loss of a plasmid, further confirming that the 75kb R-
plasmid carried the MRHA gene, and that this gene alone had been
lost from the plasmids in the MRHA-negative transconjugants. This
fact indicated that the MRHA gene could be contained within a
transposable element in these strains.
Extraction of putative transposons from MRHA-positive
transconjugants
In order to confirm tne existence of this transposon plasmid Sa
was used as the mobilising vector and the MRHA gene extracted by the
method outlined in Figure 15. Eight of the MRHA-positive transcon¬
jugants were selected - strains 89, 90, 91, 94, 95, 97, 98 and 112.
These consisted of two strains from each of the four periods of
o
infection (Fig. 18) to give a wide cross-section of the group.
Plasmid Sa was introduced into these eight strains during a five
hour mating and the transconjugants selected on DM agar containing
proline, histidine, tryptophan, Tp at lOyig/ml and Km at 20pg/ml.
Transconjugants resulting from each of the matings were purified on
the same type of selective media, then one purified transconjugant
from each strain was successively subcultured three times in BHI
broth. The third subculture was appropriately diluted and plated on
to DSTA containing Tp at lOpg/ml and Km at 20ptg/ml and incubated at
37°C. Four of the resultant colonies from each strain were then
purified on the same type of medium and one purified transconjugant
from each strain was mated for one hour with E. coli J53.
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Transconjugants were selected on DM agar containing proline,
methionine, and Km at 20pg/ml.
Seventy transconjugants from each strain were spotted on to
DSTA containing Ap, Tp, Km, Cm and DSTA alone. Strains which were
Km and Cm resistant, but Ap and Tp sensitive were purified on DSTA
and MacConkey agar, as these would contain plasmid Sa, but not the
clinical plasmid. The number of transconjugants possessing Sa alone
varied and are shown in the table below.
Strain no. 89 90 91 94 95 97 98 112
No. Sa alone 1/7Q 1/7Q 0/7Q 1/70 4/?0 4/7Q 4/70 1/y()
No. tested
These J53, Sa-containing transconjugants were then assayed for
their HA ability. Transconjugants from strains 89, 90, 95, 97, 98
and 112 were MRHA-positive for human group A erythrocytes.
Isolation of plasmids from the Sa-containing transconjugants
The plasmid DNA from the Sa-containing strains 89-J5, 90-J5,
95-J5, 97-J5, 98-J5 and 112-J5 was preprared by alkaline lysis and
compared to the standard Sa plasmid by agarose gel electrophoresis
(Figure 21). A molecular size of 35.2kb was calculated for Sa
compared to 44.4kb obtained for the Sa plasmid species in the MRHA-
positive transconjugants, except for strain 90-J5 which contained a
plasmid of 39.4kb.
The increase in size of Sa resulting from the insertion of the
MRHA gene was thus calculated as 4.2kb for strain 90-J5 and 9.2kb
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Figure 21 Agarose gel showing the comparison between the standard
plasmid Sa and the Sa piasmid species from the MRHA-
positive transconjugants. Plasmids were extracted by
alkaline lysis.
Lane 1 112-J5 Lane 6 89-J5
2 98-J5 7 Sa
3 97-J5 8 R6K
4 95-J5 9 RP4
5 90-J5 10 R1
C = Chromosomal DNA
for strains 89-J5, 95-J5, 97-J5, 98-J5 and 112-J5. The original
observed difference of 4.5kb between the plasmids in the MRHA-
positive and MRHA-negative transconjugants was lower than the value
of 9.2kb obtained with Sa as the vector, but the discrepancy is
probably because the clinical plasmid is quite large and small
increases in size are less accurate. The size of the inserted piece
of DNA as 9.2kb is very close to the size calculated for the
transposon identified in sections III and IV, indicating that the
same gene is probably present in all the strains. There was only a
4.2kb increase in the size of Sa in strain 90-J5, possibly because
part of Sa had been lost, as it is unlikely that in one strain the
gene would be half the size previously determined.
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VI EFFECT OF SUB-MICs OF ANTIMICROBIAL DRUGS ON BACTERIAL
HAEMAGGLUTINATI0N
Sub-inhibitory concentrations of antibiotics are known to
affect the adhesive ability of bacteria. Most studies have been
carried out with antibiotics present at a quarter of the minimum
inhibitory concentration (MIC). This effect on adhesion produced by
the sub-inhibitory concentrations of antibiotics might be of less
importance and relevance with the presence of the MRHA gene on an R—
plasmid (Section II and V) which can code for resistance to high
levels of antimicrobial drug.
Strains and conditions used in the study
In order to determine the effect that these sub-lethal levels
of antimicrobial drug produced on the HA caused by the MR fimbriae
of uropathogenic enterobacteria, two isolates from the City Hospital
were used. These two strains, Proteus vulgaris 95997 and E. coli
202, were chosen because they both had relatively high HA titres, so
any reductions in HA ability could be easily assayed quantitatively,
and also they were relatively sensitive to most of the antimicrobial
drugs as determined on DSTA. Strain 95997 was resistant to Ap and
Sx, and strain 202 was resistant to Sm and Sx, compared to E. coli
J62-2.
BHI broth could not be used for the HA assay in these
experiments due to the antagonistic effect it is known to have on
the action of Tp and Sx, and possible effects it might produce on
other antimicrobials. Therefore the assays were performed with
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cultures which had been grown in Difco Mueller-Hinton broth, which
is not known to be antagonistic to the action of any antimicrobials.
*
MIC determination of strains 95997 and202
The MICs of strains 95997 and 202 were determined by
subculturing from an overnight culture of the organism in
Mue 11 er-Hinton broth into fresh 4.5ml aliquots of Muel ler-Hinton
broth which contained doubling dilutions of the antimicrobial drugs
tested. These cultures were incubated statically at 37°C for 48
hours (conditions which are used when assaying HA ability). The MIC
was taken as the lowest concentration of antimicrobial drug which
inhibited visible bacterial growth. The broth MIC values for the
strains are given in Table 12.
Determination of the effect of sub-MICs of antimicrobials on
adhesion
The concentration of antimicrobial drug which constituted one
quarter of the MIC was used in this set of experiments. For the
values given as > x in Table 12, x was the concentration of
antimicrobial drug used as the quarter MIC.
Overnight cultures of the organisms in Mue11er-Hinton broth
were subcultured into fresh 4.5ml aliquots of Muel ler-Hinton broth
containing the antimicrooial at a quarter of its MIC for each drug
tested, and an equal number of Mueller-Hinton broths without any
antimicrobial drug. All broths were incubated statically at 37°c
for 48 hours. After this time, the cultures containing the
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Table 12 MIC values of P. vu lgaris strain 95997 and E. coli









Ap >500 8 >5000 8
Cm 8 2 2 500
Km 32 16 >500 250
Nal nd 4 4 4
Sm >32 2000 2000 2000
Sp 125 125 125 125
Sx 500 >2000 >2000 >2000
Tc > 4 4 250 4
Tp 16 0.5 0.5 0.5
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antimicrobial drug were used to assay HA ability of the strain, and
the same concentration of antimicrobial added to the drug-free
broths, which were then incubated for a further three hours. These
cultures were then also assayed for HA ability with human group A
erythrocytes.
Organisms which were grown for 48 hours in the presence of the
antimicrobial drug show the effect that the drug has on growing
bacterial cells. Those where the antimicrobial was added after 48
hours when the cells had reached stationary phase show the effects
of the antimicrobial drug on resting cells.
Effect on the haemagglutination of strain 95997
The results obtained are shown in Table 13. When cultures of
P. vulgaris strain 95997 were grown in the presence of the
antimicrobial drugs varying effects were observed. Sm, Sx and Tc
produced significant reductions in the HA titre but complete
inhibition was not observed. Km and Tp also produced a noticeable
effect, but this was less than that produced by the former three
antimicrobial drugs. Sp produced a slight reduction in HA, and Ap
and Cm had no effect.
The addition of antimicrobial drugs to strain 95997 during
stationary phase had little effect on the HA ability, expect for Sp
and Tc where complete inhibition was observed. Ap, Cm and Sm
produced slight reductions in HA ability, but Km, Sx and Tp had no
effect.
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Table 13 Effect of antimicrobial drugs on the HA activity of
strains 95997 and 202.
Amount of haemagglutination (1/bacterial dilution)
P. vulgaris 95997 E. coli 202
Antimicrobial Growing Resting Growing Rest:
None 64 64 4 4
Ap 64 32 4 4
Cm 64 32 CI 2
Km 8 64 CI 2
Nal nd nd 8 4
Sm 1 32 CI 2
Sp 32 CI CI 2
Sx 1 64 1 2
Tc 1 CI CI 4
Tp 8 64 1 4
CI - mliifcibioo
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Effect of antimicrobial drugs on the adhesion of strain 202
When the HA ability of strain 202 was assayed after
antimicrobial drug treatment, as above, the results differed
considerably (Table 13). Growth of this strain in the presence of
Sx or Tp reduced the HA titre, but did not completely inhibit the
agglutination, whereas growth on Cm, Km, Sm, Sp or Tc did bring
about complete inhibition. No effect was observed with Ap, and Nal
increased the amount of adhesion, as determined by HA ability. The
addition of the antimicrobial drugs to the organisms during
stationary phase had very little effect. Cm, Km, Sm, Sp and Sx
produced slight reductions, but Ap, Nal, Tc and Tp showed no effect
on the HA titre.
Introduction of R-plasmids into strain 202
In order to determine if these effects could still be produced
once the organism possessed resistance determinants to the
antimirobial drugs the R-plasmids RP4 (Ap, Km, Tc) and Sa (Cm, Km,
Sm) were introduced separately into strain 202 during an overnight
mating from the E. coli J53 hosts. Transconjugants were selected by
their resistance to Km at 50pg/ml.
The MICs of a purified transconjugant from each of these
matings were redetermined in Mueller-Hinton broth as before (Table
12).
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Antimicrobial effect on the HA of R-plasmid containing strains
The HA assay was repeated with cultures of 202 (RP4) and 202
(Sa) which had been grown in the presence (as the greatest effect
was produced with actively growing cells) of the new quarter MICs to
Ap, Km, Tc, and Cm, Km respectively, and the previous lower quarter
MICs to these antimicrobials. The results obtained are shown in
Table 14.
Ap had no effect on the HA of strain 202 (RP4) at either
concentration, reproducing the result obtained with the plasmid-free
strain. Km and Tc produced no effect when the organisms were grown
in the lower concentration of these two drugs, but at the elevated
quarter MIC complete inhibition of HA was observed.
The same trend was observed with strain 202 (Sa). Cm and Km
produced no effect at the previous quarter MIC value, but complete
inhibition of agglutination ability was observed when the quarter
MIC was raised.
From these results it can be seen that the greatest effect on
the HA of E. coli is produced with actively growing cells by
ribosomal protein synthesis inhibitors (Cm, Km, Sm, Sp, Tc),
presumably by interfering with the synthesis of fimbriae. Less
pronounced effects are produced by the folic acid synthesis
inhibitors (Sx, Tp) which indirectly affect protein synthesis. A
cell wall biosynthesis inhibitor such as Ap has no effect.
Negligible effects are produced with cells which have entered
stationary phase and already have fimbriae present on the cell
surface.
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Table 14 Effect of antimicrobial drugs on the HA ability of R-
plasmid containing strains.
a) Strain 202 (RP4)
Amount of HA in presence of antimicrobial
(pg/ml)
None Ap20oo Ap2 Km250 K™4 Tc64 Tci
Strain 202 4 - 4 - CI - CI
Strain 202 (RP4) 4 4 4 CI 4 CI 4
b) Strain 202 (Sa)
Amount of HA in presence of antimicrobial
(pg/ml)
None Cml25 Cm0.5 Km64 Km4
Strain 202 4 CI - CI
Strain 202 (Sa) 8 CI 4 CI 8
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The effect of protein synthesis inhibitors on an actively
growing culture of P. vulgaris is less dramatic, but Sp and Tc can
completely inhibit the HA when added during stationary phase.
The presence of an R-plasmid in strain 202 was not able to
overcome the effects produced if the antimicrobials were still
present at the quarter MIC of the strain.
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If E. coli, an organism which is a commensal in the gut, is to
cause infection it must possess certain characteristics to enable it
to establish an infection at various sites of the body. It has been
shown that factors such as the presence of fimbriae on the bacteria
is important in colonisation of the intestine and urinary tract and
that toxins also have a role.
Numerous surveys have been performed with extraintestinal
isolates, but the relative proportion of these strains which possess
each character tested varies from survey to survey. In addition,
which particular characters are tested for, the methods used and the
exact source of the isolates also varies. This can be illustrated
by comparing the results obtained from the survey detailed in
section I of the results and previous surveys on urinary tract
isolates.
From the values given in section I it can be seen that the
ability to cause HA was the most common property, expressed by 66%
of the lower UTI isolates, 62% of the chronic UTI isolates and 49%
of the faecal control strains. The subdivision of these reactions
into MSHA of guinea pig erythrocytes and MRHA of human group A
erythrocytes gave values of 26% MSHA and 45% MRHA respectively among
lower UTI isolates, 45% MSHA and 33% MRHA among the chronic UTI
isolates and, 40% MSHA and 30% MRHA among the faecal strains. The
proportion of organisms which produce MSHA is higher in the cases of
the chronic UTI isolates and the faecal strains which is to be
expected as Type I fimbriae are common to both pathogenic and non¬
pathogenic E. coli. However, relatively fewer of the lower UTI.
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isolates possess Type I fimbriae, but the proportion of strains
capable of MRHA is not correspondingly reduced.
More of the lower UTI isolates produce MRHA than the faecal
strains indicating that this is one factor which could be associated
with pathogenicity, but an increase in the percentage of MRHA-
positive strains would have been expected for the isolates from
chronic UTIs. Instead the level is only just above that of the
faecal strains. Normally strains from the more severe types of UTI
are more likely to cause MRHA. The strains which were examined came
from patients suffering from chronic UTIs because very few true
cases of pyelonephritis are diagnosed in Edinburgh. However, this
does not explain why the proportion of MRHA-positive strains from
this group is lower than from the lower UTI isolates.
Green and Thomas (1981) found that 56% of their isolates from
the urine of patients with pyelonephritis, cystitis and ABU produced
HA of human group A erythrocytes compared to 17% of the faecal
isolates from healthy controls. This former value was broken down
to give 52% of the cystitis isolates, 75% of the acute
pyelonephritis and 70% of the ABU isolates which were HA-positive.
Minshew et al. (1978b) showed that 50% of the strains isolated
from the urine of patients with UTIs produced MSHA of human group 0
erythrocytes compared to 15% of the faecal control strains. These
values are similar to those obtained by Green and Thomas (1981).
Vosti (1979) obtained values in this region as well, 63% of the
urinary strains he studied were able to agglutinate human
erythrocytes compared to 23% of the faecal controls (P<0.01).
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Similar values were also obtained by Varian and Cooke (1980) who
tested for the presence of fimbriae by observing adherence of the
bacteria to uroepithelial cells. Adhesion was observed with 52% of
the lower UTI isolates, 55% of the upper UTI isolates and 10% of the
faecal strains.
These values for HA ability correspond to those obtained for
the survey in this thesis for the UTI isolates, but all the values
for the percentage of faecal strains capable of producing HA are
much lower.
Much lower values were obtained by Ljungh et al. (1979); 23%
of strains isolated from acute urinary tract infections produced
MRHA of human erythrocytes and 11.5% MSHA of guinea pig
erythrocytes, 16.5% MRHA was observed among the faecal strains and
0.59% MSHA.
Brooks et al. (1980) looked at the proportion of strains which
possessed fimbriae, and they found higher percentages of strains
which were fimbriated compared to the values above, obtained for HA-
positive strains, 79% of their UTI strains were fimbriated compared
to 60% of the strains isolated from normal controls (0.02 >P >0.01).
However, no difference in the proportions of fimbriated strains from
the upper or lower urinary tract was observed.
The occurrence of the other characters tested were present at
lower frequencies than HA ability. Production of haemolysin and
utilisation of raffinose both occurred at 24% among the lower UTI
isolates, at 15 and 16% respectively among the chronic UTI isolates,
and 7 and 16% respectively among the faecal strains. The ability to
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produce a haemolysin has also been strongly correlated with
virulence in the urinary tract and this survey shows that there is a
higher proportion of haemolysin-positive strains isolated from the
urine than from the faeces. This character is also present at a
higher frequency among the lower UTI isolates than the chronic UTI
isolates. This is surprising as there was a positive correlation
between haemolysin production and MRHA ability for the chronic UTI
isolates but not the lower UTI isolates.
A significant association was found between haemolysin
production and HA ability by Green and Thomas (1981), 67% of the
urinary tract isolates which produced haemolysin also produced HA
(P <0.025). Of their UTI isolates 38% were haemolytic compared to
6% of the faecal strains. A similar association between haemolysin
and HA was found by Hughes et al. (1983).
Minshew et al.(1978b) observed 48% of UTI isolates produced
haemolysin compared to 5% of their faecal controls. These are
similar values for the frequency of haemolysin among faecal strains,
but twice as many UTI isolates produced haemolysin compared to those
examined in the Edinburgh survey. Brooks et al. (1980) found 43% of
their UTI strains were haemolytic which was significantly greater
(P < 0.001) than the strains isolated from normal subjects. This was
divided into 58% of the upper urinary tract strains and 27% of the
lower urinary tract isolates, but this difference was not
statistically significant. Values obtained by Cooke and Ewins
(1975) showed that 52% of UTI isolates and 5% of faecal strains were
haemolytic.
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In the current survey the proportion of strains able to produce
colicin V was less among the lower and chronic UTI isolates (12 and
18% respectively) than the faecal isolates (35%), which is in
contrast to results obtained by Minshew et al. (1978b) where 7% of
UTI isolates produced colicin V and no faecal strains were positive
for this character, and Vosti (1979) who found that HA-positive
isolates from the urinary tract were more likely to produce colicins
(P < 0.02). However, Hughes et al. (1983) observed that there was no
tendency for MRHA-positive strains to produce colicin V.
Due to the high percentage of faecal strains which produce
colicin V from the Edinburgh survey it cannot be considered as a
virulence character in UTIs. All these results are summarised in
Table 15.
The possession of antimicrobial drug resistance determinants by
the strains examined was not associated in any case with the MRHA
virulence character. The only trend that was noted was that the
percentage of resistant organisms increased from the faecal strains
to the lower UTI isolates to the chronic UTI isolates. This
increased resistance among the chronic UTI isolates could be due to
the longevity of the infections and the associated treatment with
antimicrobial drugs.
The proportion of strains isolated from the urine of patients
with UTIs, which possess virulence markers is higher than the
proportion isolated from the faeces of healthy controls. However,
some of the faecal strains still possess that character, indicating
that these strains could also be pathogenic. Therefore, it seems
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Table 15 Summary of survey results obtained by various workers
















15 50 (UTI) Minshew et al
(1978b)




10 52 55 Varian and Cooke
(1980)




0.59 11.5 II II
MRHA (human
gp. A)
30 45 33 Hales (1985)
MSHA (guinea
Pig)
40 26 45 II II
Fimbriae 60 79 79 Brooks et al
(1980)
Haemolysin 6 38 (UTI) Green and Thomas
(1981)
It 5 49 Minshew et al
(1978b)
II 9 27 58 Brooks et al
(1980)
II 5 52 Cooke and Ewins
(1975)
II 7 24 15 Hales (1985)
Colicin 35 12 18 Hales (1985)
II 0 7 (UTI) Minshew et al
(1978b)
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that the role of some of these pathogenicity factors is not always
straightforward.
Earlier work on the main classess of fimbriae from human and
animal enteric infections, CFA/I and II, K88 and K99, had shown that
the genes for the production of these fimbriae were carried on
plasmids (Evans et al., 1975; Penaranda et al., 1980; 0rskov and
0rskov, 1966; Smith and Linggood, 1972). It would therefore seem
reasonable to assume that the same would apply to the genes for the
production of uropathogenic fimbriae.
Hull et al. (1981) cloned both the Type I and P fimbriae from a
uropathogenic E. coli isolate, and by hybridisation of the cloned
fragments which expressed these genes to a plasmid present in the
strain was able to show by a lack of DNA homology that the genes had
originated from the chromosome. This theory for the chromosomal
location of the fimbrial genes was borne out by other workers (Rhen
et al., 1983a; van Die et al., 1983; Clegg, 1982; Berger et al.,
1982), usually because the initial restriction enzyme digestion
produced large DNA fragments of 35 to 40kb. In the case of strain
KS71 (Rhen et al., 1983a), of the several antigenic types of
fimbriae produced by the original strain, only one type was
expressed by each fragment, indicating that the genes were well
separated. The same was true for strain AD110 which produces F7
fimbriae and contained two plasmids of less than 12kb (van Die
et al., 1983).
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The only evidence for the existence of plasmid-encoded fimbriae
came from Kuch et al. (1980) who examined one urinary isolate which
produced MRHA of human erythrocytes. Spontaneous loss of the
ability to produce fimbriae was not observed but treatment of the
strains with ethidium bromide and mitomycin C led to the loss of
fimbrial production. This circumstantial evidence suggested that
the genes were plasmid-encoded and the strain had been cured.
Ethidium bromide was used to produce K88-negative mutants from
enteropathogenic strains (Jones and Rutter, 1972). However, Kuch
et al. (1980) performed no further genetic or molecular biological
experiments to demonstrate the presence of plasmids.
On the basis of this report it was essential to determine if
the fimbrial genes from the current survey could be plasmid-encoded.
The R-plasmids present in the lower UTI isolates from Edinburgh were
used as a means of selecting for transfer. By assaying the
transconjugants for the ability to cause MRHA, it was possible to
show that the genes for the production of fimbriae, in some of these
strains, could transfer between the clinical strain and the E. coli
K12 laboratory strain.
Quite a low proportion of strains possessed transferable R-
plasmids (28.8%), but the 12 strains which also transferred MRHA
ability were sufficient for further study. An examination and
comparison of the plasmids in the clinical strains and the trans-
conjugants revealed no one plasmid which was present in all the
strains. In some of the strains examined it was not possible to
visualise any plasmids even though transfer had occurred. This is
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probably due to limited sensitivity of the plasmid isolation
techniques used.
A variety of resistance determinants were associated with
transfer of the MRHA gene, although the determinants for resistance
to Ap and Tc were the most common genes to co-transfer. However,
this could be explained by the high levels of resistance to Ap and
Tc (38 and 35% respectively) among the strains rather than a direct
association of these genes. Echeverria et al. (1978) found a
similar association between the transfer of resistance to
antibiotics and LT and ST toxin genes. Further work showed that the
toxin genes and the resistance determinants for Sm, Su and Tc were
carried on the same plasmid (Echeverria and Murphy, 1980).
The MRHA character was not stable and was received by only a
percentage of the transconjugants when further transfers were
performed. Both MRHA-positive and MRHA-negative transconjugants had
received the R-plasmids and a comparison of the transfer frequencies
of the determinants showed that all the resistance determinants
within a strain were carried on the same plasmid. This suggested
that the two types of genes were not closely linked. However, loss
of MRHA ability from the E. coli J53 transconjugants was not
accompanied by loss of a plasmid but slight variations in the
molecular weight of the plasmid present in the strain.
Therefore this lack of expression of the MRHA gene could have
been due to a switching off of the operon. Once the clinical
strains have been removed from the urinary tract, there is no
pressure on them to produce fimbriae, whereas the continued
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expression of resistance determinants can be selected by growing the
organisms on selective media.
a.
The variations in molecular size of the plasmids was not
consistent and, in some cases, a slightly larger plasmid was present
in the MRHA-negative strains. It therefore seems unlikely that
complete loss of the MRHA gene had occurred.
The other MRHA-positive clinical strains, which did not possess
transferable R-plasmids may possess plasmids which encode the
fimbrial genes, however, the absence of positive selection for
fimbriated transconjugants makes their examination more difficult.
The presence of the MRHA gene on transferable plasmids will
allow easy transfer of the gene between bacteria. The occurrence of
this in vivo will lead to the spread of adhesive ability and
concurrently an increase in the pathogenic potential of the
recipient. This will result in the increase in the virulent
population of bacteria in the same way as the spread of R-plasmids
has increased the proportion of antibiotic resistant bacteria. Also
the excessive or prophylactic use of antimicrobial drugs in the
treatment of UTIs could increase not only the selective pressure for
the emergence of drug resistant bacteria, but also for virulent
organisms due to the association of the fimbrial genes with R-
plasmids.
The hypothesis that the MRHA gene was carried within a
transposable element arose when examining strains which possessed
plasmids but no resistance determinants. In an attempt to mobilise
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these plasmids from the clinical strains with plasmid R483, transfer
of the MRHA gene was achieved but the clinical plasmids were not
mobilised. The plasmid in the MRHA-positive transconjugant was very
similar in size to R483 and possessed the transposon Tn7 resistance
determinants, however, it was possible that this plasmid was not
R483, but a recombinant of the two clinical plasmids and Tn7. The
incompatibility of this plasmid with plasmid JR66a showed that it
was R483 as both plasmids are inc I ei .
It therefore appeared that the MRHA gene had been inserted into
the R-plasmid, but it was not known at this point whether this was
due to active transposition of the MRHA gene, or if R483 had excised
the gene from the chromosome or one of the plasmids. Further
experiments showed that this gene could move from one plasmid to
another so active transposition seemed a likely explanation. This
would be the first report of a MRHA gene being carried on a
functional transposon.
Subsequent to this observation the ability to transpose was
shown for the MRHA genes that were present on the R-plasmids which
had transferred from the 12 clinical strains, and for the strains
isolated from the recurrent UTIs. The genes from a selection of
these strains were inserted into plasmid Sa and it was found that
the molecular size of the inserts varied from 7 to 9.2kb.
To confirm that transposition was occurring the transfers would
have to be repeated in a rec A background, and fine genetic mapping
of the gene and its flanking regions performed to determine the
presence of any sequences homologous to IS elements.
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Further evidence for the role of transposons as carriers of
adhesin genes was provided by Rhen (1985) who described the presence
of inversely orientated DNA sequences flanking a deletable region
which encoded the B fimbriae of strain KS71. Hybridisation studies
showed that these sequences were approximately 1.2kb in length.
Further hybridisation studies with the cloned fragment encoding the
A fimbriae of strain KS71 indicated that only one set of sequences
was present and this region was not deletable.
Common DNA sequences of 0.85kb were also identified in the
vicinity of both ends of the cloned haemolysin structural gene of
E. coli strain 536 (06) (Hacker et al., 1983) and it was suggested
that these sequences might be identical with IS elements found
flanking the plasmid-encoded haemolysin sequences (Zabala et al.,
1982). The sequences adjacent to the plasmid haemolysin cistron
hybridised to chromosomal regions of haemolytic 018 and 06 E. coli
isolates and E. coli K12. This region of 1.5 to 1.8kb was retained
when the haemolysin determinant was spontaneously lost (Knapp
et al., 1984). This sequence was different from the 0.85kb region
described by Hacker et al. (1983), which was also present in
multiple copies in the bacterial chromosome. Homologous DNA
sequences flanking the chromosomal haemolysin determinant were also
found by Low et al. (1984).
Electron microscopic analysis of the cloned ST toxin gene
showed the presence of the characteristic stem and loop structure of
a transposon, therefore a non-transposable Tc resistance determinant
was spliced into the ST gene (So et al., 1979). This provided a
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marker to study transposition of the ST gene which occurred at an
approximate frequency of 4 x 10"6. Restriction and DNA sequence
analysis suggested that the ST transposon was flanked by inverted
repeats of IS1.
A study of the ST and LT regions of the enterotoxin plasmid
pJYll showed that the ST region consisted of at least two genes, tox
A and tox B which complemented one another in trans (Yamamoto and
Yokoto, 1981). This LT region was flanked by repeated DNA sequences
which were designated as JB. The ST gene, tox S, was flanked by the
inverted repeats of IS1 which were given the designation . The ST
region (tox S and ot ) was located between one of the J!) sequences and
the tox A and B genes, suggesting that the ST region was a
transposon which was carried within the LT transposon (Yamamoto and
Yokoto, 1981).
The presence of DNA sequences related to IS elements, whether .
functional or deficient, flanking such pathogenicity factors as
fimbriae and toxins suggests a common path or mechanism of evolution
for these determinants. Either the genes could have transposed into
the chromosome or plasmid from a particular source and then the
transposition function of the IS sequences were lost, although the
sequences themselves were retained. Alternatively, the genes could
have originally been present on the bacterial chromosome and the
homologous sequences to enable tranposition to occur are in the
process of evolving into functional entities. Maas (1981)
accurately forecast the location of fimbrial genes when he stated,
'Other questions that will be of interest in the future include the
possible location of adhesion factor genes on transposons and the
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possibility of phase variation for these genes, resulting in turning
on and off of gene expression'.
The ability of the MRHA gene to transpose freely from
chromosome to plasmid and back again, leaving a copy of the donor
molecule each time satisfies the conditions of stable chromosomal
inheritance and the ecological spread between strains by plasmid
transfer.
The presence of fimbriae on the bacterial surface aids the
colonisation of the urinary tract by providing a means to resist
expulsion by the flow of urine. Some women are more susceptible to
recurrent incidences of UTI and it has been shown that the bacteria
causing the reinfections are able to adhere better to the
uroepithelial cells than the bacteria causing the original infection
(Svanborg-Eden et al., 1979). If this difference is caused by an
increase in the receptors for the fimbriae on the epithelial cell
surface of these women, then possession of fimbriae by the bacteria
is going to be of a distinct advantage. Kallenius and Winberg
(1978) showed that a strain of E. coli isolated from a case of
pyelonephritis adhered to the epithelial cells of girls prone to
UTIs in greater numbers than to the epithelial cells of the healthy
controls.
From the study of recurrent UTIs in a single patient it was
again shown that the MRHA gene was able to transfer from the
clinical strain to E. coli K12 and that it was accompanied by R-
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plasmid transfer. Again the association of the MRHA gene with the
R-plasmid was not absolute, because although all the transconjugants
examined possessed the Tp R-plasmid only one quarter of them also
possessed the ability to produce MRHA. It would have been
interesting to determine what percentage of the original clinical
strains expressed the MRHA character and compare this to the number
of strains which were able to transfer the gene, but these strains
were not retained.
The initial treatment of the infection with Tp originally
selected for the R-plasmid, but once treatment had been discontinued
and the selective pressure removed loss of the plasmid from the
infecting strain would have been expected. It is probable that the
presence of an adhesin gene provided an additional advantage to the
strain in its continued ability to colonise the urinary tract. This
c.
gene may have originally been located either on the baj/terial
chromosome or the plasmid, however, the increasing incidence of
transfer at the end of the study suggests that it was originally
chromosomally located and then transposed to the R-plasmid.
There were periods when the R-plasmid was absent, but the same
plasmid would reappear in a further infection several months later.
The discontinuous perseverance of the same plasmid, as compared by
molecular size and resistance pattern suggests that the gut flora
could be providing a reservoir for this R-plasmid containing strain
and that reinfections were occurring via urinary tract contamination
by the faeces and then the ascending route of infection. On the
other hand plasmids can usually only survive for short periods of
time in the gut in the absence of selective pressure.
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The transfer efficiency of the MRHA gene to E. coli K12
appeared to increase during the last four months of the study. The
isolation of strains was relatively uniform over the 25 month period
of the study, as was the transfer of the Tp R-plasmid, but many more
MRHA-positive transconjugants were detected in the latter four
months. This increase could be due to the long term nature of the
infection and an increase in the susceptibility of the patient to
bacterial adhesion, perhaps providing indirect selection for
bacteria which possessed fimbriae, however, the number of the
original clinical isolates that were MRHA-positive is not known.
This increase in transfer surprisingly occurred two and a half
months after the infection had been cleared by treatment with
cephradine. Whether these two events were coincidental or linked in
some way is not known, however it seems unlikely that treatment with
a cephalosporin could induce transfer of the gene.
This situation is in some ways the converse of the other R-
plasmid encoded fimbriae, where over use of antimicrobial drugs
could result in an increase in the number of fimbriated bacteria.
In the case of this recurrent UT1 a single course of Tp therapy
selected for the R-plasmid, but then the problem in some respects
was the persistence and reappearance of the plasmid encoded
resistance determinants even in the absence of selection perhaps due
to the adhesin gene, complicating the antimicrobial treatment of the
infection. This indicates that one possible way to treat infections
of this nature would be to inhibit the attachment of bacteria rather
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than use the bacteristatic or bactericidal effects of antimicrobial
drugs.
The antimicrobial drugs which produce effects on the adhesion
of E. coli fall neatly into four groups determined by their mode of
action and the effect they cause: the protein synthesis inhibitors,
Cm, Km, Sm, Sp and Tc which completely inhibited the HA of strain
202 if they were present while the organism was growing; the folic
acid synthesis inhibitors, Sx and Tp which reduce the amount of HA
but do not cause complete inhibition; the peptidog1 yean
biosynthesis inhibitors, only one of which was tested (Ap), but no
effect on the adhesion was observed; and nalidixic acid, a DNA
gyrase inhibitor which produced a slight increase in the amount of
HA.
These effects were only observed if the antimicrobials were
added before the cells had entered the stationary phase of growth.
The protein synthesis inhibitors still produced a slight effect when
added during the stationary phase but did not completely inhibit HA.
The implication of these results is that if protein synthesis
is inhibited to some extent by low levels of antimicrobial drugs
during growth, production of proteinaceous fimbriae is reduced,
probably due to a reduced level of synthesis, but aberrations in the
protein produced or a lack of transport of the protein to the cell
surface may also play a role. The addition of these same drugs has
little effect on the fimbriae already present on the surface.
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Results obtained by Vosbeck et al. (1979) who looked at the
adhesion of an E. coli strain, isolated from a patient with acute
pyelonephritis, to a tissue culture line showed that a quarter MIC
of Tc reduced the adhesion by a third, but only slight reductions
were produced by treatment with Cm or Sm. Vosbeck et al. (1982)
went on to look at more isolates from UTIs. The HA of human group A
erythrocytes was decreased significantly after growth in Cm and Tc,
but less so with Sm. There were variations in the amount that
adhesion was reduced with the different strains. Sandberg et al.
(1979) also looked at the adhesion of strains isolated from patients
with acute pyelonephritis. At a quarter of its MIC Cm had virtually
no effect on adhesion of the bacteria to uroepithelial cells,
however, slight reductions were obtained with some strains. Shibl
and Gemmell (1983) also examined the effect that Cm and Sm produce
on the adhesion of a uropathogenic E. coli isolate to uroepithelial
cells. When present at one half of the MIC Cm and Sm reduced
adhesion to approximately one third of its original value.
It can be seen therefore that depending on which E. coli
strain is used some antimicrobials can significantly reduce adhesive
ability or have virtually no effect.
The same variation can also be observed with Ap, which in this
thesis produced no effect on the haemagglutination of the E. coli
strain, suggesting that any aberrations in the cell wall were not
great enough to affect the surface properties of the bacteria.
These results are in agreement with those of Vosbeck et al. (1979)
who found that Ap produced no significant effect on the adhesion of
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a pyelonephritic E. coli to cells of a tissue culture line. On the
other hand, Sandberg et al. (1979) found that a quarter MIC of Ap
consistently decreased adhesion of their pyelonephritic E. coli to
epithelial cells.
Inhibitors of folic acid synthesis produced some effect on the
HA of E. coli 202, probably due to the subsequent effect that
blockage of this pathway will produce on protein synthesis. Again
the inhibition was greatest if the drugs were present while the
cells were actively growing. A greater inhibitory effect was
observed by Vosbeck et al. (1979, 1982), who showed that at 1/64 the
MIC trimethoprim-sulphametrole could reduce adhesion of E. coli to
tissue culture cells by two thirds and that HA activity was also
significantly reduced.
The results obtained with E. coli 202 contradict the
observations of other workers especially with regard to Ap and the
protein synthesis inhibitors. In view of this the effect that
nalidixic acid produced on the HA of E. coli 202 was tested.
Vosbeck et al. (1979) had previously reported that nalidixic acid
increased the adhesion of E. coli, the amount that it was increased
varied with the strain (Vosbeck et al., 1982). The results in this
thesis also show that nalidixic acid increases HA and supports these
observations.
A different pattern of inhibition was observed for P. vulgaris.
Marked reductions in HA ability were observed following growth of
the organism in the presence of Sm, Sx and Tc, but the HA was not
completely inhibited. Again, little effect was seen if the
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antimicrobial drugs were added during stationary phase except for Sp
and Tc. These are both ribosomal protein synthesis inhibitors, but
in this case they have their effect during stationary phase, perhaps
indicating that in Proteus the synthesis of fimbriae does not occur
until late in the growth cycle, or that the fimbriae are synthesised
but collect in the cytoplasm and are not transported to the surface
until late on in growth.
A previous study on the effect that piperacillin and sagamicin
have on the adhesion of Proteus species from UTIs was performed by
Savoia et al. (1983). Both antimicrobials reduced the HA of a
P. mirabilis strain which was sensitive to both drugs, when present
at 1/8 and 1/16 of the MIC. Greater reductions were observed at 1/4
of the MIC, and sagamicin gave a larger reduction in HA than
piperacillin, but complete inhibition was not observed. The effects
on a P. inconstans strain which was resistant to piperacillin and
sagamicin were less evident and 1/4 of the MIC of piperacillin and
1/8 of the MIC of sagamicin increased adhesion.
The HA experiments were repeated with E. coli 202 which now
contained R-plasmids. The association between the MRHA gene and R-
plasmids which had been observed might have some influence on the
effects produced by sub-MICs of antimicrobial drugs. Ofek et al.
(1979) had shown that the MS adhesion of an isogenic Sm-resistant
mutant was no longer affected by sub-MICs of Sm, in contrast to the
Sm-sensitive parent, however, no investigation of R-plasmid
containing strains had been performed. The results obtained with
the R-plasmid containing E. coli 202 showed that if the
concentration of antimicrobial drug was raised to a 1/4 of the MIC
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of the resistance determinant, the same inhibitory effects on
adhesion were still seen. This effect was not produced if the 1/4
MIC of the original plasmid-free strain was used.
It is therefore possible that sub-MICs of antimicrobials could
be used to prevent bacterial attachment, providing that the MICs of
the strain were determined first and that the antimicrobial chosen
did not exhibit strain specificity. A problem that might arise from
this approach is that the low levels of antimicrobials could induce
the development of resistance and amplification of resistance genes.
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THE GENETIC CARRIER OF BACTERIAL ATTACHMENT
Barbara A. Hales and S.G.B. Amyes, Department of Bacteriology, University of
Edinburgh, Teviot Place, Edinburgh EH8 9AG, United Kingdom.
Bacterial attachment factors have been implicated in the establishment of
enterobacterial infections, both in the intestine and in the urinary tract
(Candy et al 1981; Svanborg-Eden et al 1981). In enteropathogenic
Escherichia coll these attachment factors can be plasmid-mediated, but their
genetic determinants in uropathogenic E. coll are uncertain, although they
are generally assumed to be carried on the bacterial chromosome . The
presence of pathogenic attachment factors on the surface of bacteria is
usually detected by the ability to agglutinate erythrocytes in the presence
of mannose (MRHA). However, it is not possible to employ this technique as a
selective procedure in the detection of gene transfer from one strain to
another. Therefore, in order to determine if the property of MRHA is carried
on a transferable genetic factor, such as a plasmid or transposon, indirect
techniques have to be used.
During routine isolation of strains responsible for significant bacteriuria
obtained from the Royal Infirmary in Edinburgh, various pathogenicity
characteristics were measured. Forty-five percent of these strains were
found to be MRHA-positive. In order to determine if this property is encoded
by a plasmid, the following procedure was employed. The trimethoprim (Tp)
resistance plasmid, RA83, was introduced by conjugation into those clinical
strains that did not already possess resistance plasmids (R-plasmids). The
strains containing R483 were then conjugated with the E. coli K12 strain
J6-2-2 and selection was made for Tp resistance. Only one transconjugant in
eight was found to possess MRHA ability. To determine if a plasmid from the
original strain had transferred, the cellullar DNA from this strain and the
transconjugant was prepared and characterised by agarose gel electrophoresis.
The original strain contained two plasmids of sizes 36 and 18 Mdaltons, but
the R483-containing transconjugant possessed only one plasmid with a
molecular weight similar to R483. This suggested that the MRHA ability had
actually been transferred onto R483, possibly due to the insertion of a
transposon within the plasmid.
As the molecular weight of R483 is 62 Mdaltons it is difficult to show
directly any increase in size of R483. However, when the transconjugant
plasmid DNA and that from R483 were separated by gel electrophoresis in 0.3%
agarose a consistent increase of approximately 5 Mdaltons was found in the
transconjugant DNA. This strongly suggests the MRHA ability is being
transported on a transposon. In further support of this, the MRHA gene could
be transferred successfully from strain J6-2~2 to the E. coll K12 strain J5-3
along with R483. In addition, the MRHA gene could be co-transduced with Tp
and streptomycin resistances into strain J5-3, suggesting that it had
inserted into the R483 genome close to these two resistance determinants.
The results describe the first report of the transfer, by conjugation, of the
MRHA gene associated with urinary tract bacterial pathogenicity, into a
standard E. coli strain. They show that the MRHA gene resides on a
transposon of about 5 Mdaltons in size and that it has been able to insert
into the R483 plasmid. It is still not known whether this transposon first
resided on the chromosome or one of the two plasmids in the original strain.
We thank the SHHD for grant number K/MRS/50/492 which funded this project.
Candy, D.C.A. et al. (1981) Ciba Found. Symp. 80: 72
Svanborg-Eden, C. et al. (1981) Ciba Found. Symp. 80: 161
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PI Relationship between Nasal Vims Levels, Inflammatory Response andFeverProduction in Influenza
D.M. COATES, C. SWEET, H.A. OVERTON and H. SMITH (Department ofMicrobiology, Univer¬
sity of Birmingham)
Influenza virus A/PR/8/34 (H1N1) produces similar nasal virus levels in the ferret to H3N2 strains,
but elicits a lower inflammatory response which correlates with a lower fever. To determine
whether these properties of PR/8 are related to the H1N1 subtype, recombinant strains clone 64b
(H1N2) and clone 31 (H3N1), and recent H1N1 strains A/USSR/90/77 and A/Fiji/15899/83 were
tested.
P2 Molecular Studies of the Differential Replication of Two Influenza Vims Clones
H.A. OVERTON, C. SWEET, D.M. COATES and H. SMITH (Department of Microbiology, Univer¬
sity of Birmingham)
Two clones of the recombinant influenza virus A/PR/8/34 — A/England/939/69 differ in their
sensitivity to pyrexia! temperatures. This is related to their different extent of replication in the
upper respiratory tract of ferrets, a factor which contributes to their difference in virulence.
Replication is being studied in vitro by examining synthesis of viral polypeptides and nucleic acids
at normal and pyrexial temperatures.
P3 EIA Detection ofPigs Which Lack Receptor forK88 Adhesin
D.S. CHANDLER, J.A. CRAVEN* and R.K.J. LUKE (School of Agriculture, La Trobe University,
and *Attwood Veterinary Research Laboratory, Westmeadows, Victoria, Australia)
An EIA procedure, utilizing immobilized K88 antigen or K88-producing bacteria, has been used to
detect pigs which lack the receptor for the K88 adhesin produced by some strains of Escherichia
coli. Samples from animals which lack K88 receptor (non-adhesive animals) do not react in the
EIA. Screening of 2400 pigs from 19 piggeries has shown approximately 20% of the animals to be
non-adhesive. The incidence on particular farms has been found to range from 8 to 40%.
P4 Characterization of Transferable FimbriaIAntigens from Uropathogenic Strains
B.A. HALES and S.G.B. AMYES (Department of Bacteriology, University of Edinburgh)
v The transfer of mannose-resistant haemagglutinating ability from uropathogenic strains to E. coli
' K12 can, in some cases, be mediated by indigenous plasmids. The gene responsible was shown to
be carried on a small transposon which has been inserted into plasmid Sa. The fimbrial proteins
have been purified and examined by SDS-PAGE.
P5 Cytotoxicity of a Bovine Isolate ofPasteurella haemolytica A1 for Elicited, Cultured, Peritoneal
MouseMacrophages
J.J.P. HUTCHINSON (International Development Laboratories, E.R. Squibb and Sons, Moreton,
Wirral)
The cytotoxicity of P. haemolytica Al, but not of E. coli, has been shown to be specific for
mononuclear leukocytes of ruminants. The current poster presents preliminary findings showing
that these organisms are cytotoxic for thioglycollate-elicited, cultured, peritoneal mouse macro¬
phages, and that cytotoxicity is manifest when growth ofP. haemolytica in tissue culture medium
causes the count to exceed a threshold level.
P6 Molecular Analysis of IncC Plasmids Specifying Multiple Antibiotic Resistance Found in Gram-
Negative Bacteria
H. GRIFFIN, T.J. FOSTER and D.C. COLEMAN (Microbiology Department, Trinity College,
Dublin)
IncC plasmids of 120 Mdal were found in different species of enterobacteria isolated from the
same ward of a Dublin hospital. Cloned DNA fragments carrying resistance markers were used as
hybridization probes to determine their relatedness.
M9
CARRIAGE OF THE MANNOSE-RESISTANT HAEMAGGLUTINATION GENE BY AN R-PLASMID
WHICH PERSISTS THROUGH A RECURRENT URINARY TRACT INFECTION
B.A.Hales and S.G.B.Amyes, Department of Bacteriology, University Medical
School, Teviot Place, Edinburgh EH8 9AG, Scotland.
A study was carried out over a period of 25 months on a female patient
suffering from recurrent urinary tract infections. Urine specimens were
collected regularly and the bacterial pathogen isolated and identified.
Initially the infection was treated with co-trimoxazole, but the infecting
E.coli strain developed resistance to trimethoprim (Tp). The Tp R-plasmid
containing strain persisted for 11 months even in the absence of Tp
therapy. Treatment with cephradine cured the infection (Amyes et al ,1981),
but strains possessing the Tp R-plasmid subsequently reappeared in a
further infection. These results indicated that some factor was playing a
role in the persistence of the R-plasmid in the absence of selective
pressure.
Ninety-five of the strains isolated over this period transferred Tp
resistance to E-c°1i K12 strain J62-2,and, in each case the resistance
determinants for ampicillin', streptomycin, spectinomycin and
sulphamethoxazole were co-transferred. The Tp-resistant transconjugants
were assayed for the ability to cause mannose-resistant haemagglutination
(MRHA) of human group A erythrocytes and 24 (25.3%) were shown to be
positive. These MRHA-positive transconjugants were more prevalent from
isolates of later infections - 9 out of 65 transconjugants in the first 19
months, and 15 out of 30 in the last 6 months of the study. The presence
of the MRHA gene in E.col i K12 suggested that the gene was plasmid
encoded, its efficiency oT~~ transfer increasing with the number of
reinfections.
The plasmid DNA from the MRHA-positive transconjugants was purified
and examined by agarose gel electrophoresis. All strains possessed the
same 75kbase (kb) plasmid. The DNA from aselection of MRHA-negative, Tp-
resistant transconjugants was also examined for comparison. These strains
also contained a single plasmid, but it was 4.5kb smaller. Inability to
transfer the MRHA gene obviously did not correlate with loss of a plasmid,
and the difference in molecular size of the plasmids suggested that the
MRHA-positive transconjugants possessed an additional piece of DNA. We had
previously found the MRHA gene to be carried on a transposable element in
certain uropathogenic strains (Hales & Amyes,1983) so, in order to
determine if this MRHA gene was carried on a transposon the R-plasmid Sa
was introduced into 8 of the MRHA-positive transconjugants to allow its
transposition into a known plasmid vector, which was then transferred to
E.coli K12 strain J53. The adhesive nature of the Sa-containing J53
transconjugants was then determined with the haemagglutination assay.
Plasmid DNA from the resultant MRHA-positive strains was purified and
examined as before. A molecular size of 35.2kb was obtained for the
standard Sa compared to 44.4kb calculated for the plasmids in the MRHA-
positive J53 strains. This gives a more accurate estimate of the size of
the insertion as 9.2kb.
We wish to thank the Scottish Home and Health Department for the grant
which funded this research.
Amyes SGB, McMillan CJ & Drysdale JL. (1981). In: New trends in
antibiotics : research and therapy. GG Grassi, LD Sabath (Eds). Amsterdam:
Elsevier, pp325-327.
Hales BA & Amyes SGB. (1983). The genetic carrier of bacterial attachment.
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The effect of a range of antimicrobial Drugs on the haemagglutination of two
clinical isolates from urinary tract infections
Barbara A. Hales and S. G. B. Amyes
Department ofBacteriology, The Medical School. University ofEdinburgh, Teviot Place, Edinburgh
EH8 9AG, Scotland
A range of nine common antimicrobial drugs were tested for their effect on adhesion
of the mannose-resistant haemagglutination-positive Proteus vulgaris strain BH77
and Escherichia coli strain BH121, isolated from patients with urinary tract infec¬
tions. Minimum inhibitory concentrations of the antimicrobials for these strains were
determined in Mueller-Hinton broth and the effect of each antimicrobial, at the
quarter MIC values, on the Haemagglutination of the strains was then determined.
Hacmagglutination could only be prevented by inhibitors of protein synthesis. After
the introduction of an R-plasmid into strain BH 121 this effect was annihilated. When
the new MICs were determined, the inhibition was still observed at the new quarter
MIC values.
Introduction
Bacterial adhesion to the mucosal surface of the urinary tract is considered to be an
important first step in the bacteria-host interactions which give rise to infection
(Svanborg-Eden el «/., 1981). The fimbriae responsible for this attachment aid the
migration of pathogenic organisms, originating from the faeces, up into the urinary tract
to the bladder and on to the kidneys.
These infections, in most cases, arc treated with antibiotics at a concentration that will
eliminate the causative agent from the host by killing it or rendering it more susceptible
to host defence mechanisms (Beachey, Eisenstein & Ofek, 1981). It has been known for
some time that antibiotics at sub-inhibitory concentrations, as well as stimulating
phagocytosis (Alexander & Good, 1968), can also inhibit the production of bacterial
virulence factors in vitro (Lorian et al., 1978).
In this study nine common antimicrobial drugs, at sub-inhibitory levels, were tested
for their effect on haemagglutination when added during either resting or growing
phase. These drugs comprised inhibitors of protein, DNA, peptidoglycan and folic acid
synthesis.
Methods
Two clinical strains—Proteus vulgaris (BH77) and Escherichia coli (BH121), isolated
from different patients with urinary tract infections at the City Hospital, Edinburgh,
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Table I. Minimum inhibitory concentrations (mg/1) for bacterial strains
Bacterial Minimum inhibitory concentration (mg/1)
strain Ap Cm Ka ND Sm Sp Sx Tc Tp
Pr. vulgaris (BH77) >500 8 32 nd >32 125 500 8 16
E. coli (BH 121) 8 2 8 2 >500 125 >500 2 01
BHI34 > 5000 2 >500 2 >500 125 >500 125 01
BH 135 8 500 125 2 >500 500 >500 125 01
Ap, Ampicillin; Cm, chloramphenicol; K.a, kanamycin; NA, nalidixic acid; Sm, streptomycin; Sp,
spectinomycin; Sx, sulphamethoxazole; Tc, tetracycline; Tp, trimethoprim.
were studied. Both these strains expressed mannose-resistant hacmagglutinating
(MRHA) fimbriae. Two derivatives of the E. coli strain BHI21 were also used. Strain
BH134 possessed R-plasmid RP4 (Ap, Tc, Ka)* and strain BH135 possessed R-plasmid
Sa (Cm, Ka, Sm, Su, Sp). Minimum inhibitory concentrations (MIC) were determined
in the presence of doubling dilutions of antimicrobial drug in Mueller-Hinton broth
(Difco, Detroit, U.S.A.) after incubation for 18 h at 37°C. The end point was designated
as the lowest concentration of drug which inhibited visible bacterial growth.
Adhesive ability of the bacteria was assayed by a modification of the haemaggluti-
nation method of Svanborg-Eden & Hansson (1978). The organisms were cultured in
Mueller-Hinton broth and the agglutination assayed with human group A erythrocytes.
The effects of the drugs on haemagglutination were determined by two methods: (a) the
organism was grown in Mueller-Hinton broth in the presence of a quarter the MIC of
the antimicrobial for 48 h at 37°C (for those strains with MIC values given as >x (Table
I), x is the concentration taken as the quarter MIC), (b) the organism was grown in the
absence of drug, which was then added at a quarter the MIC during stationary phase,
these cultures were then incubated for a further 3 h at 37°C. Haemagglutinating ability
was then determined and related to an untreated control.
Results
The MICs of the antimicrobial drugs for each strain tested is shown in Table I.
The haemagglutination results obtained for the two clinical strains differed consider¬
ably (Table II). There was little observed effect on the adhesion of Pr. vulgaris except for
the reductions in haemagglutinating ability after growth in the presence of sulpha¬
methoxazole, streptomycin and tetracycline. There was also slight reductions when
strain BH77 was grown in the presence of kanamycin and trimethoprim. Spectinomycin
and tetracycline caused complete inhibition of haemagglutination when they were added
during stationary phase, these were the only antimicrobials to produce a significant
effect.
After growth in the presence of chloramphenicol, kanamycim, streptomycin, spectino¬
mycin and tetracycline complete inhibition of E. coli strain BH121 adhesion was
observed. Addition of these drugs during stationary phase had little or no effect on
adhesion. Growth of the strain in the presence of trimethoprim and sulphamethoxazole
•Abbreviations see Table I.
Antibiotic inhibition of adhesion 3
Table II. Effect of antimicrobial drugs on haemagglutinating ability at one quarter the minimum
inhibitory concentration
Haemagglutination titre (1/bacterial dilution)
Pr. vulgaris E. coli
Drug Growth in Stat, phase Growth in Stat, phase
None 64 64 4 4
Ap 64 32 4 4
Cm 64 32 CI 2
Ka 8 64 CI 2
NA nd nd 8 4
Sm 1 32 CI 2
Sp 32 CI CI 2
Sx 1 64 1 2
Tc 1 CI CI 4
Tp 8 64 1 4
nd, not determined; CI, complete inhibition.
produced reductions in haemagglutinating ability, but again little effect was observed
with their addition during the stationary phase. Ampicillin produced no significant
effect on adhesion under either set of conditions. Nalidixic acid had no effect on
adhesion when added during stationary phase, but growth in its presence increased
haemagglutinating ability.
The presence of either R-plasmid RP4 or Sa in strain BH121 annihilated the effect the
relevant antimicrobials had on adhesion at the previous concentrations, but when the
MICs were redetermined and the assay repeated at the new quarter MIC values complete
inhibition of adhesion was still seen with kanamycin, chloramphenicol nd tetracycline.
Growth in the presence of ampicillin again had no effect.
Discussion
Antimicrobials which inhibit protein synthesis such as chloramphenicol, kanamycin,
streptomycin, spectinomycin and tetracycline also inhibit the adhesive ability of E. coli,
if they are present during growth, indicating that the adhesive surface fimbriae are
proteinaceous and produced during growth. Addition of these drugs during stationary
phase has little effect on adhesion, therefore they can have no effect on existing fimbriae,
but can prevent their production.
Inhibitors of peptidoglycan synthesis have no significant effect on adhesion, so
abnormalities in the cell wall cannot prevent the presence and anchoring of the fimbriae.
Nalidixic acid which inhibits DNA gyrase increases the adhesion, an observation which
has been previously reported (Vosbeck et al., 1982). Some effect on the bacterial
adhesion was seen when folic acid synthesis was inhibited with trimethoprim or sulpha-
methoxazole and this is probably due to the subsequent effect that trimethoprim has on
the prevention of protein synthesis (Amyes & Smith, 1974). It would therefore seem that
the greatest effect is at the DNA translation stage. The same effect on adhesion is
observed if the strain possesses an R-plasmid as long as the concentration of the drug is
still at quarter-MIC level. These results contrast wtih the effect of sublimiting concen-
4 B. A. Hales et al.
trations of streptomycin, in streptomycin resistant strains, showing mannose-sensitive
attachment (Ofek et al., 1979). Unlike the results presented here, these workers showed
the presence of the antibiotic at the quarter MIC value in the chromosomal mutant had
no effect.
The fimbriae of Pr. vulgaris are affected by a totally different set of conditions and
complete inhibition can only be produced if spectinomycin or tetracycline are added
during stationary phase, suggesting a different mechanism of production and expression.
Savoia et al. (1983) have shown that sublimiting concentrations of piperacillin and
sagamycin affected haemagglutination ability when Proteus species were grown in their
presence. Our results demonstrate that this effect is not a universal response.
These in-vitro effects could be considered to be of some use in the clinical situation, if
the MICs of the infecting agents were determined first. However, the possibility that con¬
centrations of drugs below the MIC might induce the development of resistance more
rapidly and allow amplification of any R-plasmids present in the bacteria (Wiedemann,
1981) may well override this advantage.
Acknowledgements
We wish to thank the Biomedical Research Committee of the Scottish Home and Health
Department for grant K/MRS/50/492 which funded this project.
References
Alexander, J. W. & Good, R. A. (1968). Effect of antibiotics on the bacteriocidal activity of human
leukocytes. Journal ofLaboratory andClinical Medicine, 71, 971-83.
Amyes, S. G. B. & Smith, J. T. (1974). Trimethoprim action and its analogy with thymine
starvation. Antimicrobial Agents and Chemotherapy, 5, 169-78.
Beachey, E. H., Eisenstein, B. I. & Ofek, I. (1981). Sub-lethal concentrations of antibiotics and
bacterial adhesion. Ciba Foundation Symposium 80,288-301.
Lorian, V., Koike, M., Zak, O., Zanon, V., Sabath, L. D., Grassi, G. G. & Stille, W. (1978).
Effects of sub-inhibitory concentrations of antibiotics on bacteria. In Current Chemotherapy,
Vol. 1, (Siegenthaler, W. & Luthy, R., Eds), pp. 72-8. American Society for Microbiology,
Washington D.C.
Ofek, I., Beachey, E. H., Eisenstein, B. I., Alkan, M. I. & Sharon, N. (1979). Suppression of
bacterial adherence by subminimal inhibitory concentrations of^-lactam and aminoglycoside
antibiotics. Reviews ofInfectious Diseases 1, 832-7.
Savoia, D., Martinetto, P., Achino, A. & Pugliese, A. (1983). Adhesion of Proteus species to
various cell types. European Journal ofClinical Microbiology 2, 571-6.
Svanborg-Eden, C., Hagberg, L., Hanson, A., Korhonen, T., Leffler, H. & Oiling, S. (1981).
Adhesion of Escherichia coli in urinary tract infection. Ciba Foundation Symposium 80,
161-87.
Svanborg-Eden, C. & Hansson, H. A. (1978). Escherichia coli pili as possible mediators of attach¬
ment to human urinary tract epithelial cells. Infection and Immunity 21, 229-37.
Vosbeck, K., Mett, H., Huber, U., Bohn, J. & Petignat, M. (1982). Effects of low concentrations of
antibiotics on Escherichia coli adhesion. Antimicrobial Agents and Chemotherapy 21, 864-9.
Wiedemann, B. (1981). Development of bacterial resistance to antibiotics. In New Trends in
Antibiotics: Research and Therapy (Grassi, G. G. & Sabath, L. D., Eds), pp. 179-202.
Elsevier/North Holland. Biomedical Press.
(Manuscript accepted 17 April 1985)
